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Background: Men who have sex with men (MSM) remain the group most heavily affected by HIV 
in the United States (US), with MSM of color further disproportionately represented. In July 2012, 
the US Food and Drug Administration (FDA) approved the use of tenofovir disoproxil fumarate plus 
emtricitabine (TDF-FTC, Truvada) for use as pre-exposure prophylaxis (PrEP) in HIV-negative adults 
who are at high-risk of HIV infection. Despite its effectiveness, PrEP prescriptions are reaching only 
a small proportion of those who could benefit from the drug and prescription rates vary both by 
race and geographic region. The goal of this dissertation was to explore the complex relationship 
among multilevel predictors of PrEP use in a geographically diverse sample of MSM in the US.   
 
Methods: Data from a cross-sectional survey of MSM residing in all 50 US states was used to test 
a series of hypotheses regarding PrEP use.  Using the framework of the social-ecological model 
and multi-level logistic and linear regression we explored if (a) variables at the individual- (i.e. 
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demographics, identity), social- (MP factors and social behaviors), and state-levels (state equality, 
HIV prevalence, socio-economic factors) influenced the outcome (Aim 1 and 2: PrEP use and Aim 
3: Patient Trust in Physician) among MSM with a focus on the equality of the state (LBGTQ+ and 
racial equality); we further extended this hypothesis to examine if our state equality measures 
modified the association between individual identity-level variables (sexual and racial/ethnic 
identity) and our outcome (PrEP use or PTP scores), and (b) if the association between state-level 
(LGBTQ+ and racial equality) and individual-level (sexual and race/ethnic identity) variables and 
PrEP use was mediated through patient trust in physician (PTP).  We examined these hypotheses 
among all participants, and then conducted a sub-analysis looking at the first hypothesis, among 
only MSM of color, as this group currently has the highest HIV incidence in the US and we felt 
warranted a closer look in an attempt to tease out reasons for this high risk.  
 
Results: Aim 1 included 4,165 HIV-negative MSM of whom 13.4% (N = 560) were taking PrEP at 
the time of the survey. In Aim 2, there were 1,465 HIV-negative MSM of color, of whom 13.6% (N 
= 199) were taking PrEP. In the analyses for both aims, we found that age, several main partner 
(MP) factors, number of sexual partners, STI history, and the LGBTQ+ equality of the state where 
the participant resides were all significantly associated with higher odds of using PrEP, while sexual 
identity and other main partner (MP) factors were associated with lower use. In aim 1 alone, higher 
education and a mid-level HIV prevalence were also associated with higher PrEP use. Lastly, only 
in aim 2, race/ethnicity was shown to be associated with PrEP use, with Hispanic and Asian MSM 




In aim 3, of the 2,750 HIV-negative participants who reported having a primary care provider, 
there were several individual- and social-level factors associated with PTP scores. Geographic 
region, sexual identity, and individual drug use were shown to be associated with lower PTP scores, 
while participants who reported PrEP use were shown to have higher PTP scores. The interaction 
analysis suggested that racial/ethnic identity influenced PTP differently depending on the racism 
level at the state-level. After  stratifying on the racism/racial equality variable of the state, the 
results suggest, that with the exception of black participants, compared to whites, all other races 
had higher PTP scores in high racial equality states (less racism) than in low racial equality states 
(more racism). 
 
Conclusions: This is one of the first studies that explored several multi-level predictors of PrEP use, 
and given our large sample, it also offered a unique opportunity for us to examine the influence 
of state-level factors on PrEP use, as both a main effect and as an effect modifier. The results of 
our work suggests that individual-, social-, and state-level variables, specifically the LGBTQ+ 
equality of the state of residence, are associated with PrEP use. The findings of this study suggest 
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CHAPTER 1: INTRODUCTION 
 
BACKGROUND 
The aim of this dissertation was to explore the relationship among multilevel predictors of 
Pre-Exposure Prophylaxis (PrEP) use among men who have sex with men (MSM) in the United 
States (US), who continue to be disproportionately affected by HIV. Using the social ecological 
model (SEM) as a backdrop, we aimed to contextualize how factors working at and interacting 
across multiple levels of organization may explain why some groups are more likely to use PrEP 
than other groups.  PrEP is one of the newest HIV prevention tools, but for it to be effective, those 
at highest risk need to understand the benefits of the medication and use it as prescribed. 
HIV and MSM 
The incidence of HIV in the US is approximately 50,000 cases per year, with MSM 
disproportionately affected.1 The Centers for Disease Control and Prevention (CDC) estimated that 
in 2017, MSM represented about four percent of the male population,2 yet accounted for 
approximately 70% (27,000) of the 38,739 new HIV diagnoses in the United States (US), with 1 in 
6 unaware that they were infected.1  
Biological, behavioral, and structural factors make the dynamics of the epidemic in the US 
complex.3 Most studies exploring associations with HIV among MSM have largely focused on 
individual-level factors, with many of those studies showing that individual-level factors alone are 
insufficient in the explanation of high transmission in this population.4 Individual- (race, age, SES, 
behavioral factors), social- (partner characteristics for both main and casual partner, provider care 
relationships), and structural- (state policies, access to health care, equality issues) level factors 
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have been shown to be associated with risk of HIV infection.3 MSM have the additional burden of 
homophobia, stigma and discrimination solely related to their sexual identity, which may further 
increase their risk of HIV acquisition.5-7 Stigma and homophobia have been shown to be negatively 
associated with the physical and mental health of MSM, affecting their overall health and their 
capacity to seek and access healthcare services as well as potentially shape the quality of the 
services that they receive (i.e. type or quality of primary care providers).7-9  However, individual-
level identity, sexual and race/ethnic identity, may influence how MSM react to stigma and 
discrimination in their efforts to prevent HIV through mechanisms such as PrEP uptake. 
HIV and MSM of Color 
MSM of color are the most impacted by HIV, and differences in acquisition among MSM 
by race has varied, and in some groups increased over time.10 From 2005 to 2014, HIV diagnoses 
in white MSM declined 18% overall, whereas among Hispanic/Latino and African American MSM, 
diagnoses rose by 24% and 22% respectively.10 Among young African American MSM (13-24 year 
of age) the increase in HIV diagnosis was 87% during this period.10 MSM of color likely identify with 
multiple minority identities (sexual and race/ethnicity) and their experiences may differ from that 
of those with no or only a single minority identity (e.g. heterosexual ethnic minorities or white 
LGBT individuals).11 Research has described that there may be a greater impact on one’s health 
behavior of having multiple minority identities than the sum of the impact of each identity 
alone.12,13 Compared to white MSM, these differences may influence the way MSM of color reveal 
their sexual identity to family and friends as well as healthcare providers, the nature of their 
relationships, and how they access HIV-related care.14 Homophobia and same-sex 
stigma/discrimination (both internal and external) have been said to be a contributing factor in an 
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individual’s decision to disclose and previous research has found that MSM of color are less likely 
than white MSM to identify as gay or disclose same-sex behaviors to others.15 MSM who do not 
identify as gay may not be as connected to the LGBTQ+ community, where HIV prevention may 
occur. Moreover, providers who often rely on a patient’s self-reported sexual identity may not 
accurately assess the risk for STDs and HIV of a non-disclosing patient. Examining MSM of color 
and how their intersecting identities are impacted by both racial and sexual minority 
discrimination, especially in the places where they reside, may be crucial to understanding their 
HIV-risk and protective behaviors, including prevention interventions such as PrEP use.  
PrEP and MSM 
In July 2012, the US Food and Drug Administration (FDA) approved the use of tenofovir 
disoproxil fumarate plus emtricitabine (TDF-FTC, Truvada) for use as pre-exposure prophylaxis 
(PrEP) in HIV-negative adults who are at high-risk of HIV infection.16 While PrEP has been found 
effective in preventing HIV infection, its impact on the epidemic is contingent on uptake among 
those at highest risk.  The CDC guidelines recommend that PrEP be offered to people who are HIV-
negative and at substantial risk for HIV.17 Specifically for MSM, the CDC recommends PrEP use for 
those not in a mutually monogamous relationship with a partner who recently tested HIV-
negative, those who are a gay or bisexual man and who have had anal sex without a condom or 
been diagnosed with a sexually transmitted infection (STI) in the past 6 month and/or who are in 
a HIV-discordant relationship.17  Initial reports regarding PrEP suggest that knowledge of PrEP as 
a form of prevention has been limited and the uptake of the drug was initially slow.18-21 A report 
by Gilead Sciences (Truvada’s manufacturer), found that, in the US between January 2012 and 
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September 2016, almost 100,000 people started taking PrEP.22 Based on filled prescriptions for 
PrEP, the majority of those taking the drug were Caucasian (74%) 23 and men (87%).21,24  
Geographically, four states (CA, NY, TX, FL) account for 50.5% of PrEP initiations, with New 
York (15.9%) and California (16.7%) accounting for the majority, 24 despite the fact that both Texas 
and Florida have higher numbers of new HIV diagnoses.25 Overall, the data suggests that while the 
use of PrEP is increasing in the US, uptake is not proportionally aligned with the groups or the 
geographic regions where HIV incidence is highest.23,24  
Provider challenges 
Although increased healthcare access may enhance PrEP uptake, there are still structural 
challenges to PrEP use even for those who have access to healthcare. Some studies have shown 
issues with provider knowledge of PrEP, while others have focused on the concerns of a provider’s 
willingness to prescribe PrEP as a prevention tool,26,27 with the willingness of provision often 
varying by race.28 Furthermore, there have been contradictory views about which types of 
providers should prescribe PrEP, a condition coined the “purview paradox.” This event occurs 
when infectious disease specialists believe that primary care providers are more likely to have 
contact with high risk HIV negative patients while primary care providers believe that anti-
retroviral prescription is in the purview of the infectious disease doctors and may not feel 
equipped to discuss sexual behavior.29-32 In any event, this ‘paradox’ leads to fewer providers 
informing about PrEP or providing it to patients. Although we believe concerns regarding 
behavioral disinhibition to be erroneous and inflated, providers have expressed this concern as 
well as concerns about patient adherence and challenges in identifying individuals who would 
benefit from the drug.26,31,33 Some providers feel it is only appropriate to prescribe PrEP to 
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serodiscordant couples,26,34 and although this is one  recommended group, partners of virally 
suppressed individuals may not be the group at highest risk.32,35 Moving forward, it is imperative 
that all doctors ask about sexual history and conduct regular HIV/ STI screening while providing 
sexual health information in an accurate and nonjudgmental manner.  
 
OVERVIEW AND GAPS IN THE LITERATURE 
In order to design effective PrEP programs, it is important to not only understand what 
predicts uptake but to also identify barriers to its use among the populations that need it the most. 
Previous PrEP studies have often focused on one ecological level or another (i.e. individual or 
community) or they have explored predictors on only one level (e.g., individual-level) while making 
recommendations on another (e.g., social-, or structural-level).36 Yet, similar to other behaviors 
related to disease prevention, it is likely that in addition to individual-level factors, social- and 
structural-level factors and the interactions within and between each level may also impact the 
use of PrEP.37 Moreover, some factors may be acting as effect modifiers or as mediators in the 
associations.  
Individual-level factors: In the literature, individual-level factors, including age 38-41, 
race/ethnicity 42-44 sexual behavior 42,45,46, and education 42,47, have been explored as predictors of 
PrEP acceptability. While some studies found these individual-level factors were associated with 
PrEP acceptability, the associations were not consistent across studies and no clear patterns 
regarding predictors of acceptability emerged. Similarly, a number of studies explored behavioral 
factors such as condomless sex 19,20,45, STI history 42,48 and high number of sexual partners 42,48 as 
predictors of PrEP acceptability, again not finding any clear pattern across studies. The 
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contradictions between studies could be attributed to the timing of when the study was conducted 
(i.e. pre-or post the release of the efficacy results),19 differences in the population sampled, or the 
impact of  higher-level contextual factors, such as regional differences in equality for sexual and 
other minority groups.49  
Social-level factors: In several HIV studies, an individual’s social network has been shown 
to influence health and health behaviors to reduce HIV risk behaviors among high-risk, hard-to-
reach populations, including MSM and MSM of color.50 A number of studies have looked at 
relationships between serodiscordant partners, yet there have been limited PrEP studies on MSM 
in seroconcordant negative relationships, with both casual or main partners.51 One study found 
no difference in the intent to use PrEP among MSM with a main partner compared to those 
without partners.52 Another study found that HIV-negative MSM reported an interest in taking 
PrEP to protect themselves from an HIV-positive primary partner, regardless of type of relationship 
(i.e. monogamous vs. open).53 Despite the increase in interest in PrEP, exploring partner 
relationships and the factors that may motivate a person to use PrEP is important, as intimate 
relationships may be a key determinant in the decision making.51 
Another social factor potentially associated with PrEP use is the doctor-patient 
relationship. PrEP requires a prescription, designating providers the gate keepers to PrEP access.  
A positive relationship between a doctor and a patient can reinforce a patient’s self-efficacy and 
motivate them to decrease risky behavior and increase protective behaviors.54 In a study exploring 
the experiences of MSM with healthcare, participants reported that they separate their sexual 
healthcare from their primary healthcare due to distrust of providers, fear of judgment and/or 
embarrassment.55-57 Any reluctance to disclose sexual identity or discuss sexual behaviors with 
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PCP may discourage and delay care.56,58,59 What is more, the relationship between a doctor and a 
patient may also be influenced by structural-level factors, including a state where a person resides.  
MSM of color may be particularly distrustful given the history in the US, studies including the 
Tuskegee experiments and other harms of black patients by health professionals. These 
maltreatments have come to symbolize ethical misconduct and could be contributors to the 
mistrust and the disparities in healthcare provision we see today as well as explain why MSM of 
color have higher rates of HIV as they are less likely to be provided PrEP.60,61 
Structural-level Factors: Environmental and structural-level factors can impact PrEP use 
through a number of mechanisms, including the HIV prevalence of a location, income, healthcare 
accessibility, and through legislation that discourages equality (i.e. homophobia, racism and 
stigma). Inequality may impact individual health seeking behavior 62 as well as other social-level 
factors, such as access to appropriate healthcare.52  The impact of these structural-level factors 
may be direct and/or indirect and mediated or modified through secondary factors, such as 
individual- and social-level factors including relationships with healthcare providers. 
Understanding the potential impact state policies and environments have on patient-provider 
relationships may help us understand decisions to use PrEP.  Furthermore, the relationship 
between a doctor and a patient may be influenced by the geographic region, such as the state one 
practices/lives in, and the culture and policies of that region. One study found that distrust in 
physicians in the US varied by race/ethnicity, with minorities having a higher distrust of physicians 




Additional state-level factors, including HIV prevalence, income, health care access, and 
cost, are potentially associated with PrEP use and can vary by state. The prevalence of HIV in a 
state is a risk factor for HIV transmission as it impacts the likelihood of exposure,10 and this may 
impact risk perception and therefore PrEP uptake.  In the US, the burden of HIV is not dispersed 
evenly across states/regions nor racially/ethnically. In most areas, HIV is concentrated in urban 
areas. However, in Southern states, which account for approximately 44% of all people living with 
HIV, diagnosis is higher in smaller metropolitan and nonmetropolitan areas.25 Blacks and Latinos 
disproportionately reside in the South and are significantly affected by HIV in that area.64,65  There 
are a number of factors likely influencing the high HIV prevalence in the Southern states, including 
socioeconomic factors such as income inequality, access to healthcare and generally poorer health 
outcomes.25,66   
Lack of healthcare access can prevent those infected with HIV from being diagnosed, and 
when diagnosed, from accessing treatment and controlling their viral load with medication and 
those at risk who are HIV-negative from receiving counseling and prescriptions for prevention care 
such as PrEP.  HIV-positive MSM of color have been are less likely to have access care, be on ARVs 
and to have an undetectable viral load than white MSM.67,68 This uncontrolled HIV in the sexual 
networks of MSM of color may be another reason for increased risk of acquisition. Furthermore, 
state policies may also have an impact on factors that influence HIV prevalence.66 The CDC reports 
that southern states have not widely accepted new HIV prevention advances (i.e. newer HIV 
testing kits) which could delay the detection of acute HIV diagnosis.66 Delaying diagnosis would 
subsequently delay the treatment and increases the likelihood of transmission to others. A high 
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HIV prevalence in a region may impact PrEP use by influencing an individual’s HIV risk perception, 
as well as influencing the healthcare provider’s opinion on the importance of prescribing the drug. 
Healthcare access and ability to pay for PrEP are likely a direct barrier to PrEP uptake.69  
People need to be able to see a healthcare provider, to obtain a prescription, and to pay the cost 
of the drug. The cost of the drug alone for those without insurance is approximately $17,000 per 
year, with additional fees for doctor visits and any ancillary services required.70 While there are 
PrEP assistance programs (both from the state and the pharmaceutical company) they often do 
not cover all costs. Some insurance plans, including Medicaid, provide coverage of PrEP.70 
Medicaid expansion at the state-level increased access to healthcare and lowered drug costs for 
many,71 however, not all states participated in the expansion. In 2015, 21 states had opted out of 
the ACA Medicaid expansion, potentially limiting the access and availability of PrEP in those 
states.71 Some of those states are where HIV incidence is at its highest, such as Georgia and Florida, 
opted out of the ACA Medicaid expansion.10,71 
Lastly, state-level equality policies toward sexual and racial minorities may impact PrEP use 
through their influence on minority stress. Minority stress has been shown to be associated with 
HIV risk behavior and health seeking behavior overall.72-74 In the US, there are 32 states without 
fully inclusive protections for sexual minorities,75 with over 50% of the LGBTQ+ population living 
in states with low to negative LGBTQ+ friendly policy scores.76 The systemic discrimination of 
LGBTQ+ groups can hinder a person’s motivation or even their ability to get tested for HIV, and 
prevent PLWHA from seeking the care and treatment needed to manage their disease and prevent 
transmission. State-level inequality may impact PrEP use directly, with the impact likely being 
greater on those with dual minority identities.  For example, racial inequality may differentially 
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impact racial minorities, while sexual minority inequality may act differently depending on the 
sexual identity of an individual. Individuals with both racial and sexual minority identities may be 
impacted even more than those with a single minority identity.  Thus, state-level equality policies 
may modify the association of individual-level factors, such as sexual and racial/ethnic identity, on 
PrEP use, underscoring the limitations and potentially severe consequences of considering 
individual-level interventions in isolation from larger systemic factors.  
 
OVERVIEW OF THE DISSERTATION 
Theoretical Framework – Social Ecological Model 
As suggested by the Social Ecological Model (SEM), the motivation, decisions, and 
behaviors regarding PrEP use are likely developed through socially structured interactions among 
the individual, their social network, and the environment within which they live.77 Individual-level 
factors are often shaped by broader structural factors and there has been increasing recognition 
of the importance of the social and structural drivers that may motivate someone to use a 
prevention intervention, such as PrEP.78 The social theory recognizes that although individuals are 
responsible for their own health, an individual’s ability to assume this responsibility may be 
influenced by factors on multiple levels. Using the SEM as a backdrop, this dissertation considered 
how factors working at and interacting across multiple levels of organization may explain 
predictors of why some groups are more likely to use PrEP than other groups.  Figure 1 illustrates 
how we applied the SEM to PrEP use and how it guided the statistical methodology (i.e. multi-level 
modeling) and subsequent analysis. 79 Using the SEM, we contextualized individuals’ behaviors 
using dimensions made up of the individual- (i.e. demographics and identity), the social- (i.e. 
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behaviors, persons trust in physician, partner factors), and environmental/structural-level (i.e. HIV 
prevalence, local, state policies or national statutes) to provide a framework for describing the 
impact of factors at different levels and their interactions between levels.50 The overlapping rings 
illustrate the porous nature between each level of organization, depicting how they may interact. 
Based on the literature and consistent with the SEM, we hypothesized that state-level 
characteristics may both be directly and indirectly (i.e. mediation) associated with the use of PrEP.  
The specific aims of  the dissertation were as follows: 
 
Aims 
Aim 1: Examine the predictors of PrEP use at the individual-(sexual identity, racial/ethnic identity, 
etc.) and state- (sexual minority equality measures, racism measure, income equality, HIV 
prevalence, etc.) levels 
• Sub aim 1a: Assess the extent to which variability in PrEP use by state is due to state- vs. 
individual-level factors. 
• Sub aim 1b: Examine the association of individual-level and state-level factors with PrEP 
use. 
• Sub aim 1c: Assess interaction among state-level sexual and racial discrimination/equality 
measures and individual-level sexual and racial/ethnic identity in predicting PrEP use. 
 
AIM 2: Examine the predictors of PrEP use at individual- and state-levels among only MSM of color 
• Sub aim 2a: Assess the extent to which variability in PrEP use by state is due to state- vs. 
individual-level factors.  
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• Sub aim 2b: Examine the association of individual-level and state-level factors with PrEP 
use. 
• Sub aim 2c: Assess interaction among sexual identity and state-level sexual minority 
equality in predicting PrEP use. 
 
AIM 3: Examine the relationship among individual- and state-level factors and patient trust in their 
physician (PTP) in predicting PrEP use 
• Sub aim 3a: Assess the extent to which variability in PTP by state is due to state vs 
individual-level factors. 
• Sub aim 3b: Examine the association of individual-level and state-level factors with PTP. 
• Sub aim 3c: Assess interaction among state-level sexual and racial discrimination/equality 
measures and individual-level sexual and racial/ethnic identity in predicting PTP 
• Sub aim 3d: Explore PTP as a mediator of the association between individual- and state-
level factors and PrEP use.  
To our knowledge, this is the first study looking at the complex inter-relationship among 
factors organized at multiple levels in predicting PrEP use. 
CONCLUSION 
A thorough exploration of the complicated relationship among the individual-, 
interpersonal-, and contextual-level factors and how they may impact PrEP use within the SEM 
framework may shed some light on the divergent findings in previous PrEP literature. 
Furthermore, the impact that effect modification or mediation may partially explain the 
inconsistencies in the predictors of PrEP studies seen in the literature and explain the suboptimal 
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uptake of PrEP. Understanding the multi-levels associated with PrEP use may provide vital 
information about the facilitators and barriers to PrEP use so that programs can effectively develop 
tailored interventions to address specific populations and ensure that we get the maximum benefit 
from this biomedical HIV prevention tool.  The aim of this dissertation was to explore the complex 
relationship among the described multilevel predictors of PrEP use in a geographically diverse 
sample of MSM in the US. Further aims were to identify direct predictors at the individual and 
state-level and to assess whether structural characteristics of state of residence, specifically sexual 
minority friendly policies and racism measures, modify the association between individual sexual 
and racial identity characteristic and PrEP use. Lastly, we wanted to examine whether some of the 
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CHAPTER 2: EXPLORATION OF THE COMPLEX RELATIONSHIP AMONG 
MULTILEVEL PREDICTORS OF PREP USE AMONG MEN WHO HAVE SEX 




Background: Men who have sex with men (MSM) continue to be disproportionately affected by 
HIV, however, there is wide variation in HIV incidence in the United States (US). More than half of 
new cases occur in MSM of color and in MSM who reside in the southern states.  Despite increasing 
awareness, pre-exposure prophylaxis (PrEP) use remains low in the US. Studies have explored 
associations of individual level factors and PrEP use with inconsistent results. However, there has 
been less work evaluating higher-level predictors, such as contextual factors (HIV prevalence, 
racial/ethnic and sexual minority equality policies), nor has cross-level interaction been explored 
as a possible explanation for the contradictory results. 
Methods: Between May 2015-March 2016, a cross-sectional survey was conducted among a 
geographically-diverse sample of 4,165 HIV-negative MSM. Participant survey data was linked to 
publicly-available state-level data based on participant’s residential zip code. Guided by the social-
ecological model, multivariable multilevel logistic regression was used to explore the association 
of individual-(demographics/behavioral), social-(main partner [MP]), and contextual-(state level 
LBGT and racial inequality, HIV prevalence, poverty and insurance coverage) level factors and PrEP 
use. 
Results: Overall, 13.4% of participants were taking PrEP at time of study. Participants who did not 
self-identify as gay had lower odds of PrEP use ([OR=0.489,CI(0.356, 0.672)]. Those with a MP who 
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was HIV-positive [OR=4.5,CI(2.880,6.886)] or taking PrEP [OR=16.5,CI(9.670,28.205)] had higher 
odds, while participants with HIV-negative MPs not on PrEP [OR=0.5,CI(0.350 0.623) or of 
unknown HIV-status [OR=0.3,CI(0.191,0.620)] had lower odds of PrEP use compared to those 
without a MP. Participants residing in states with higher LGBTQ equality score had higher odds of 
taking PrEP [OR=1.6,CI(1.134,2.215)]. No cross-level interaction was seen.    
Conclusions: The LGBTQ equality of a state may be a marker for a more progressive environment 
implying that states with more inequality may have structural barriers specific to LGBTQ 
populations. Moreover, individual level variables, such as MP social relationships, may be a point 













Men who have sex with men (MSM) accounted for approximately 2–3% of the United 
States (US) population in 2016,  but accounted for 67% (26,844) of the 40,324 new HIV diagnoses.1 
In July 2012, the US Food and Drug Administration (FDA) approved the use of tenofovir disoproxil 
fumarate plus emtricitabine (TDF-FTC, Truvada) for use as pre-exposure prophylaxis (PrEP) in HIV-
negative adults who are at high-risk of HIV infection.2 Although PrEP effectively prevents HIV 
infection, its impact on the epidemic is contingent on uptake among those at highest risk.  
 
Despite the availability of PrEP, knowledge of it as a form of prevention has been limited, 
and uptake has been low and unequally distributed by population subgroups and geographic 
region.3-7 The majority of PrEP users in the US are male (95.3%), white (68.7%) and from the 
Western part of the US (29.7%).8 However, in 2016, African-American (10,226; 38%) and Latino 
(7,689; 29%) MSM accounted for the majority (67%)9 of all new HIV diagnoses, and the Southern 
US states experienced the greatest burden of HIV incidence, illness, and deaths compared to other 
US regions.10,11 In fact, from 2008 to 2013, nine southern US states have had the highest HIV and 
AIDS diagnosis rates in the country.10,12     
A number of individual-level factors, including age,13,14 race/ethnicity,15-18 sexual 
behavior,13,17,19 and education14,19 have been found to be associated with PrEP use, however, the 
associations were inconsistent across studies and no clear patterns emerged. The contradictions 
between studies could be due to the impact of  higher-level contextual factors working as 
confounders or modifiers of the individual-level associations.20 Few studies have looked at equality 
of the state and its association with PrEP use. One study explored structural stigma of states in the 
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US, which included an LGBTQ inequality variable in their composite score. This study reported that 
state-level LGBTQ structural stigma does impact HIV prevention efforts, including PrEP use, citing 
that individuals living in states with lower levels of structural stigma were associated with 
increased odd of having heard and of having used PrEP.21  
The Social Ecological Model (SEM) suggests that health behavior is influenced by social 
interactions between individuals, their social networks, and their environment.22 While individual-
level factors like demographics may impact health seeking behaviors, the impact of these 
individual-level predictors could be context specific and may function differently depending on 
environmental factors. Thus, it is possible that the impact of individual-level factors may vary by 
region in terms of stigma and discrimination against sexual and racial/ethnic minorities, income, 
and healthcare access. Examining the factors that influence PrEP use at both the individual- and 
state-level, may help explain why uptake is still lagging among those at highest risk. Insight into 
the reasons for low PrEP uptake is urgently needed in order to direct resources toward the 
populations where PrEP use could have the greatest impact on reducing HIV incidence. 
The aim of this study is to explore the complex relationship among individual- 
(demographics), social- (partner characteristics), and contextual- (characteristics of state of 
residence) level factors of PrEP use and to assess interaction among selected state-level and 
individual-level factors. Few studies have explored the relationship between both the LGBTQ and 
the racial equality of the state and PrEP use among MSM and to our knowledge no studies have 
explored interactions between multi-level predictors. To address this gap we examined the 
complex inter-relationship among factors organized at multiple levels to explore PrEP use with a 






Dataset, study population, and data collection 
The data for these analyses come from a cross-sectional survey of a geographically-diverse 
sample of MSM in the US that was conducted from May 2015 to March 2016.  The study methods 
have been described elsewhere,23 but the design is briefly presented here.  Participants were 
eligible for participation in the survey if they were age 18 years or older, cisgender male, and 
reported sex with other men in the past 5 years. For this analysis, participants who identified as 
HIV-positive were excluded as they would not be eligible for PrEP use.  
Participants were recruited in a number of different ways. (1) Online via a sexual 
networking website, where a banner was hosted advertising the survey for 30 days; (2) Online via 
various internet gay porn sites, where the same banner was used for a period of 39 days;  (3) 
Mobile devices via a geo-social sexual networking app popular with men-for-men connections, 
where we had a pop-up message that was displayed to participants when they opened the app for 
the first time during a given 12-hour window; (4) Online via a social networking site popular with 
the general public (not primarily oriented toward MSM or about facilitating sexual relationships), 
where we ran an advertisement for 11 days; (5) street intercept outside of locations in New York 
City frequented by MSM, (6) invitation to participants in a an ongoing panel study of 1,071 HIV-
negative MSM identified by a marketing firm.  All participants completed a brief self-administered 
survey of approximately twenty minutes. Those recruited via street intercept completed the 
survey on an iPad equipped with Computer-Assisted Self-Interview (CASI) software, and all others 
did so online via a personal computer or phone app. The survey included questions about 
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demographic characteristics, including zip code of residence, HIV risk/protective behaviors, 
partner characteristics (e.g. main/casual, HIV status, PrEP use, etc.) as well as participant’s use of 
PrEP. 
Measures 
Outcome Variable  
The outcome for these analyses was self-reported, current PrEP use at time of survey and 
was determined using responses to the question: “What is your HIV status?“ Response options 
were: (1) HIV-positive and undetectable,  (2) HIV-positive, but detectable, (3) HIV-negative, on 
PrEP, (4) HIV-negative, not on PrEP, (5) Don’t know/unsure. Participants who reported they were 
HIV-positive were excluded. Participants who reported don’t know/unsure of HIV status were 
counted as HIV-negative for the purpose of this analysis. The outcome was categorized as on PrEP 
versus not on PrEP. 
Predictor variables- Individual-level factors included demographic and HIV-related behavior 
Participant age was self-reported and was examined both as a continuous and a categorical 
variable (18-29, 30-39, 40-49 and 50+ years), with categories based on the distribution of the data 
to ensure sufficient frequencies in each category. Race and ethnicity were categorized into 5 
distinct groups (Hispanic, non-Hispanic Black, non-Hispanic White, non-Hispanic Asian and other). 
The ‘other’ category included American Indian, Alaska Native, Native Hawaiian, Pacific Islander and 
other and was collapsed due to the small sample sizes in each of these groups. Level of education 
was categorized into 3 categories (High school diploma, GED or less; some college, currently 
enrolled in college and/or associates degree; 4-year college degree or more). Sexual identity was 
examined as four categories in the descriptive analysis (gay, bisexual, heterosexual and other) and 
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due to the low numbers within the heterosexual and other groups the variable was collapsed into 
an indicator for gay identity versus did not identity as gay for the regression analysis.   
Participants were asked about the number of sex partners they had had in the last 3 
months, which was categorized into 4 groups (0 partners, 1 partner, 2-5 partners and >5 partners) 
based on the distribution of the data. Participants were provided with a list of sexually transmitted 
infections (STIs) and asked to indicate which infections they had been diagnosed within the last six 
months. The variable was collapsed into an indicator for having been diagnosed with any STI in the 
past six months.  Similarly for drug use, participants were provided with a list of recreational drugs 
(including non-prescribed and prescription drugs) and asked which they had used them in the past 
six months and then collapsed into an indicator for any drug use. 
Social Factors related to a Main Partner - All participants were asked if they had a main 
partner (MP) with whom they were in a committed relationship and if so, their knowledge of their 
main partner's HIV and PrEP status. For these analyses we included a 5 category variable for main 
partner (MP) status with the following categories: (1) no MP, (2) MP is HIV+, (3) MP and I don't 
know their status, (4) MP and they are HIV-negative and on PrEP (5) MP and they are HIV-negative 
and not on PrEP.  
State-level Characteristics - All state-level measures of HIV prevalence, healthcare access, equality 
for sexual and racial/ethnic minorities, and state income were explored for the year 2015.  
State HIV prevalence was ascertained from the CDC annual HIV Surveillance Report among 
adults and adolescents and was categorized using the CDC ranking.24 Healthcare access was 
assessed based on the percent uninsured (via private or government insurance) in each state. Data 
was obtained from the Kaiser Family Foundation and modeled as a continuous variable. 25  
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The state Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) equality measure came 
from the Human Rights Campaign (HRC) state scorecard which is a report on statewide laws and 
policies that affect LGBTQ people and their families.26 The HRC categorizes these scores into four 
groups: 1) High Priority to Achieve Basic Equality, 2) Building Equality, 3) Solidifying Equality and 
4) Working Toward Innovative Equality. We dichotomized the variable into low (categories 1 and 
2) and high (categories 3 and 4) LGBTQ equality states. 
To asses state-level structural racism, a measure was used that ranks states by the 
proportion of the state’s non-black residents who regard blacks more negatively than the national 
median.27 Elmendorf and Spencer et al. created the variable using multilevel regression with post-
stratification, a statistical technique that has shown to yield estimates of state-level public opinion. 
Using  their results, each state was ranked from 1-50 with 1 representing the state with the highest 
proportion of nonblack residents who are ‘prejudiced overall’.27   
State-level poverty was defined using the US Census Bureau's American Community Survey 
Briefs for poverty in 2014 and 2015. The poverty rate measures the percentage of people whose 
household income fell below their state’s assigned poverty threshold. Poverty thresholds are 
assigned to individuals or families based on family size and composition.28  
Statistical analysis  
Descriptive statistics (means/standard deviations and percentages) were calculated to 
describe the individual-, social-, and state-level characteristics of the sample overall and stratified 
by PrEP use. To assess bivariate associations with PrEP use, chi-squared (Fishers exact when the 
expected cell count is <5) or Wilcoxon rank sum tests were used.   
28 
 
To examine the association of individual-, social- and state-level characteristics with PrEP 
use, we developed crude and multivariable logistic regression models with random intercepts to 
calculate odds ratios (ORs) and 95% confidence intervals (CIs) of interest.  The level-1 unit was the 
participant and the level-2 unit was the state.  
Pseudo intraclass correlation coefficients (ICC, or pseudo-ICC) and median odds ratios 
(MOR) were calculated in order to assess the extent that variability in PrEP use was due to state- 
vs. individual-level factors. Model 1 was an ‘empty’ model which assessed the extent that the 
variability in PrEP use was due to state- vs. individual- level factors (ICC and/or MOR).  Model 2 
included demographic characteristics (age, race, education, sexual identity), Model 3 included 
social factors (number of partners, STIs, main partner’s status). Models 2-3 allowed for the 
assessment of the impact of the set of individual-level factors on PrEP use. Model 4, included all 
state-level characteristics to examine the association of state-level characteristics with PrEP use. 
Model 5 was extended to include all variables into a final model.  
To explore whether the intersection of individual sexual and race/ethnic identity with 
state-level stigma shapes the use of PrEP, we examined whether there was interaction among 
state-level equality measures (LGBTQ and racial scores) and individual-level variables (sexual and 
racial/ethnic identity) in predicting PrEP use. The initial analysis explored a 4-way interaction with 
all four variables., all possible product terms, including all 2-way, 3-way and 4-way product terms 
for all possible combinations of the 4 variables were added to the adjusted model.29 This model 
was then compared to 3 other models: 1-the main effects model, 2- model with only all 2-way 
interactions and 3-the model with 2- and 3- way interactions. The nested models were evaluated 
using p-values at 0.10 level of the interaction terms and AIC values to identify the best fitting 
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model.30 Analyses were undertaken using SAS 9.4 with the GLIMMIX macros for binary outcomes 




Description of the sample overall  
There were 4,165 HIV-negative participants with 560 (13.4%) participants who reported 
taking PrEP at the time of the survey. More than one-third were between 18-29 years old (35.1%) 
with the average age being 38.3 years old. More than half of the participants were white (64.8%) 
and had a college degree or more (51.6%) and identified as gay (81.8%). The greatest percentage 
resided in the South (32.6%). (Table 1) 
Less than half (40.5%) of participants reported having a main partner. Of those with a main 
partner, 7.6% reported knowledge that their partner was HIV-positive and 6.4% reported 
knowledge that their main partner was HIV-negative and taking PrEP. More than half of 
participants (64.3%) reported having more than two sexual partners in the past three months and 
using drugs in the last three months (69.4%). Over 15% of the participants reported having been 
diagnosed with an STI within the last six months. (Table 1) 
More than half of the participants lived in states in the two lowest LGBTQ equality 
categories (58.5%), in the lowest structural racism category (62.1%) and in the second to lowest 
HIV prevalence range (10.0-19.9%) (52.1%). Of the participants in the study, the mean percentage 




PrEP use was highest among those age 30-39 (16.6%) compared to 12.8% among those 
aged 18-29, 14.5% among 40-49, and 10.7% among those older than 50 years (p=<0.001). 
Participants residing in the Northeast (17.3%) were more likely to be taking PrEP as compared to 
those from the West (15.0%), South (11.2%), and the Midwest (10.8%) (p=<0.001). Participants 
who reported having a 4-year degree or more (17.2%) were more likely to be taking PrEP than 
participants who had some college or equivalent (9.9%) or a high school degree, GED or less (8.0%) 
(p=<0.001). Participants who identified as gay (14.7%) were more likely to use PrEP as compared 
to those who identified as bisexual, straight or other (8.0% vs 0.0% vs. 12.5% p=<0.001). 
Participants who had a MP who was currently taking PrEP (75.3%) were more likely to be taking 
PrEP than those who had a MP who was HIV-positive (40.3%), those with a MP who was HIV-
negative and not on PrEP (6.1%), those who had a MP with an unknown/uncertain HIV status 
(5.8%), and those who had no MP (14.2%,  p=<0.001). Of the participants who reported having 
more than 5 partners in last 6 months, 25.9% were taking PrEP compared to only 13.3% who had 
2-5 partners, 4.7% who only had 1 partner and those 3.2% with 0 partners (p=<0.001). Participants 
who used drugs in the last 3 months (15.1%) and those who had been diagnosed with an STI 
(32.7%) were more likely to take PrEP than their counterparts (9.6% and 11.0%, respectively, 
p=<0.001). Of the participants who resided in the states with the second highest LGBTQ equality, 
18.4% were taking PrEP compared to those who lived in the highest tiered equality states (16.4%) 
and those who lived in the two lowest equality states,10.6% and 10.7%, respectively, (p=<0.001). 
Lastly, those who lived in the state with the highest HIV prevalence (20.3%) were more likely to be 




Multilevel mixed effects model with random effects  
Table 2 shows the assessment of variance for each model. Model 1 (empty model/pseudo-
ICC), suggests that 2.4% of the total variance in PrEP use is due to between state differences 
whereas 97.6% is explained by individual differences. Models 2 (individual level variables) and 4 
(state level variables) suggest  that, after adjusting for these respective variables, less than 1% of 
variance is due to differences in characteristics between the states while the remaining is due to 
unmeasured differences between individual- and state -level characteristics. In contrast, model 3, 
which explored social and behavioral characteristics of the individual, showed the greatest 
variation. Model 3 suggests that 1.8% of the residual variation in PrEP use that persists is due to 
the systematic differences between states while 98.2% is due to individual differences. There is no 
ICC nor MOR for Model 5 (full model), as expected, there was not enough variation in the response 
to attribute any variation to state or individual  effects, controlling for everything else in the 
model.31  
Crude logistic regression model results 
In the univariate models, the odds of taking PrEP among those 30-39 years old were 
significantly higher than among those 18-29 [OR=1.33, CI(1.053, 1.685)]. Education was positively-
associated with PrEP use in a dose response pattern, although the association was significant only 
for those with a 4-year degree or more compared to high school diploma, GED or less [OR=2.31, 
CI(1.640, 3.242)]. (Table 3) 
Participants who had an HIV-positive MP [OR=4.63, CI(3.025, 7.085)] or who’s MP was 
taking PrEP [OR=16.30, CI(9.648, 27.525)] had significantly higher odds of PrEP use while 
participants with a MP whose HIV status was unknown [OR=0.36, CI(0.208, 0.633)] or whose MP 
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was HIV-negative but not taking PrEP [OR=0.40, CI(0.305, 0.516)] had significantly lower odds of 
PrEP use compared to those who did not have a MP. PrEP use was positively associated with 
number of partners in the past three months, [2-5 partners (OR=3.51, CI(2.260,5.456)] and had >5 
partners (OR=7.90 CI5.113, 1.196, versus no partners)]. Similarly, participants who reported drug 
use in the last three months [OR=1.64, CI(1.314, 2.037)] or had been diagnosed with an STI in the 
last six months [OR=3.97, CI(3.193, 4.935)] had a higher odds of PrEP use. (Table 3) 
Participants who lived in a state with more LGBTQ equality [OR=1.71, CI(1.372, 2.139)] and 
lived in the states with the highest HIV-prevalence [OR=2.00, CI(1.120, 3.558)] had significantly 
higher odds of taking PrEP than those who lived in state with less equality or had an HIV prevalence 
less than 10.0%, respectively. (Table 3) 
Multivariate logistic regression models results 
Table 3 displays five models with covariate-adjusted multilevel logistic regression results 
(OR’s and 95% CI’s) for individual-, social-, and/or state- level predictors of PrEP use. In model 2 
(Table 3, column 3), the adjusted association of individual-level demographic characteristics with 
PrEP use was explored finding significant associations with age, region, race, education, and sexual 
identity. The odds of taking PrEP decreased as age increased, with significance only seen among 
the oldest group [OR= 0.77, CI (0.586, 1.00)] compared to those 18-29 years old. Participants who 
reported that they did not identity as gay were less likely to take PrEP as compared to those who 
identified as gay [OR=0.55, CI (0.413, 0.740)]. PrEP use was positively-associated with residence in 
the Northeast [OR=1.41, CI(1.025, 1.936)] and the West [OR=1.38, CI(1.014, 1.864) compared to 
the South.  Those who were Black [OR=1.410, CI(1.024, 1.941)], and who had a 4-year degree 
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[OR=2.29, CI(1.617, 3.235)] had higher odds of PrEP use compared to those who were White, and 
had a high school diploma or less, respectively.  
In model 3 (Table 3, column 4) the association of social behaviors with PrEP use was 
explored.  Those who had an MP who was HIV-positive [OR=4.6, CI(3.025, 7.085)] and who’s 
partner was on PrEP [OR=16.3, CI(9.648, 27.525)] had a higher odds of taking PrEP compared to 
those who did not have a main partner at all. Furthermore, those with a MP whose HIV status was 
unknown [OR=0.3; CI(0.191, 0.605)] and whose MP was HIV-negative and not on PrEP [OR=0.5; 
CI(0.346, 0.607)] had lower odds of taking PrEP compared to participants with no MP. A linear 
association with PrEP use was seen with the number of sexual partners in the past three months.  
Participants who reported 2-5 partners [OR=3.3 CI(2.083, 5.153)] and greater than 5 partners 
[OR=6.7 CI(4.256, 10.388)] had a higher odds of PrEP use compared to those with no partners. 
Additionally, participants who reported having used drugs in the last 3 months [OR=1.3; CI(1.044, 
1.693)] and who had been diagnosed with an STI in the last 6 months [OR=3.3 CI(2.550, 4.143)] 
had a higher odds of taking PrEP compared to those who had not used drugs or been diagnosed 
with an STI.  
Model 4 (Table 3, column 5) shows the adjusted association of state level characteristics 
with PrEP use. Residents of states with the high LGBTQ equality score [OR=1.7, CI(1.316, 2.297)] 
and of states with the highest HIV prevalence [OR=1.7, CI(1.047, 2.906)] had higher odds of PrEP 
use compared to residents of states with low LGBTQ equality scores and with the lowest HIV-
prevalence (less than 10.0%), respectively.  
Finally, Model 5 (Table 3, column 6) shows the results from the full model with all 
individual-, social-, and state-level variables included.   Model 5 was similar to the earlier models 
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with the exceptions of age, drug use, and prevalence. In model 2, which only included participant 
demographics, participants who were >50 years of age had lower odds of taking PrEP than those 
18-29 years of age. Conversely, in the adjusted model, participants who were 30-39 [OR=1.3, 
CI(1.021, 1.752)] and those who were 40-49 [OR=1.4; CI(1004, 1.834)] were now seen to have 
higher odds of using PrEP compared to the youngest group (18-29 years) and older participants 
were no longer statistically significant. In regards to the social-level characteristics, all variables 
stayed the same as in model 3, with the exception of drug use which was no longer significant in 
the final model. Lastly, comparable to model 4, the LGBT equality scored remained significant, 
where participants who resided in states with higher LGBTQ equality scores [OR=1.6, CI(1.134, 
2.215)] had a higher odds of taking PrEP as compared to those with lower equality scores, 
however, states with the second lowest HIV prevalence scores became significant. In the adjusted 
model, participants between 10.0-19.9 [OR=0.7, CI(0.451, 0.982)] had lower odds of taking PrEP 
compared to states with the lowest HIV-prevalence (less than 10.0), while the higher odds of PrEP 
use associated with residing in a state with the highest prevalence rate was no longer statistically 
significant in the final adjusted model.  
Lastly, all possible four-, three-, and two-way, interactions were tested. Interactions that 
were not significant were removed and models were refitted. In the 2-way interaction, the product 
term #5 (Sexual identity * Racial equal) was significant at our a priori alpha of 0.1 (p-value =0.0801).  
Using the principle of parsimony, the significant 2-way interaction between Sexual identity * Racial 
equality was added to the final adjusted model (model 5). The interaction between sexual identity 
and racial equality was no longer significant in the absence of the other interaction terms 





Applying the concepts from the SEM, the findings from this analysis suggest that there is a 
complicated relationship among and between the individual-, social-, and the contextual-level 
factors and how they impact who and where in the US PrEP is being used. 
Importantly, our findings suggest that contextual-level factors at the state level, specifically 
the equality for LGBTQ residents of a state, may be a marker for multiple causal factors or even 
play a direct and targeted role in influencing PrEP use among MSM. Characteristics that make a 
state more or less equal may be institutionalized through legislation that discourages equality, 
impacting sexual minorities risk and health seeking behavior21 as well as hindering access to 
appropriate healthcare.32 Such barriers could decrease the awareness or availability of HIV 
prevention strategies, such as PrEP, for individuals at highest risk for HIV acquisition.  
Previous research has noted that sexual minorities living in states without legal protections 
(e.g., same-sex marriage) were more likely to report symptoms of depression, anxiety, and alcohol 
use which could lead to adverse health outcomes.33-35 Furthermore, studies that specifically 
explored structural stigma and PrEP use have shown that individuals who lived in high structural 
stigma states were less likely to have taken PrEP.21  Oldenburg et.al. suggested that states with 
higher structural stigma may have reduced awareness about the modalities of PrEP, as well as lack 
of access to providers who prescribe the drug.21 The study by Oldenburg and colleagues measured 
structural stigma using a composite score addressing a number of dimensions of state prejudicial 
social environments which included LGBTQ state policies. Our analysis used a score that focused 
specifically on statewide LGBTQ equality laws and policies that affect LGBTQ people and their 
families, however, we also included state level characteristics that may influence HIV prevention 
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within sexual minority populations to sift through state characteristics and determine if one was 
more strongly associated with PrEP use than others. Throughout the analysis, the state-level 
LGBTQ equality variable remained strongly associated with PrEP use even after controlling for 
multiple factors at the individual- (age, race/ethnicity, educational attainment, and sexual 
identity), social- (main-partner status and behavioral factors) and state- (structural racism, HIV 
prevalence, poverty rate and percent uninsured) level. The combination of these factors suggests 
that equality, or inclusivity of the LGBTQ community in a state may be a particularly important 
contributor to the current dynamics of PrEP use. It is possible that MSM who live in more inclusive 
states, are more likely to experience better social support through their community and 
subsequently may have better physical and mental health outcomes.33,36 In addition, states with 
more inclusivity of the LGBTQ community may also have more access to healthcare, specifically 
healthcare that focuses on gender/sex specific health. While we adjusted for access to healthcare 
via the percent uninsured in the state, a state which is more inclusive to the LGBTQ community 
may provide a more open environment for people to disclose their sexual identity and behavior to 
their provider increasing the likelihood that someone is more likely to have heard about PrEP, feel 
comfortable asking about it, and potentially motivating someone to take it. In the future more 
research could look at geographic distance from a participant’s zip code to a PrEP clinic as a 
measure of access.   
Structural racism is a system which permits privileges associated with “whiteness” and 
perpetuates disadvantages associated with “color.”37 It has been conceptualized as state-level 
disparities across domains that directly influence mobility in society and/or healthcare and other 
resources available for a given racial group.34 There has been a considerable amount of research 
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showing that MSM of color often feel isolated from the broader LGBTQ communities or have 
experienced racism and discrimination within them.38,39 Our findings showed that the structural 
racism score was not significantly associated with PrEP use. While race and racism may play a 
strong part of who is taking PrEP, racism of a state is difficult to measure in a single variable and 
may not have been captured with the variable used in this analysis.  
Overall, social and behavioral variables were strongly associated with PrEP use. Participants 
with a MP who was HIV-positive or who was currently taking PrEP were more likely to be taking 
PrEP themselves. Our results are consistent with other research conducted among serodiscordant 
couples where it was shown that HIV-specific social support within couples was associated with 
fewer reported HIV risk behaviors,40 and may suggest that intimate relationships can foster 
improved risk reduction behaviors.41 We hypothesize that there potentially may be increased 
communication, awareness, and education about HIV and HIV prevention between partners 
where one is either taking ART or using PrEP. In addition, participants who reported more sexual 
partners or who had received an STI diagnosis in the last 6 months were more likely to have been 
taking PrEP at the time of the study.  Among PrEP users, high rates of STIs have been reported and 
concerns have been raised that PrEP use may be linked with an increase in STI incidence due to 
risk compensation.42 In this context, risk compensation is defined as the PrEP users’ perception of 
decreased risk of acquiring HIV which may lead to engagement in riskier sexual behavior and 
subsequently increasing the likelihood of acquiring an STI.42 Other studies have cited that PrEP 
does not necessarily lead to increases in risky behavior, but rather that PrEP brings into care a 
population of MSM who are already at high risk for HIV and STIs.43 While our analysis is unable to 
determine if the STI occurred before or after the initiation of PrEP, if PrEP is associated with an 
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increase in STI rates or higher partner numbers, this would suggest the need to increase risk 
reduction counseling when prescribing PrEP. 
Overall, social/behavioral variables were strongly associated with PrEP use. Participants 
with MP’s who were HIV-positive or were currently taking PrEP were more likely to be taking PrEP 
themselves. This may be related to HIV-specific social support within couples. Johnson et al. found 
that among serodiscordant couples, HIV-specific support within the couple was associated with 
fewer HIV-risk behaviors and greater self-reported ART adherence.41 Interestingly, participants 
who had HIV-negative MPs not taking PrEP or who were unaware of their MPs HIV-status were 
less likely to be taking PrEP than people with no MP. These findings build on others who have 
found that intimacy motivations may play a role in PrEP adoption for MSM couples 44 and suggest 
that understanding the impact of intimate relationship characteristics on sexual risk prevention 
decision making is an avenue for further exploration. 
Participants who reported a recent STI diagnosis, were more likely to have been taking 
PrEP.  We are unable to deduce whether the STI was the impetus to begin using PrEP or whether 
those on PrEP were more likely to be screened for an STI as part of their PrEP care. However, 
among PrEP users, high rates of STIs have been reported and concerns have been raised that PrEP 
use may be linked with an increase in STI incidence due to increased unprotected sex.42 Other 
studies have found that PrEP does not necessarily lead to increases in risky behavior, but rather 
that PrEP brings a population already at high-risk for HIV and STIs into more intensive care where 
STIs are more routinely screened for and treated.42 Nevertheless, the results suggest the need to 
increase risk-reduction counseling when prescribing PrEP. 
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Lastly, US region, race, education, and sexual identity were all associated with PrEP use in 
the first models. However, when both social and contextual factors were added to the model, only 
age, education and identity remained significant. Participants between 30-50 years old and with a 
college degree were more likely to be taking PrEP than those who were in the youngest group (less 
than 30) and those with a high school diploma or less, respectively. Moreover, men who reported 
that they did not identity as gay were shown to be less likely to be taking PrEP as compared to 
those who reported that they were gay. We posit that all three variables may be linked to exposure 
to the LGBTQ community and moreover exposure to PrEP and information about its efficacy. Older 
and more educated MSM may have more increased knowledge of HIV and HIV risk, improved 
access to healthcare and may be more likely to feel at ease disclosing their sexual identity and 
their sexual behavior to their providers facilitating improved knowledge and access to PrEP. On 
the other hand, participants who did not identify as gay may not be as integrated into the LGBTQ 
community and therefore may not receive information regarding HIV risk and prevention 
interventions, such as PrEP.  In addition, this group may be less comfortable disclosing their risk 
behavior to providers and therefore less likely to be prescribed PrEP. 
Limitations 
There are a number of potential limitations that should be mentioned. First the data is 
from a cross-sectional study. Analyses from cross-sectional studies are often not able to determine 
causal relationships as it is impossible to establish a temporal relationship between the exposure 
and the outcome. For example, a participant could have lived in a state with high equality and 
initiated PrEP and then moved to a state with low equality and continued taking PrEP, making a 
causal relationship impossible to be determined in this type of analysis. Another limitation is social 
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desirability bias. Taking PrEP has been associated with the stigma of being related to HIV-risk and 
has been given the reputation of enabling promiscuity, inconsistent condom use, and unsafe sex.45 
Therefore the sensitive nature of some of the questions regarding drug use, partner number, or 
even the outcome, PrEP use, may lead some respondents to answer incorrectly. Furthermore, the 
outcome, PrEP use, could also potentially be a source of outcome misclassification. The outcome 
variable asked if the participant was currently taking PrEP, with no information on whether the 
participant had taken the drug in the past. Both of these limitations could result in potential 
misclassification or underreporting of PrEP use. Another limitation is that the study relied on self-
reported data, once again potentially leading to misclassification due to recall error, 
misunderstanding of the questions, or error in entering the response and the reported information 
cannot be verified. However, given that the surveys were self-administered, false reporting is likely 
to be minimal.  There may also be some error in the state-level variables.  Many of the constructs 
in the analysis do not have an accepted definition or validated measurement and we relied on 
measures that may include some misclassification of our exposure or have issues with construct 
validity.  Importantly, while the analysis recruited participants from all 50 states, recruitment was 
mainly conducted online and are not representative of all MSM in the US. Lastly, the statistics used 
to quantify fitness (i.e. deviance statistics, AIC, BIC and pseudo-R2) of a MLM with a dichotomous 
outcome are often difficult to interpret. However, while there are other statistical models which 
will account for clustering of data, our interest in this study was to identify level II units (LGBTQ 
equality and structural racism of a state) that are associated with PrEP use and not just a 





Previous studies on PrEP use were often limited to participants in clinical trials and 
demonstration projects and mostly focused on high-risk populations.46 This study is one of very 
few which have looked at the impact of contextual (state-level) equality on PrEP use in a ‘real’ 
world setting in which PrEP is generally available. Our findings suggest that LGBTQ+ equality of the 
state may influence PrEP use. The equality landscape in the US varies greatly by state, and while 
recent laws had been moving towards increased equality country wide, in the current political 
environment, many LGBTQ+ rights are being rolled back at the federal and state levels.47  The 
findings of this study suggest that increasing inequality for LGBTQ+ people may have a negative 
impact on PrEP use and could limit our ability to meet the goals put forward by the US President 
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TABLES AND FIGURES 
 
Table 2 - 1. Description of individual-, social-, and state-level characteristics overall and by PrEP 
use. 









     
Age 4165     
   Mean (SD)  38.3 (13.8) 38.39 (14.0) 37.64 (12.2) <0.001* 
   Median (Range)  35.0 (65.0)    
Age, n (%) 4165     
   18-29  1461 (35.1) 1274 (87.2) 187 (12.8) 0.001 
   30-39  929 (22.3) 775 (83.4) 154 (16.6) 
 
   40-49  750 (18.0) 641 (85.5) 109 (14.5) 
 
   >50  1025 (24.6) 915 (89.3) 110 (10.7)  
Recruitment, n (%) site 4165     
   Sexual networking website  724 (17.4) 650 (89.8) 74 (10.2) <0.001 
   general social networking  
   website  
372 (8.9) 326 (87.6) 46 (12.4)  
   Street intercept  266 (6.4) 200 (75.2) 66 (24.8)  
   Geo-social sexual  
   networking  
   phone app  
 1594 (38.3) 1362 (85.4) 232 (14.6)  
   Online Gay Porn sites  378 (9.1) 340 (89.9) 38 (10.1)  
   panel study participants  831 (20.0) 727 (87.5) 104 (12.5)  
US Region of residence, n 
(%) 4165 
    
   Northeast  996 (23.9) 824 (82.7) 172 (17.3) <0.001 
   Midwest  827 (19.9) 738 (89.2) 89 (10,8)  
   South  1359 (32.6) 1207 (88.8) 152 (11.2)  
   West  983 (23.6) 836 (85.0) 147 (15.0)  
Race/ethnicity, n (%) 4164     
   Native American / Alaskan  
   / Hawaiian / Pacific    
   Islander / Other 
 214 (5.1) 186 (86.9) 28 (13.1) 0.266 
   Black  336 (8.1) 278 (82.7) 58 (17.3)  
   Hispanic  748 (18.0) 656 (87.7) 92 (12.3)  
   Asian  167 (4.0) 146 (87.4) 21 (12.6)  
   White  2699 (64.8) 2339 (86.7) 360 (13.3)  
Education, n (%) 4165     
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   High School Diploma, GED,     
   or less 
 528 (12.7) 486 (92.0) 42 (8.0) <0.001 
   Some College, Associates   
   Degree, or currently  
   enrolled in college 
 1476 (35.4) 1330 (92.1) 146 (9.9)  
   4-Year College Degree or  
   more 
 2161 (51.9) 1789 (82.8) 372 (17.2)  
Sexual Identity, n (%) 4165     
   Gay  3407 (81.8) 2907 (85.3) 500 (14.7) <0.001 
   Bisexual  671 (16.1) 617 (92.0) 54 (8.0)  
   Straight  29 (0.9) 39 (100.0) 0 (0.0)  
   Other  48 (1.2) 42 (87.5) 6 (12.5)  
Social-level Characteristics     
Main Partner Status, n (%) 4165     
   No Main Partner (MP)  2479 (59.5) 2128 (85.8) 351 (14.2) <0.001 
   MP is HIV-positive  124 (3.0) 74 (59.7) 50 (40.3)  
   MP HIV status unknown or    
   uncertain 
 244 (5.9) 230 (94.3) 14 (5.8)  
   MP HIV negative and on   
   PrEP 
 93 (2.2) 23 (24.7) 70 (75.3)  
   MP HIV negative and not  
   on PrEP 
 1225 (29.4) 1150 (93.9) 75 (6.1)  
Number of partners in past 
3 months, n (%) 
4165     
   0  574 (13.8) 550 (95.8) 24 (4.2) <0.001 
   1  995 (23.9) 948 (95.3) 47 (4.7)  
   2-5  1459 (35.0) 1265 (86.7) 194 (13.3)  
   >5  1137 (27.3) 842 (74.1) 295 (25.9)  
Drug use in the last 3 
months, n (%) 
4165     
   No  1273 (30.6) 1151 (90.4) 122 (9.6) <0.001 
   Yes  2892 (69.4) 2454 (84.9) 438 (15.1)  
STD in past 6 months, n (%) 3487     
   No  2958 (84.8) 2632 (89.0) 326 (11.0) <0.001 
   Yes  529 (15.2) 356 (67.3) 173 (32.7)  
State-level Characteristics      
Equality , n (%)      
Human Rights Campaign 
State Equality Index1 
4165     
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   Working Toward  
   Innovative Equality 
 955 (22.9) 798 (83.6) 157 (16.4) <0.001 
   Solidifying Equality  773 (18.6) 630 (81.5) 143 (18.5)  
   Building Equality  376 (9.0) 336 (89.4) 40 (10.6)  
   High Priority to Achieve  
   Basic Equality 
 2061 (49.5) 1841 (89.3) 220 (10.7)  
Structural Racism1, n (%) 4165     
   Low equality  2586 (62.1) 2255 (87.2) 331 (12.8) 0.118 
   High equality  1579 (37.9) 1350 (85.5) 229 (14.5)  
Prevalence, n (%)      
   <10.0% 4165 1094 (26.3) 961 (87.8) 133 (12.2) 0.0007 
   10.0% - 19.9%  2170 (52.1) 1852 (85.4) 318 (14.7)  
   20.0% - 29.9%  738 (17.7) 662 (89.7) 76 (10.3)  
   >/=30%  163 (3.9) 130 (79.8) 33 (20.3)  
Poverty Rate2 4165     
   Mean (SD)  14.7 (2.2) 14.7 (2.2) 14.8 (2.0) 0.349* 
   Median (Range)  15.3 (13.8) 15.3 (13.8) 15.4 (13.8)  
Percent Uninsured3 4165     
   Mean (SD)  9.1 (3.4) 9.2 (3.5) 8.7 (3.3) 0.005* 
   Median (Range)  8.6 (14.3) 8.6 (14.3) 7.1 (14.3)  
*Wilcoxon rank sum test p-value 
1Human Rights Campaign (HRC) state scorecared  
2Elmendorf and Spencer variable 
3 2015 US Census Bureau's American Community Survey Briefs for poverty  












Table 2 - 2. Results of multilevel logistic regression models with random intercept with variables 
entered in blocks by level 
Model Summary Model1 Model 2 Model 3 Model 4 Model 5 
Ʈ2 of random 
effects 
0.0803 0.0160 0.0593 0.00496 0 
VPC or ICC 0.024 0.005 0.018 0.002 0 
MOR 1.31 1.13 1.26 1.07 1 
PCV  80.1 26.1 93.8  
Fit Statistics      
   AICC 3221.9 3192.54 2658.99 3255.27 2595.47 
   BIC 3272.34 3223.76 2680.17 3272.61 2652.97 
PCV: proportional change of the variance, VPC: variance partition coefficient, ICC: intra class 









Model 2 Model 3 Model 4 Model 5 
 OR (CI)                                                
P-value 
ICC 
OR (CI)                                                
P-value 
OR (CI)                                              
P-value 
OR (CI)                                          
P-value 
OR (CI)                                         
P-value 
Individual-level Characteristics 
Age       
   18-29 REF  REF   REF 
   30-39 1.3 (1.053, 1.685)  
0.017 
 1.2 (0.927, 1.498)   
0.178 
  1.3 (1.021, 1.753)  
0.003 
   40-49 1.2 (0.933, 1.566)  
0.150 
 1.1 (0.838, 1.425)  
0.58 
  1.34 (1.004, 1.834)  
0.047 
   >50 0.9 (0.665, 1.108)  
0.238 
 0.8 (0.586, 1.000) 
0.050 
  0.9 (0.694, 1.282)  
0.705 
US Region of 
residence 
      
   South REF  REF   REF 
   Northeast 1.4 (0.992, 2.032)  
0.055 
 1.4 (1.025, 1.936)  
0.036 
  1.3 (0.822, 2.138)  
0.240 
   Midwest 0.9 (0.661, 1.317)  
0.686 
 1.0 (0.721, 1.355)  
0.940 
  1.0 (0.640, 1.641)  
0.917 
   West 1.3 (0.934, 1.838) 
0.1152 
 1.4 (1.014, 1.864)  
0.041 
  1.1 (0.645, 1.725)  
0.829 
Race/ethnicity       
   White REF  REF   REF 
   Black 1.4 (0.932, 1.740)  
0.128 
 1.4 (1.024, 1.941)  
0.035 




   Hispanic 0.9 (0.662, 1.101)  
0.221 
 0.9 (0.708, 1.198)  
0.537 
  1.0 (0.726, 1.306)  
0.859 
   Asian 0.8 (0.515, 1.349)  
0.456 
 0.7 (0.421, 1.115)  
0.127 
  0.7 (0.430, 1.268) 
0.269 




Pacific   
Islander / 
Other 
1.0 (0.640, 1.481)  
0.900 
 1.0 (0.658, 1.543)  
0.971 
  1.1 (0.677, 1.730)  
0.740 
Education       
   High School 
Diploma, GED,    
or less 
REF  REF   REF 







1.3 (0.876, 1.815) 
0.210 
 1.2 (0.850, 1.769)  
0.273 
  1.0 (0.686, 1.518)  
0.920 
   4-Year 
College Degree 
or more 
2.3 (1.640, 3.242)  
<0.001 
 2.3 (1.617, 3.235)  
<0.001 
  1.8 (1.208, 2.560)  
0.004 
Sexual Identity       
   Gay REF  REF   REF 
   Did not 
identify as gay  
0.5 (0.388, 0.692) 
<0.001 
 0.6 (0.413, 0.740)  
<0.001 







      
   No Main 
Partner (MP) 
REF   REF  REF 
   MP is HIV-
positive 
4.1 (2.781, 5.999)  
<0.001 
  4.6 (3.025, 7.085)  
<0.001 
 4.5 (2.879, 6.882)  
<0.001 




0.4 (0.208, 0.633)  
<0.001 
  0.3 (0.191, 0.605)   
<0.001 
 0.3 (0.191, 0.621)  
<0.001 
   MP HIV 
negative and 
on PrEP 
19.0 (11.562, 31.130)  
<0.001 
  16.3 (9.648, 27.525) 
<0.001 
 16.5 (9.661, 28.188)    
<0.001 
   MP HIV 
negative and 
not on PrEP 
0.4 (0.305, 0.516)  
<0.001 
  0.5 (0.346, 0.607)  
<0.001 




past 3 months 
      
   0 REF   REF  REF 
   1 1.1 (0.675, 1.866)  
0.654 
  1.3 (0.756, 2.240)  
0.340 
 1.7 (0.669, 2.007)  
0.597 
   2-5 3.5 (2.260, 5.456)  
<0.001 
  3.3 (2.083, 5.153)  
<0.001 
 3.2 (1.994, 4.974)  
<0.001 
   >5 7.9 (5.113, 12.196)  
<0.001 
  6.7 (4.256, 10.388)  
<0.001 
 6.7 (4.275, 10.529)  
<0.001 
Drug use in the 
last 3 months 
      
   No REF   REF  REF 
   Yes 1.6 (1.314, 2.037)  
<0.001 
  1.3 (1.044, 1.693)  
0.022 




STD in past 6 
months 
      
   No REF   REF  REF 
   Yes 4.0 (3.193, 4.935)  
<0.001 
  3.3 (2.550, 4.143)  
<0.001 
 3.2 (2.461, 4.055)  
<0.001 
State-level Characteristics 
Equality        
HRC state 
Equality Index1 
      
   Low equality REF    REF REF 
   High equality 1.7 (1.372, 2.139) 
<0.001 
   1.6 (1.216, 2.108)  
0.001 
1.6 (1.119, 2.203)  
0.010 
State Racism2       
   High state     
   racism 
REF    REF REF 
   Low state  
   racism 
1.4 (1.117, 1.860)  
0.006 
   1.3 (0.978, 1.651)  
0.072 




100,000, n (%) 
      
   <10.0 REF    REF REF 
   10.0% - 19.9 
1.0 (0.777, 1.430)  
0.729 
   1.0 (0.758, 1.289)  
0.930 
0.7 (0.511, 0.991)  
0.045 
   20.0% - 29.9 
0.8 (0.540, 1.249)  
0.349 
   1.0 (0.6559, 1.542)  
0.969 
0.8 (0.432, 1.303)  
0.299 
   ≥30 
2.0 (1.120, 3.558)  
0.020 
   1.8 (1.107, 2.963)  
0.019 
1.4 (0.731, 2.624)  
0.309 
Poverty Rate3 1.0 (0.938, 1.010)  
0.743 
   1.0 (0.965, 1.072)  
0.522 






1.0 (0.930, 1.010)    
0.132 
   1.0 (0.957, 1.053)  
0.872 





Model 2 Model 3 Model 4 Model 5 
Ʈ2 * 
 
0.080 0.016 0.059 0.005 0 
VPC or ICC 
 
2.4 0.485 1.77 0.15 0 
MOR 
 
1.31 1.13 1.26 1.07 1 
PCV 
  
80.1 26.1 93.8 0 
Fit Statistic  
     




3192.54 2658.99 3255.27 2595.47 




3223.76 2680.17 3272.61 2652.97 
1Human Rights Campaign (HRC) state scorecard 
2 Variable created from The Geography of Racial Stereotyping: Evidence and Implications for VRA Preclearance After Shelby County 
3 2015 US Census Bureau's American Community Survey Briefs for poverty  
4 Kaiser Family Foundation - Health Insurance Coverage of the Total Population  





CHAPTER 3:  EXPLORATION OF MULTILEVEL PREDICTORS OF PREP USE 





Background: HIV incidence in the United States (US) is highest among MSM of color.  However, 
Black and Latinos receive fewer PrEP prescriptions than Whites.  Studies to date have focused on 
individual- and social-factors driving this inequity, but structural racism and anti-LBGT+ stigma may 
also play a role. 
Methods: Data from a 2015-2016 cross-sectional survey conducted among a geographically-
diverse sample of HIV-negative MSM in the US was linked to publicly-available state-level data on 
zip code of residence. Multivariable multilevel logistic regression was used to explore the 
association between PrEP use and individual-, social-, and state-level factors among MSM of color. 
Results: Of the 1,465 HIV-negative MSM of color, 13.6% were currently taking PrEP. In the final 
regression model, residents of states with high LGBTQ+ equality had significantly higher odds 
[OR=2.0, CI(1.058, 3.720)] of PrEP use compared to residents of states with low equality even after 
adjusting for individual- and social-level characteristics of participants.  
Conclusions: State-level LGBTQ+ inequality may operate as a barrier to PrEP use in MSM of color.  
Reducing institutionalized LBGT+ inequality coul be an important initiative to help the US achieve 






Black and Latino men who have sex with men (MSM) are the group most affected by HIV 
in the United States (US).1 It is estimated that in their lifetime, one-in-two Black and one-in-four 
Latino MSM will be diagnosed with HIV, compared to one-in-eleven White MSM.2 In 2012, the use 
of the medication tenofovir disoproxil fumarate plus emtricitabine (TDF-FTC, Truvada) was 
approved as pre-exposure prophylaxis (PrEP) in HIV-negative adults who are at high-risk of HIV 
infection.3 Despite its effectiveness, reports have found that PrEP prescriptions are reaching only 
a small proportion of those who could benefit from the drug and prescription rates among those 
eligible vary both by race and geographic region.4  
In 2016, Black and Latinos accounted for the smallest percentage of PrEP prescriptions to 
date and although the South had 52% of new HIV diagnoses, only 27% of PrEP users were from 
the South.5  Structural barriers such as racism, anti-immigration sentiment, homophobia, and 
socio-economic factors can prevent MSM of color from either seeking or accessing needed 
healthcare and/or treatment.6 Furthermore, these barriers may be working together 
synergistically to hinder engagement in HIV prevention strategies, such as PrEP.  Given the cultural, 
political and legal diversity by state in the US, some of the barriers faced by MSM of color may vary 
depending on the geographic region of residence.7,8 One study in the southern US found that 
compared to Black and White persons, Latinos were more likely to enter into HIV care late in the 
course of their infection with a majority of those presenting with several AIDS-defining 
events/conditions.9  
MSM of color, likely identify with multiple minority identities (i.e. sexual, racial, ethnic) and 
the barriers and stigma they experience may differ from that of those with a single minority 
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identity (i.e. heterosexual ethnic minorities or White LGBT individuals).10 This concept has been 
coined ‘intersectional stigma,’ and recent studies have shown that there is a greater impact on 
health with persons with multiple minority identities than the sum of the impact of each identity 
alone.11-13 A study among HIV-positive young Black MSM explored the interplay between sexual 
health and two forms of stigmas-HIV and sexual minority stigma. The study found participants 
were at risk for experiencing multiple domains of stigma related to both their HIV status and their 
sexual identity, moreover, those who reported higher levels of stigma also reported more 
unprotected sex while under the influence of drugs or alcohol.14   
Factors that may contribute to the geographic epidemic in the South, specifically among 
MSM of color, include pervasive and multi-layered HIV-related stigma, poverty, high levels of 
sexually-transmitted infections (STI) including HIV, racial and ethnic discrimination, poor access to 
health and social services, and laws that further HIV-related stigma and fear, such as HIV 
criminalization.15 Examining how the intersecting identities of MSM of color are impacted by both 
racial and sexual minority discrimination in the places where they reside may be crucial to 
understanding barriers to PrEP use for those who need it the most.  
There are few studies that have explored the impact of both state-level LGBTQ and racial 
equality and PrEP use among MSM of color, and to our knowledge, none have assessed interaction 
among measures of state-level stigma and individual-level factors. To address this gap, we 
examined the complex inter-relationship among factors organized at the state-, social-, and 






Study sample and data collection 
The data for these analyses come from a cross-sectional survey of a geographically-diverse 
sample of MSM in the US that was conducted from May 2015 to March 2016.  The study methods 
have been described elsewhere16 but the design is briefly presented here.  Participants were 
eligible if they were age 18 years or older, cisgender male, and reported sex with other men in the 
past 5 years. As this paper focuses on predictors of PrEP use among MSM of color, participants 
who identified as White and who indicated that they were HIV-positive were excluded from this 
analysis.  
Participants were recruited via six different methods: (1) Online via a sexual networking 
website, where a banner was hosted advertising the survey for 30 days; (2) Online via various gay 
porn internet sites, where the same banner was used for a period of 39 days;  (3) Mobile devices 
via a geo-social sexual networking app popular with men-for-men connections, where we had a 
pop-up message that was displayed to participants when they opened the app for the first time 
during a given 12-hour window; (4) Online via a social networking site popular with the general 
public, where we ran an advertisement for 11 days; (5) Street intercept outside of locations in New 
York City frequented by MSM; (6) An invitation to participants in a an ongoing panel study of 1,071 
HIV-negative MSM identified by a marketing firm.  All eligible participants completed a brief self-
administered survey that took approximately twenty minutes. Those recruited via street intercept 
completed the survey on an iPad equipped with Computer-Assisted Self-Interview (CASI) software, 
and all others did so online via a personal computer or phone app. The survey included questions 
about demographic characteristics, including zip code of residence, HIV risk/protective behaviors 
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The outcome for these analyses was self-reported, current PrEP use at time of survey and 
was determined using responses to the question: “What is your HIV status?“ Response options 
were: (1) HIV-positive and undetectable, (2) HIV-positive, but detectable, (3) HIV-negative, on 
PrEP, (4) HIV-negative, not on PrEP, (5) Don’t know/unsure. Participants who reported they were 
HIV-positive were excluded. Participants who reported don’t know/unsure of HIV status were 
counted as HIV-negative for the purpose of this analysis. The outcome was categorized as on PrEP 
versus not on PrEP. 
Predictor variables -Individual-level factors included demographic and HIV-related behavior 
Participant age was self-reported and was examined both as a continuous and a 4 category 
variable (18-29, 30-39, 40-49 and 50+ years), with categories based on the distribution of the data 
to ensure a sufficient number in each category. Race and ethnicity were categorized into 4 distinct 
groups (Black, Hispanic, Asian, and other). The ‘other’ category included American Indian, Alaska 
Native, Native Hawaiian, Pacific Islander and other,  which were combined due to the small sample 
sizes in each of these groups. Level of education was examined in 3 categories (High school 
diploma, GED or less; some college, currently enrolled in college and/or associates degree; 4-year 
college degree or more). Sexual identity was examined as three categories in the descriptive 
analysis (gay, bisexual, and other) and due to the low numbers, the variable was dichotomized into 
an indicator for gay identity versus did not identity as gay for the regression analysis.   
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Behavioral characteristics included the number of sex partners and drug use in the last 
three months as well as diagnosis with any sexually transmitted infection (STI) in the last six 
months. The number of sex partners was categorized into 4 groups (0 partners, 1 partner, 2-5 
partners and >5 partners) based on the distribution of the data. To assess STIs and drug history, 
participants were provided a list of STIs and recreational drugs (including non-prescription and 
prescription) and were asked to indicate which infection they had been diagnosed with and which 
drugs they had used in the respective time period. STIs and drug use were both dichotomized into 
an indicator for any STI or drug use. 
Social Factors related to a Main Partner 
All participants were asked if they had a main partner (MP) with whom they were in a 
committed relationship and if so, their knowledge of their MPs HIV and PrEP status. For these 
analyses we included a five category variable for MP status with the following categories: (1) no 
MP, (2) MP is HIV+, (3) MP and I don't know their status, (4) MP and they are HIV-negative and on 
PrEP (5) MP and they are HIV-negative and not on PrEP.  
State-level Characteristics - All state-level measures used were from 2015.  
State HIV prevalence - State HIV prevalence was ascertained from the CDC annual HIV 
Surveillance Report among adults and adolescents and was categorized using the CDC ranking.17 
Healthcare access - In 2012, the Supreme Court's ruling on the Affordable Care Act (ACA) allowed 
states to opt out of the law's Medicaid expansion mandate. Healthcare access was assessed based 
on whether in  2015, the state had adopted the Medicaid expansion  mandate and was 
dichotomized to yes or no.18  
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LGBTQ+ equality - The state Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) 
equality measure came from the Human Rights Campaign (HRC) state scorecard. The HRC assigns 
a score based on statewide laws and policies that affect LGBTQ people and their families.19 The 
HRC categorizes these scores into four groups: 1) High Priority to Achieve Basic Equality, 2) Building 
Equality, 3) Solidifying Equality and 4) Working Toward Innovative Equality. We dichotomized the 
variable into low (categories 1 and 2) and high (categories 3 and 4) LGBTQ equality states. 
Racism - To asses state-level racism, a measure was used by Elmendorf and Spencer and 
colleagues that ranks states by the proportion of the state’s non-Black residents who regard Blacks 
more negatively than the national median.20 They created a using multilevel regression with post-
stratification, a statistical technique that has shown to yield estimates of state-level public opinion. 
With their results, each state was ranked from 1-50 with 1 representing the state with the highest 
proportion of non-Black residents who are ‘prejudiced overall’.20   
State-level poverty – State level poverty was defined using the US Census Bureau's 
American Community Survey Briefs for poverty in 2014-2015. The poverty rate measures the 
percentage of people whose household income fell below their state’s assigned poverty threshold. 
Poverty thresholds are assigned to individuals or families based on family size and composition.21  
Statistical analysis  
Descriptive statistics (means/standard deviations and percentages) were calculated to 
describe the individual-, social-, and state-level characteristics of the sample overall and stratified 
by PrEP use. To assess the statistical significance of differences in PrEP use, chi-squared or 
Wilcoxon rank sum tests were used.   
61 
 
We then developed crude and multivariable multilevel logistic regression models with 
random intercepts to calculate crude and adjusted odds ratio (OR and AOR) and 95% confidence 
intervals (CIs) for the association of each independent variable with the outcome of current PrEP 
use. The level-1 unit was the participant and the level-2 unit was the state.  
Pseudo intraclass correlation coefficients (ICC, or pseudo-ICC) and median odds ratios 
(MOR) were calculated in order to assess the extent that variability in PrEP use was due to state- 
vs. individual-level factors. Model 1 was an ‘empty’ model.  Model 2 included demographic 
characteristics (age, race, education, sexual identity), Model 3 included interpersonal/social 
factors (number of partners, STIs, main partner’s status). Models 2 - 3 allowed for the assessment 
of the impact of the set of individual- and social level factors on PrEP use. Model 4, included all 
state-level characteristics to examine the association of state-level characteristics with PrEP use. 
Model 5 was extended to include all variables into a final model.  
To explore whether the intersection of individual sexual and race/ethnic identity interacts 
with state-level stigma to shape PrEP uptake, we examined whether there was interaction among 
state-level equality measures (LGBTQ and racial scores) and individual-level variables (sexual and 
racial/ethnic identity) in predicting PrEP use. The initial analysis explored a 4-way interaction with 
all four variables by adding all possible product terms, including all 2-way, 3-way and 4-way 
product terms for all possible combinations of the 4 variables, to the adjusted model.22 This model 
was then compared to 3 other models: 1-the main effects model, 2- model with only all 2-way 
interactions and 3-the model with 2- and 3- way interactions. The significance of interaction was 
assessed at alpha=0.10 due to the reduced power when testing for interaction.23 All main effects 
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were tested at alpha=0.05.  Analyses were undertaken using SAS 9.4 and PROC GLIMMIX for binary 
outcomes (SAS, Cary, NC). 
RESULTS  
Description of the sample overall  
Out of 1,465 HIV-negative MSM of color included in the analysis, 199 (13.6%) reported 
taking PrEP at the time of the survey. Almost half of the participants were between 18-29 years 
old (49.3%) with the average age being 32.9 years old. More than half of the participants were 
Hispanic (51.1%) and identified as gay (81.2%). The greatest percentage resided in the South 
(32.6%) and reported having a college degree or more (44.4%). (Table 1) 
More than half of the participants reported not having a MP (63.8%). Of those with a MP 
(N=530, 36.2%), the majority reported having a MP who was HIV-negative and not on PrEP (N=377, 
71.1%), while 7.4% (N=39) reported knowledge that their partner was HIV-positive and 4.5% 
(N=24) reported knowledge that their MP was HIV-negative and taking PrEP. More than half of 
participants reported having more than one sexual partner (62.2%) and using drugs (67.7%) in the 
past three months. Over 15% of the participants reported having been diagnosed with an STI 
within the last six months. (Table 1) 
Over half of the participants lived in states with the lowest LGBTQ+ equality (50.4%), the 
lowest structural racism (56.3%), in the second to lowest HIV prevalence range of 10.0-19.9 per 
100,000 (56.7%), and lived in the states which participated in Medicaid expansion offered by the 
ACA (65.7%). The mean poverty rate of the states in which participants lived was 14.9% (SD=2.0), 
just above the 2015 national average of 13.5%, and the mean state-level percent uninsured for 





PrEP use was highest among those age 30-39 (17.2%) compared to 11.5% among those 
aged 18-29, 16.1% among 40-49, and 11.3% among those older than 50 years (p = 0.035). 
Participants residing in the North (19.2%) reported the highest use of PrEP as compared to those 
from the West (13.5%), Midwest (12.9%), and the South (9.7%) (p<0.001). Participants who 
reported having a 4-year degree or more (18.0%) were more likely to be users of PrEP than 
participants who had some college or equivalent (10.6%) or a high school degree, GED or less 
(8.6%, p < 0.0001). Participants who reported that their MP was currently taking PrEP (62.5%) 
reported more use of PrEP, followed by those who had HIV-positive partners (43.6%) as compared 
to those whose MP HIV status was unknown (8.9%), or negative and not on PrEP (6.4%), and those 
with no MP (14.4%, p  < 0.0001). Of the participants who reported having more than 5 partners in 
the past 3 months, 23.5% were taking PrEP compared to only 14.4% who had 2-5 partners, 6.6% 
who only had 1 partner and 4.1% who reported 0 partners (p < 0.0001). Participants who had 
recently used drugs (15.4%) and been diagnosed with an STI (27.4%) reported more use of PrEP 
than their counterparts (9.7%, p = 0.003 and 11.1, p < 0.0001, respectively).  
PrEP use was highest amongst participants who lived in the highest LGBTQ+ equality states 
(17.4%) as compared to those in low equality states (9.9%; p < 0.0001). Similarly, PrEP use was 
more common among participants who lived in states with lower state racism (15.9% vs 10.6%; p 
< 0.004) and who lived in states that had approved of the Medicaid expansion (15.4% vs. 10.2%; p 




Multivariate logistic regression  
Table 2 shows the assessment of variance for each model. Model 1 (empty model/pseudo-
ICC), suggests that 4.2% of the total variance in PrEP use is due to between state differences 
whereas 95.8% is explained by individual differences. Model 3, which explored social/behavioral 
characteristics of the individual, showed the greatest variation, with 2.7% of the residual variation 
in PrEP use persisting due to systematic differences between states. Model 4 (state-level variables) 
suggest that after adjusting for the state-level variables, less than 1% of variance is due to 
differences in characteristics between the states while the remaining variance is due to 
unmeasured differences between individual- and state-level characteristics. The ICC and MOR 
were 0, 1 respectively for Models 2 and 5, as there was not enough variation in the response to 
attribute any variation to state- or individual-level effects, controlling for all variables in the 
model.25 
Crude logistic regression model results 
In the univariate models, the odds of taking PrEP were significantly higher among those 
30-39 years old (OR=1.56, 95% CI: 1.084, 2.252), from the Northeast (OR=2.22, 95% CI: 1.478, 
3.344), and those who had a 4-year degree or more (OR=2.25, 95% CI: 1.344, 3.754) than among 
those 18-29, from the South, and with those with a high school diploma, GED or less, respectively. 
Participants who did not identify as gay had a significantly lower odds of taking PrEP as compared 
to those who identified as gay (OR=0.63, 95% CI: 0.401, 0.993). (Table 3) 
Participants who had an HIV-positive MP (OR=4.64, 95% CI 2.344, 9.194) or who’s MP was 
taking PrEP (OR=9.78, 95% CI: 4.043, 23.650) had significantly higher odds of PrEP use while 
participants whose MP was HIV-negative but not taking PrEP (OR=0.40, 95% CI: 0.254, 0.638) had 
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significantly lower odds of PrEP use compared to those who did not have a MP. PrEP use was 
positively associated with number of partners in the past three months, [2-5 partners (OR=3.95, 
95% CI: 1.916,8.134) and >5 partners (OR=7.0, 95% CI: 3.419, 14.337)], compared to no partners, 
with those who reported drug use in the last three months (OR=1.69, 95% CI: 1.171, 2.429) or had 
been diagnosed with an STI in the last six months (OR=2.9, 95% CI: 2.017, 4.158). (Table 3) 
Participants who lived in a state with more LGBTQ equality (OR=1.84, 95% CI: 1.258, 2.702) 
had significantly higher odds of taking PrEP than those who lived in state with less equality. (Table 
3) 
Table 3 displays five models with covariate-adjusted multilevel logistic regression results 
(OR’s and 95% CI’s) for individual-, social-, and/or state- level predictors of PrEP use. Model 2 
(Table 3, column 3), the adjusted association of individual-level demographic characteristics with 
PrEP use showed there was a positive association between PrEP use and residence in the 
Northeast [adjusted odds ratio (aOR=2.09, 95% CI: 1.377, 3.168) and the West (aOR=1.57, 95% CI: 
1.020, 2.426) compared to the South and having a 4-year degree or more (aOR=2.21, 95% CI: 
1.303, 3.730) versus a high school degree or less. Participants who were Hispanic (aOR=0.68, 95% 
CI: 0.467, 0.996) or Asian (aOR=0.51, 95% CI: 0.286, 0.892) had lower odds of using PrEP as 
compared to those who identified as Black.  
In model 3 (Table 3, column 4), the association of PrEP use with social-factors was explored.  
Those who had an MP who was HIV-positive (aOR=4.02, 95% CI: 1.939, 8.315) and who’s partner 
was HIV-negative and on PrEP (aOR=10.91, 95% CI: 4.355, 27.344) had higher odds of taking PrEP 
compared to those who did not have a main partner at all. Furthermore, participants with an HIV-
negative MP who was not on PrEP (aOR=0.43; 95% CI: 0.261, 0.709) had lower odds of taking PrEP 
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compared to participants with no MP. A dose-response association with PrEP use was seen with 
the number of sexual partners in the past three months. Participants who reported 2-5 partners 
(aOR=3.75, 95% CI: 1.795, 7.842) and greater than 5 partners (aOR=6.02, 95% CI: 2.900, 12.496) 
had a higher odds of PrEP use compared to those with no partners. Lastly, participants who had 
been diagnosed with an STI in the last 6 months (aOR=2.63, 95% CI: 1.782, 3.886) had a higher 
odds of taking PrEP compared to those who had not been diagnosed with an STI.  
Model 4 (Table 3, column 5) shows the adjusted association of state level characteristics 
with PrEP use. Residents of states with the high LGBTQ+ equality score (aOR=1.93, 95% CI: 1.107, 
3.350) had higher odds of PrEP use compared to residents of states with low LGBTQ+ equality 
scores.  
Finally, Model 5 (Table 3, column 6) shows the results from the full model with all 
individual-, social-, and state-level variables included.   All variables statistically significant in the 
earlier models remained significant in the final model, with the exception US region of residence. 
In addition, although not significant in model 1, in the final model, participants who did not identify 
as gay (aOR=0.52, 95% CI: 0.317, 0.850) had lower odds of using PrEP compared to those who 
identified as gay. 
Lastly, all possible four-, three-, and two-way, interactions were tested among state-level 
LGBT equality, state-level racial equality, and both the individual variables, sexual identity and 







PrEP research has often focused on individual-level factors, such as demographics and 
behavioral characteristics, however, structural-level factors, such as the structural stigma of a 
state, may also play a role. Our findings show that MSM of color who resided in states with more 
LGBTQ+ equality had a higher odds of using PrEP even after controlling for individual, social, and 
structural level factors. The strong association suggests that equality, or inclusivity, of the LGBTQ+ 
community is an important contributor to the use of PrEP. States with more inclusivity of the 
LGBTQ+ community may have either the ability or the resources to reach MSM of color and 
provide more access to healthcare, specifically healthcare that focuses on minority health. 
Moreover, these states with increased equality may have progressive social policies where 
behaviors and identities that are often stigmatized in other areas may be enacted with less fear 
and more aid. Parker and Aggleton described how stigma can manifest itself at the structural level 
via discriminatory legislation and policies and can occur when such policies disinvest in research 
or prevention interventions, more so if those disinvestments target minority populations.26  
Perhaps, one example of where more progressive policies could be useful is in the 
Southern part of the US, where eight of the ten states with the highest rates of new HIV diagnoses 
are located.27 The conservative environment of the South has been implicated in fostering the 
spread of HIV and HIV-stigma.28 A number of states in the South only provide abstinence-based 
sex education and/or have laws that criminalize behavior related to HIV exposure or transmission, 
which can lead to shame or could discourage individuals from seeking HIV prevention, care, or 
treatment.28 Several studies have shown the negative impacts of stigma on population health, 
including increasing the likelihood of engaging in high-risk behavior and adverse mental health 
conditions.29,30 One study focused on structural stigma and HIV prevention in the US and showed 
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that residents of states with high-level structural stigma were less likely to have heard of or used 
PrEP and suggested that it may be a function of reduced awareness of PrEP, as well as lack of 
access to providers who prescribe the drug.30 Their analysis used a composite score addressing 
four dimensions of state LBGTQ+ prejudicial components with one of the dimensions including a 
focus on four LGBTQ+ state policies.30 Our analysis extended this work by using a more 
comprehensive measure of LGBTQ+ equality consisting of more than seventeen state laws and 
policies that affect not only the individual but also laws that affect their families. In addition, our 
analysis included and adjusted for other state-level characteristics that may interact with and/or 
compound LGBTQ+ state stigma.  
Together with stigma, variables such as racism, HIV-prevalence, poverty, and healthcare 
access could be confounders to PrEP use. To reach the populations at most need of PrEP, it will be 
important to disentangle the effects of stigma experienced by MSM of color and its barriers with 
PrEP use. Although much of the current stigma literature focuses on the consequences of only one 
form of stigma, MSM of color will likely experience the additional stress of multiple minority 
stigmas which are often correlated and interrelated and their combined effects may not just be 
additive.31 There has been research showing that MSM of color not only are disproportionately 
affected by HIV but that they often feel isolated from the broader LGBTQ+ communities and/or 
have experienced racism and discrimination within them.6,32 A study by Han and colleagues found 
that a large majority of MSM of color reported racism from within the gay community, and that 
the racism experienced was a significant source of stress which led to an increased likelihood of 
engaging in high-risk sexual behaviors.33 
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The analysis presented here, explored the intersectionality of multiple minority identities 
interacting with multiple forms of inequality and subsequently its impact on PrEP use. The findings 
of this study did not find a significant association between PrEP use and the state racism score, 
nor did we find any evidence of interaction among minority identities and state-level equality 
measures. To a degree, our lack of significance could be due to the racism experienced within the 
gay community rather than at the state level, as we did not have this measure in our study. This 
could suggest that the racism experienced at the community-level is important in the health-
seeking behaviors of MSM of color.  Alternatively, it could be that state-level racism is highly 
variable within the state and/or that level of racism is difficult to measure, and our variable may 
not have captured this construct adequately. Although our measure of state racism was not 
predictive, we did find variation in the odds of PrEP use by individual race/ethnic identity.  
Participants in our study who identified as either Latinos or Asians had lower odds of taking PrEP 
compared to Black participants, suggesting that PrEP use is both suboptimal among MSM of color 
and differential by race/ethnicity, even after controlling for individual level factors. MSM of color 
should not be treated as a panethnicity, and that each group, as well as other factors including 
sexual identity and nativity, need to be considered and addressed with specific culturally 
appropriate HIV prevention strategies.  
Social/behavioral variables were strongly associated with PrEP use. Participants with MPs 
who were HIV-positive or were currently taking PrEP were more likely to be taking PrEP 
themselves. This is consistent with other studies which suggested that when positive relationship 
dynamics exist and partners provide emotional, informational, and instrumental support to each 
other, their relationship may lead to better anti-retroviral treatment adherence via improved 
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mental health, increased knowledge about HIV, and increased accountability.34,35 Participants who 
had HIV-negative MPs that were not taking PrEP were less likely to be taking PrEP than people 
with no MP. This finding requires further investigation and should focus on identifying effective 
PrEP messaging that targets MSM in relationships and explores the intimate aspects of 
relationships and sexual decision-making.36 
In this study, participants with more sexual partners or a recent STI diagnosis, were more 
likely to be taking PrEP. Studies have reported high rates of STIs among PrEP users and concerns 
have been raised that PrEP use may be linked to decreases in condom use, while other studies 
have found that PrEP might not lead to behavior change but that it may be bringing a population 
at risk into the healthcare system.37 PrEP use guidelines recommend frequent testing for STIs, 
typically at quarterly intervals.38 Therefore, the findings that participants who are using PrEP have 
a higher odds of an STI diagnosis could be partially explained by the likelihood of having been 
screened for STIs rather than the actual STI risk. Due to the nature of this study, we were unable 
to deduce whether the higher number of sexual partners or an STI diagnosis was a cue to initiate 
PrEP or whether those on PrEP were more likely to increase number of partners, which might 
result in a higher likelihood of STIs. 
In the final model, other individual-level variables significantly associated with PrEP use 
include age and sexual identity. Participants between 30-39 years had higher odds of taking PrEP, 
while participants who reported that they did not identify as gay had lower odds of taking PrEP. 
MSM in this mid-age range of 30-39 may have increased knowledge of HIV- and HIV-risk and 
improved access to healthcare and subsequently a prescription to PrEP as compared to those 
participants who were younger.39,40 Similarly, participants who did not identify as gay may be less 
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comfortable discussing their sexual behavior with a healthcare provider and/or may be less 
integrated into the LGBTQ+ community, which may impact knowledge and access to PrEP.39   
Limitations 
There are several limitations that should be mentioned. First, the data is from a cross-
sectional study where the exposures and outcome were simultaneously assessed and temporal 
order for some associations cannot be determined. Another limitation is possible misclassification 
of the outcome due to social desirability bias or misunderstanding of the outcome question. For 
example, participants were asked if they were currently taking PrEP, but were not asked if they 
had ever taken PrEP. Some participants may have discontinued use by the time of our survey, 
therefore our measure may under-report lifetime PrEP use. Furthermore, some of our state-level 
constructs do not have a generally accepted and validated measure, thus the measures used may 
have reliability and validity issues, including construct validity and uncontrolled or residual 
confounding. Although participants were recruited from all 50 states, recruitment methods may 
not have resulted in a representative sample of MSM in the US and therefore findings may lack 
eternal validity. Lastly, statistics used to quantify fitness (i.e. pseudo-R2) of a MLM with a 
dichotomous outcome are often difficult to interpret.41  
CONCLUSION 
The findings suggests that individual-, social-, and state-level variables, and importantly, 
the LGBTQ+ equality of the state of residence were associated with PrEP use among MSM of color. 
MSM of color experience intersecting forms of stigma, including but not limited to racism and 
homophobia, assessed in this paper, but also anti-immigrant sentiment, which we were unable to 
evaluate. However, this may be an important factor based on our findings around individual 
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race/ethnicity. In February 2019, the current administration announced, Ending the HIV Epidemic 
in America, a new initiative which seeks to reduce all new HIV infections by 90% in the next 10 
years. However, unless the complex set of socio-behavioral and structural factors, including 
discrimination, stigma, and socioeconomical factors are considered, it is expected that HIV will 
continue to disproportionately affect the same at-risk populations and those with dual minority 
identity may be at an even higher risk. Although there has been much improvement regarding 
LGBTQ+ and racial justice in the US, the equality landscape in the country varies greatly by state 
and recent rollbacks in federal laws of sexual and reproductive health rights, and rights for LGBTQ+ 
and their families are cause for alarm.42,43 Our findings suggest that the policies that increase 
inequality and stigma associated with minority statuses may hinder the administration’s new 
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TABLES AND FIGURES 
 




N (%)           
1465 (100) 
Non-PrEP users 
N (%)            
1266 (86.4%) 
PrEP user 
N (%)            
199 (13.6%) 
p-Value 
Individual level characteristics 
Age 1465     
   Mean (SD)  32.9 (11.2) 32.8 (11.4) 33.9 (9.8) 0.1384 
   Median (Range)  30.0 (61.0)    
Age 1465     
   18-29  722 (49.3) 639 (88.5) 83 (11.5) 0.035 
   30-39  361 (24.6) 299 (82.8) 62 (17.2)  
   40-49  223 (15.2) 187 (83.9) 36 (16.1)  
   >50  159 (10.9) 141 (88.7) 18 (11.3)  
Recruitment Website 1465     
   Sexual networking 
website 
 176 (12.0) 160 (90.9) 16 (9.1) <0.001 
   General social 
networking website 
 137 (9.4) 121 (88.3) 16 (11.7)  
   Street intercept  137 (9.4) 101 (73.7) 36 (26.3)  
  Geo-social sexual 
networking phone app  
 666 (45.5) 581 (87.2) 85 (12.7)  
   Online Gay Porn sites  116 (7.9) 100 (86.2) 16 (13.8)  
   Panel study participants  233 (15.9) 203 (87.1) 30 (12.9)  
US Region of residence 1465     
   South  487 (33.2) 440 (90.4) 47 (9.7) <0.001 
   North  370 (25.3) 299 (80.8) 71 (19.2)  
   Midwest  179 (12.2) 156 (87.2) 23 (12.9)  
   West  429 (29.3) 371 (86.5) 58 (13.5)  
Race/ethnicity 1465     
   Native American / 
Alaskan / Hawaiian / Pacific   
Islander / Other 
 214 (14.6) 186 (86.9) 28 (13.1) 0.164 
   Black  336 (22.9) 278 (82.7) 58 (17.3)  
   Hispanic  748 (51.1) 656 (87.7) 92 (12.3)  
   Asian  167 (11.4) 146 (87.4) 21 (12.6)  
Education 1465     
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   High School Diploma, 
GED,    or less 
 232 (15.8) 212 (91.4) 20 (8.6) <0.001 
   Some College, Associates  
Degree, or currently 
enrolled in college 
 583 (39.8) 521 (89.4) 62 (10.6)  
   4-Year College Degree or 
more 
 650 (44.4) 533 (82.0) 117 (18.0)  
Sexual Identity 1486     
   Gay  1190 (81.2) 1017 (85.5) 173(14.5) 0.837 
   Bisexual  237 (16.2) 215 (90.7) 22 (9.3)  
   Other  38 (2.6) 34 (89.5) 4 (10.5)  
Social-level Characteristics 
Main Partner Status 1465     
   No Main Partner (MP)  935 (63.8) 800 (85.6) 135 (14.4) <0.001 
   MP is HIV-positive  39 (2.7) 22 (56.4) 17 (43.6)  
   MP HIV status unknown 
or uncertain 
 90 (6.1) 82 (91.1) 8 (8.9)  
   MP HIV negative and on 
PrEP 
 24 (1.6) 9 (37.5) 15 (62.5)  
   MP HIV negative and not 
on PrEP 
 377 (25.7) 353 (93.3) 24 (6.4)  
Number of partners in past 
3 months 
1465     
   0  220 (15.0) 211 (95.9) 9 (4.1) <0.001 
   1  334 (22.8) 312 (93.4) 22 (6.6)  
   2-5  507 (34.6) 434 (85.6) 73 (14.4)  
   >5  404 (27.6) 309 (76.5) 95 (23.5)  
Drug use in the last 3 
months 
     
   No  474 (32.4) 428 (90.3) 46 (9.7) 0.003  
   Yes  991 (67.7) 838 (84.6) 153 (15.4)  
STD in past 6 months      
   No  1242 (84.8) 1104 (88.9) 138 (11.1) <0.0001 
   Yes  223 (15.2) 162 (72.7) 61 (27.4)  
State-level Characteristics 
Equality       
HRC state Equality Index 1465     
   Low equality  739 (50.4) 666 (90.1) 73 (9.9) <0.001 
   High Equality  726 (49.6) 600 (82.6) 126 (17.4)  
Structural Racism 1465     
   High state racism (<22)  640 (43.7) 572 (89.4) 68 (10.6) 0.004 
78 
 
   Low state racism (>=22)  825 (56.3) 694 (84.1 ) 131 (15.9)  
Medicaid Expansion 1465     
   No  502 (34.3) 451 (89.8) 51 (10.2) 0.006 
   Yes  963 (65.7) 815 (84.6) 148 (15.4)  
Prevalence 1465     
   Mean (SD)  16.7 (7.6) 16.7 (7.5) 16.8 (8.5) 0.817 
   Median (Range)  15.4 (60.9)    
Poverty Rate 1465     
   Mean (SD)  14.9 (2.0) 14.9 (2.0) 14.8 (1.9) 0.576 
   Median (Range)  15.4 (13.8)    
Percent Uninsured 1465     
   Mean (SD)  9.6 (3.6) 9.8 (3.7) 8.9 (3.2) <0.001 
   Median (Range)  8.6 (14.3)    
*Wilcoxon rank sum test p-value 
1Human Rights Campaign (HRC) state scorecard 
2 Variable created from The Geography of Racial Stereotyping: Evidence and 
Implications for VRA Preclearance After Shelby County 
3 2015 US Census Bureau's American Community Survey Briefs for poverty  







Table 3 - 2. Multilevel Logistic Regression Models with Random Intercept with Variables Entered in Blocks by Level 
Model Summary Model1 Model 2 Model 3 Model 4  Model 5 
Ʈ2 of random 
effects 0.1434 0 0.09158 0.03005 0 
VPC or ICC 4.2 0 2.7 0.91 0 
MOR 1.44 1.00 1.33 1.18 1.00 
PCV           
PCV: proportional change of the variance, VPC: variance partition coefficient, ICC: intra class coefficient, MOR: median odds ratio 
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Table 3 - 3. Five-level covariate-adjusted multilevel logistic regressions (OR, AOR, and 95% CI’s) between individual, social and state 




OR) Model1 Model 2 Model 3 Model 4 Model 5 
 OR (CI)                                                
P-value 
ICC 
OR (CI)                                                
P-value 
OR (CI)                                         
P-value 
OR (CI)                                               
P-value  
 AOR (CI)                                                     
P-value 
Individual-level Characteristics 
Age       
   18-29 REF  REF   REF 
   30-39 
1.6 (1.084, 2.252)     
0.017  
1.3 (0.902, 1.903)  
0.154   
1.5 (1.018, 2.312)    
0.041 
   40-49 
1.5 (0.986, 2.349)     
0.058  
1.3 (0.827, 2.003)   
0.260   
1.6 (0.966, 2.593)       
0.068 
   >50 
1.0 (0.589, 1.783)     
0.930  
0.9 (0.499, 1.535)    
0.638   
1.2 (0.626, 2.165)         
0.628 
US Region of 
residence       
   South REF  REF   REF 
   Northeast 
2.2 (1.478, 3.344)    
0.0003  
2.1 (1.377, 3.168)     
0.001   
1.8 (0.642, 5.194)      
0.251 
   Midwest 
1.4 (0.799, 2.34)    
0.241  
1.5 (0.841, 2.549)     
0.173   
1.9 (0.712, 5.257)       
0.189 
   West 
1.5 (0.961, 2.229)    
0.075  
1.6 (1.020, 2.426)     
0.041   
1.4 (0.475, 4.371)       
0.509 
Race/ethnicity       
   Black REF  REF   REF 
   Hispanic 
0.7 (0.475, 1.008)      
0.055  
0.7 (0.467, 0.996)    
0.0477   




   Asian 
0.7 (0.375, 1.144)    
0.136  
0.5 (0.286, 0.892)    
0.019   
0.5 (0.251, 0.883)        
0.019 
   Other* 0.8 (0.463, 1.270)      
0.30  
0.7 (0.439, 1.211)    
0.220   
0.8 (0.430, 1.322)       
0.321 
Education       
   High School 
Diploma, GED,    
or less REF  REF   REF 







1.3 (0.723, 2.136)     
0.426  
1.3 (0.724, 2.145)    
0.422   
1.0 (0.559, 1.789)        
1.00 




2.3 (1.344, 3.754)      
0.002 
 2.2 (1.303, 3.730)    
0.004 
  1.7 (0.977, 3.016)        
0.060 
Sexual 
Identity       
   Gay REF  REF   REF 
   Did not 
identify as gay 
0.6 (0.401, 0.993)    
0.047  
0.7 (0.420, 1.051)    
0.079   




Status       
   No Main 
Partner (MP) REF   REF  REF 
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   MP is HIV-
positive 
4.6 (2.344, 9.194)     
<0.001   
4.0 (1.939, 8.315)    
<0.001  
3.6(1.704, 7.700)      
0.001 




0.5 (0.251, 1.163)    
0.114   
0.5 (0.213, 1.035)       
0.061  
0.5 (0.204, 1.024)        
0.057 
   MP HIV 
negative and 
on PrEP 
9.8 (4.043, 23.650)    
<0.001   
10.9 (4.355, 27.344)     
<0.001  
12.8 (4.888, 
33.462)      <0.001 
   MP HIV 
negative and 
not on PrEP 
0.4 (0.254, 0.638)       
<0.001   
0.4 (0.261, 0.709)        
0.0012  




past 3 months       
   '0 REF   REF  REF 
   '1 
1.6 (0.715, 3.594)    
0.249   
2.1 (0.870, 4.825)        
0.0998  
2.0 (0.830, 4.714)        
0.1225 
   2-5 
4.0 (1.916, 8.134)     
<0.001   
3.8 (1.795, 7.842)     
0.001  
3.9 (1.825, 8.137)       
0.001 
   >5 
7.0 (3.419, 14.337)     
<0.001   
6.0 (2.900, 12.496)     
<0.001  
6.7 (3.199, 
14.103)      <0.001 
Drug use in 
the last 3 
months       
   No REF   REF  REF 
   Yes 
1.7 (1.171, 2.429)     
0.006   
1.4 (0.964, 2.113)    
0.0745  
1.9 (0.983, 2.215)      
0.060 
STD in past 6 
months       
   No REF   REF  REF 
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   Yes 
2.9 (2.017, 4.158)     
<0.001   
2.6 (1.782, 3.886)     
<0.001  
2.6 (1.698, 3.825)      
<0.001 
State-level Characteristics 
Equality        
HRC State 
Equality Index       
   Low equality REF    REF REF 
   High 
equality 
1.8 (1.258, 2.702)      
0.002    
1.9 (1.107, 3.350)     
0.022 
2.0 (1.058, 3.720)       
0.033 
State Racism     
 
 
   High racism  
REF    REF REF 
   Low racism 
1.3 (0.844, 2.112)          
0.211    
1.2 (0.727, 1.875)    
0.513 
1.2 (0.711,2.136)        
0.447 
Medicaid 
Expansion        
   No REF    REF REF 
   Yes 
1.3 (0.781, 2.130)       
0.313    
0.8 (0.437, 1.554)     
0.542 
0.5 (0.218, 1.144)        
0.098 
Prevalence 
1.0 (0.982, 1.030)    
0.644    
1.0 (0.980, 1.027)    
0.808 
1.0 (0.971, 1.040)        
0.770 
Poverty Rate 
1.0 (0.880, 1.064)         
0.489    
1.0 (0.904, 1.095)     
0.918 
1.0 (0.913, 1.127)        
0.787 
Model Summary Model1 Model 2 Model 3 Model 4 Model 5 
Ʈ2   0.1434 0 0.09158 0.03005 0 
VPC or ICC  4.2 0 2.7 0.91 0 
MOR  1.44 1.00 1.33 1.18 1.00 
   PCV       
Fit Statistic       
   AICC  1157.04 1142.30 1018.98 1159.40 1000.90 
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   BIC  1160.73 1166.10 1039.15 1171.87 1049.80 
 
* Native American / Alaskan / Hawaiian / Pacific   Islander / Other 
1Human Rights Campaign (HRC) state scorecard 
2 Variable created from The Geography of Racial Stereotyping: Evidence and Implications for VRA Preclearance After Shelby County 
3 2015 US Census Bureau's American Community Survey Briefs for poverty  
4 Kaiser Family Foundation - Health Insurance Coverage of the Total Population  
*Estimated variance of random effect
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CHAPTER 4:  EXPLORATION OF MULTILEVEL PREDICTORS OF PRIMARY 
CARE PROVIDER TRUST AND ITS EFFECT ON PREP USE AMONG MEN 




Background: PrEP is reaching only a small proportion of those who could benefit from the drug 
and prescription rates among those eligible vary both by race/ethnicity and geographic region. 
Primary providers (PCP) are gatekeepers to the provision of PrEP and in recent decades, trust with 
PCP has been in decline. Individual-and structural-level factors have been shown to be associated 
with mistrust, factors including race/ethnicity and the geographic region one resides in. 
Furthermore, mistrust in PCP may be associated with a decreased willingness to take PrEP in 
populations that need it the most.   
Methods: Between May 2015-March 2016, a cross-sectional survey was conducted among a 
geographically diverse sample of HIV-negative MSM. The participant survey data was linked to 
publicly available state-level data based on participant’s residential zip code. Multivariable 
multilevel logistic regression was used to explore the association between multilevel variables and 
patient trust in physician (PTP) among a diverse sample of MSM. In addition, interaction analysis 
was performed among state-level race/ethnicity and LGBTQ+ equality variables and the individual-
level variables, sexual identity and race/ethnicity. 
Results: There were 2,750 HIV-negative participants who reported having a PCP. The results 
showed very little variation in PTP scores between states. However, several individual- and 
interpersonal-level factors including geographic region [Residents of the West β=-0.88, SE(0.27), 
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p-value=0.002], sexual identity [non-gay identity β=-0.48, SE(0.15), p-value=0.003], individual drug 
use [drug use β=-0.41, SE(0.13), p-value=0.004], and PrEP use [PrEP users β=0.75, SE(0.18), p-
value=0.0002]  were associated with PTP. Interaction analysis suggests that a person’s racial 
identity on PTP score varied depending on the racial equality of the state.  
Conclusions: Trust is central to the patient-physician relationship. Understanding the potential 
impact state policies and environments have on individual-level factors and its association with 





In July 2012, the US Food and Drug Administration (FDA) approved the use of tenofovir 
disoproxil fumarate plus emtricitabine (TDF-FTC, Truvada) for use as pre-exposure prophylaxis 
(PrEP) in HIV-negative adults who are at high-risk of HIV infection.1 In 2016, the CDC estimated 
that there were 1.1 million US adults who showed indications for PrEP use. This included 
approximately 814,000 men who have sex with men (MSM), who disproportionately accounted 
for a large majority of new HIV cases.2,3 Notwithstanding, only 7-8% of those eligible for PrEP were 
prescribed the drug by the year 2015.3 What’s more is that PrEP uptake has been unequally 
distributed by population subgroup and geographic region.4-6 Black individuals account for 
approximately 40% of persons with indications for taking PrEP but white individuals are nearly six 
times more likely to be prescribed the drug.3 PrEP has the potential to make a significant impact 
on new diagnoses if provision could be delivered to the populations who need it the most. 
Understanding the facilitators and barriers to its use, could guide future PrEP interventions. 
As with any new biomedical intervention, primary care providers (PCP) are the gate 
keepers, and a good doctor-patient relationship, is critical when disseminating information and 
encouraging uptake of new medications.7 A trusting doctor-patient relationship allows patients to 
be honest about their behaviors and needs, so that appropriate treatments can be discussed and 
ultimately delivered.  What’s more, is that a good relationship has also been shown to increase 
patient self-efficacy and protective behaviors, as well as motivate patients to decrease high-risk 
behaviors.8 However, trust in providers has been in decline in the US in recent decades.9 If there 
is mistrust, patients are less apt to communicate accurate information on behaviors and in 
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consequence be less likely to receive information specific to their situation. At present, there is 
documented research on medical mistrust among both racial/ethnic minorities and within sexual 
minority communities.10,11 However, there is limited research which focuses on how mistrust by 
sexual identity and race/ethnicity varies by geographic region and related to environmental 
factors. 12  
The disclosure of one’s sexual identity, their sexual behaviors, the feelings of perceived 
judgement or homophobia, and concerns about confidentiality are just a few barriers that may 
influence the relationship between MSM and their physicians.13-15 An overall distrust of providers 
has been reported by MSM, and some MSM go as far as separating their sexual healthcare from 
their primary healthcare due to this mistrust, fear of judgment, and/or embarrassment.16-18 Other 
MSM have reported delays in seeking HIV/STI services due to such barriers.16,17,19,20 This type of 
discrimination received or perceived is rooted in homophobia and can affect whether MSM seek 
and are able to obtain appropriate, quality and relevant health care.21-23 Any type of delay in care 
puts an already at risk population at even greater risk. 
Medical mistrust has also been shown to be more prevalent among racial and ethnic 
minority populations.24 Several studies have explored these populations and their distrust of 
medical research, of the health care system, and distrust of health care providers.24-26 In a study 
exploring knowledge and willingness to use PrEP among Black MSM at a community event, one-
in-five participants reported that they did not trust doctors and healthcare workers, and the 
variable mistrust was one of the strongest predictor of a willingness to use PrEP.11 Furthermore, 
studies have shown that racial and ethnic minority patients are more likely than white patients to 
refuse treatment.27 Mistrust by African Americans has been said to stem from the history of racial 
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discrimination and exploitation by the medical field, with studies including the Tuskegee 
experiments and other harms of black patients by health professionals. These studies have come 
to symbolize ethical misconduct and could be contributors to the mistrust and the disparities in 
healthcare provision we see today.25,28 Although most of the research to date is centered on black 
and African Americans in the US, it is not unforeseen that the mistrust and provider bias may be 
more prevalent and apply to other racial and ethnic minorities.  
Although there has been limited research, distrust of physicians in the US has been shown 
to vary by race/ethnicity and according to where one lives, with minorities more often having a 
higher distrust of physicians than whites.12 Depending on where one lives, state policies have the 
potential to influence social norms around perception and behavior towards sexual and racial 
minorities and people with fewer economic resources. In turn, these policies may affect how a 
provider treats or serves a patient and if there is mistreatment or even perceived mistreatment, 
this may increase mistrust. Understanding the potential impact state policies and environments 
have on patient-provider relationships may help us understand an individual’s decision to use 
PrEP. Acknowledging that PTP varies geographically and that LGBTQ+ and racial/ethnicity bias by 
a PCP can lead to further mistrust is relevant, as this could suggest that structural-level factors 
may impel mistrust.29  
Lastly, mistrust may be further complicated when there are intersecting minority identities 
(i.e. racial and sexual minority identity) and may be further impacted by context (the region that 
one lives). For example, one might expect more mistrust among minorities living in regions with 
higher levels of racism or anti-LGBTQ+ policies. Moreover, those with dual minority identities 
(MSM of color) may have more barriers than those with a single minority identity (white MSM). 
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These concerns are not unfounded, a recent study in MSM, indicated a potential for inequitable 
provision of PrEP across racial groups due to provider bias. This study cited that black MSM were 
rated as more likely than white MSM to engage in increased unprotected sex, reducing the 
provider’s willingness to prescribe the medication.30 These interacting variables may discourage 
and delay care seeking for those at highest risk.17,19,20  Therefore, the aim of this paper is to explore 
PCP mistrust among a geographically diverse sample of MSM in the US and assess how mistrust 





Study sample and data collection 
The data for these analyses come from a cross-sectional survey of a geographically-diverse 
sample of MSM in the US that was conducted from May 2015 to March 2016.  The study methods 
have been described elsewhere,31 but an abridge description is presented here.  Participants were 
eligible if they were age 18 years or older, cisgender male, and reported sex with other men in the 
past 5 years. All participants who were HIV-positive were excluded from these analyses. 
Participants were recruited via six different methods: (1) Online via a sexual networking 
website, where a banner was hosted advertising the survey for 30 days; (2) Online via various gay 
porn internet sites, where the same banner was used for a period of 39 days;  (3) Mobile devices 
via a geo-social sexual networking app popular with men-for-men connections, where we had a 
pop-up message that was displayed to participants when they opened the app for the first time 
during a given 12-hour window; (4) Online via a social networking site popular with the general 
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public, where we ran an advertisement for 11 days; (5) Street intercept outside of locations in New 
York City frequented by MSM; (6) An invitation to participants in a an ongoing panel study of 1,071 
HIV-negative MSM identified by a marketing firm.  All eligible participants completed a brief self-
administered survey that took approximately twenty minutes. Those recruited via street intercept 
completed the survey on an iPad equipped with Computer-Assisted Self-Interview (CASI) software, 
and all others did so online via a personal computer or phone app. The survey included questions 
about demographic characteristics, including zip code of residence, HIV risk/protective behaviors, 
including current PrEP use, questions about their primary care physician and trust in their 
physician, and, lastly, questions on partner characteristics (e.g. main partner’s HIV status and PrEP 
use). The participant survey data was then linked to publicly-available state-level data about state-
level economic and healthcare access indicators, HIV prevalence, as well as measures of LBGT 
equality and racism, based on participant’s residential zip code. 
Measures 
Outcome 
The outcome for these analyses was patient trust in physician (PTP). Those who reported 
having a PCP (N=2750) were asked to complete a brief validated measure of PTP. The tool included 
five questions: (1) Sometimes my doctor cares more about what is convenient for (him/her) than 
about my medical needs, (2) My doctor is extremely thorough and careful, (3) I completely trust 
my doctor’s decisions about which medical treatments are best for me, (4) My doctor is totally 
honest in telling me about all of the different treatment options available for my condition and (5) 
All in all, I have complete trust in my doctor. Responses options were in 5-point Likert scale from 
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strongly agree to strongly disagree. Responses were summed (range 5–25), with higher scores 
indicating more trust.32 
Predictor variables 
Individual- Level variables included demographics.  Participant age was based on self-report 
and was examined both as a continuous and a 4-category variable (18-29, 30-39, 40-49 and 50+ 
years), with categories based on the distribution of the data to ensure a sufficient number in each 
category. Race and ethnicity were categorized into 4 distinct groups (white, black, Hispanic, Asian, 
and other). The ‘other’ category included American Indian, Alaska native, native Hawaiian, Pacific 
Islander and other, which were combined due to the small sample sizes in each of these groups. 
Level of education was examined in 3 categories (High school diploma, GED or less; some college, 
currently enrolled in college and/or associates degree; 4-year college degree or more). Sexual 
identity was examined as three categories in the descriptive analysis (gay, bisexual, and other) 
and, due to the small numbers, the variable was dichotomized into an indicator for gay identity 
versus those who did not identify as gay, for the regression analysis.   
Social-level factors  
We defined social-level factors as behaviors or interactions that pertained or occurred 
between persons. These factors included, sexual behaviors, drug use, and STIs, PrEP use, since it 
requires communication with and a prescription from a physician, and main partner’s (MP) HIV 
status.  
Behavioral characteristics included the number of sex partners and drug use in the last 
three months as well as diagnosis with any sexually transmitted infection (STI) in the last six 
months. The number of sex partners was categorized into 4 groups (0 partners, 1 partner, 2-5 
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partners and >5 partners) based on the distribution of the data. To assess drug and STI history, 
participants were provided a list of recreational drugs (including non-prescription and 
prescription) and STIs and were asked to indicate which they had used or been diagnosed with the 
respective time period. Drug use and STIs were both dichotomized into an indicator for any versus 
none. 
All participants were asked about their current PrEP status. Responses were determined 
using replies to the question: “What is your HIV status?“ Options were: (1) HIV-positive and 
undetectable, (2) HIV-positive, but detectable, (3) HIV-negative, on PrEP, (4) HIV-negative, not on 
PrEP, (5) Don’t know/unsure. Participants who reported don’t know/unsure of HIV status were 
counted as HIV-negative for the purpose of this analysis. The outcome was categorized as on PrEP 
versus not on PrEP.  
Participants were asked if they had a main partner (MP) with whom they were in a 
committed relationship and, if so, their knowledge of their MPs HIV and PrEP status. For these 
analyses we included a five-category variable for MP status with the following categories: (1) no 
MP, (2) MP is HIV+, (3) MP and I don't know their status, (4) MP and they are HIV-negative and on 
PrEP (5) MP and they are HIV-negative and not on PrEP.  
State-level Characteristics - All state-level measures used were from 2015.  
The state Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) equality measure came 
from the Human Rights Campaign (HRC) state scorecard. The HRC assigns a score based on 
statewide laws and policies that affect LGBTQ people and their families.33 The HRC categorizes 
these scores into four groups: 1) High Priority to Achieve Basic Equality, 2) Building Equality, 3) 
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Solidifying Equality and 4) Working Toward Innovative Equality. We dichotomized the variable into 
low (categories 1 and 2) and high (categories 3 and 4) LGBTQ equality states. 
To asses state-level racism, a measure was used that ranks states by the proportion of its 
non-black residents who regard blacks more negatively than the national median.34 Elmendorf and 
Spencer et al. created the variable using multilevel regression with post-stratification, a statistical 
technique that has shown to yield estimates of state-level public opinion. Using  their results, each 
state was ranked from 1-50 with 1 representing the state with the highest proportion of nonblack 
residents who are ‘prejudiced overall’.34 This measure was modeled as a numeric variable. 
State HIV prevalence was ascertained from the CDC annual HIV Surveillance Report among 
adults and adolescents. Using the rankings set by the CDC, rates of HIV diagnoses per 100,000 
people were categorize into four categories: <10.0, 10.0-19.9, 20.0-29.9, and >/=30.35  
State-level poverty was defined using the US Census Bureau's American Community Survey 
Briefs for poverty in 2014-2015. The poverty rate measures the percentage of people whose 
household income fell below their state’s assigned poverty threshold. Poverty thresholds are 
assigned to individuals or families based on family size and composition.36 Both variables were 
continuous variables in the model. Healthcare access was determined based on the percent 
uninsured (via private or government insurance) in each state. Data was obtained from the Kaiser 
Family Foundation and modeled as a continuous variable.37  
Statistical analysis  
Descriptive statistics (means, standard deviations, and percentages) were calculated to 
describe the individual-, social-, and state-level characteristics of the sample overall and mean PTP 
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scores were reported by characteristic. Wilcoxon Two-Sample Test and Kruskall Willis were used 
to calculate p-values. 
Crude and multivariable multilevel linear regression models were created with random 
intercepts to estimate the variance explained by and the association of each independent variable 
with PTP scores. The level-1 unit was the participant and the level-2 unit was the state.  
Model 1 was an ‘empty’ model which assessed the extent that the variability in PTP scores 
was due to state- vs. individual-level factors.  Intraclass correlation coefficients (ICC) were 
computed. Model 2 included individual-level demographic characteristics (age, race, education, 
and sexual identity), Model 3 included interpersonal/social factors (number of partners, STIs, main 
partner’s status). Models 2-3 allowed for the assessment of the association of the set of individual- 
and interpersonal-level factors on PTP scores. Model 4 included all state-level characteristics to 
examine the association of state-level characteristics and PTP score. Model 5 was extended to 
include all variables into a final model.  
The analysis was then extended to explore whether the intersection of individual sexual 
and race/ethnic identity interacts with state-level LGBTQ+ and racial equality to shape PTP scores. 
The initial analysis explored a 4-way interaction with all four variables by adding all possible 
product terms, including all 2-way, 3-way and 4-way product terms for all possible combinations 
of the 4 variables, to the adjusted model.38 This model was then compared to 3 other models: (1) 
the main effects model, (2) model with only all 2-way interactions and (3) the model with 2- and 
3-way interactions. The significance of interaction was assessed at alpha=0.10 due to the reduce 
power when testing for interaction.39 Significant interaction will indicate that the impact of the 
main exposure (individual’s sexual and/or racial identity) on PTP score varies depending on state-
96 
 
level sexual minority and racial equality. Stratified analysis were conducted when a significant 
interaction was present. Specifically, if we found evidence of interaction, we stratified on state-
level equality measures to determine how equality modifies the association between individual-
identity and PTP score. All main effects were tested at alpha=0.05.  Analyses were undertaken 
using SAS 9.4 and PROC MIXED for binary outcomes (SAS, Cary, NC). 
RESULTS  
Description of the sample overall  
There were 2,750 HIV-negative participants who reported having a PCP. Most of the 
participants were between 18-29 years old (34.3%), followed >50 years of age (25.8%). The 
average age was 38.6 years old (SD=13.9). More than half of the participants were white (64.4%), 
identified as gay (78.8%), and reported having a college degree or more (51.1%). The greatest 
percentage resided in the South (31.4%). (Table 1)  
More than half of the participants reported that they were not taking PrEP at time of study 
(84.2%), and did not have a MP (61.0%). Of those with a MP (39.0%), the majority reported having 
a MP who was HIV-negative and not on PrEP (75.6%). In the past three months more than half of 
participants reported having more than one sexual partner (87.6%) and using drugs (64.1%). Over 
10% of the participants reported having been diagnosed with an STI within the last six months. 
(Table 1) 
Over half of the participants lived in states with the lowest LGBTQ+ equality (57.4%), the 
highest racial equality (54.2%), and in the second to lowest HIV prevalence range of 10.0-19.9 per 
100,000 (53.8%). The mean poverty rate of the states in which participants lived was 14.8% 
(SD=2.2), just above the 2015 national average of 13.5%, and the mean state-level percent 
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uninsured for participants was 9.0% (SD=3.4),36 which was similar to the national average in 
2015.37 
 Mean PTP scores  
The mean PTP score for all participants was 17.6 (SD=3.2) out of a possible maximum of 
25. Participants residing in the Northeast had higher PTP scores (17.9, SE=3.3) at the time of the 
study as compared to those from the South (17.6, SE=3.3), the Midwest (17.6, SE=2.9), and the 
West (17.2, SE=3.3), (p=<0.001). Participants who identified as gay (17.7, SE=3.2) and reported 
that they were taking PrEP at time of study (18.2, SE=2.9) had significantly higher scores that those 
who did not identify as gay (17.1, SE=3.3, p<0.001) or who were not taking PrEP (18.2, SE=3.3, 
p=<0.001), respectively. Participants who had a MP who was currently taking PrEP (18.6, SE=3.1) 
had significantly higher PTP scores than those who had a MP who was HIV-positive (17.7, SE=3.6), 
those who had no MP (17.6, SE=3.1), with a MP who was HIV-negative and not on PrEP (17.5, 
SE=3.2),  those who had a MP with an unknown/uncertain HIV status (17.4, SE=3.3; p=0.054). 
Lastly, participants who reported using drugs in the last 3 months (17.8, SE3.3) had significantly 
higher PTP scores than participants who reported no drug use (17.5, SE=3.2; p <0.001). (Table 1) 
Logistic regression Modeling Results 
Table 2 shows the assessment of variance for each model. Model 1 (empty model/ICC), 
suggests that 0.5%, or less than 1% of the total variance in PTP scores is due to between state 
differences whereas 99.5% is explained by individual differences. After adjusting for the respective 
variables per model, each model had a ICC of less than 1%, suggesting that there was little variance 
due to differences in characteristics between the states and that the remaining variance is due to 
unmeasured differences between individual- and state -level characteristics. There was no ICC 
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estimated for Models 5 as there was not enough variation in the response to attribute any 
variation to state- or individual-level effects, controlling for all variables in the model.40 
Crude Linear regression model results 
Table 3 describes the association of independent variables with PTP scores. In the bivariate 
models (Table 3, column 2), participants from the West [β=-0.39, SE(0.18), p-value=0.04] and those 
who did not identify as gay [β=-0.55, SE(0.15), p-value<0.0001] had a significantly lower PTP score 
as compared to those from the South and who identified as gay, respectively.  
Participants who were taking PrEP [β=0.70, SE (0.17), p-value<0.0001] and those who had 
a MP who was taking PrEP [β=1.0, SE (0.40), p-value=0.01] had significantly higher PTP scores 
compared to those who were not taking PrEP or did not have a MP, respectively. Conversely, 
participants who reported taking drugs in the last three months [β=-0.38, SE (0.13), p-value=0.004] 
had a significantly lower PTP score compared to those who did not take drugs during the same 
time period.  There were no significant associations between state characteristics and PTP score.  
Table 3 displays five models with covariate-adjusted multilevel linear regression results for 
individual-, social-, and/or state- level predictors of PTP scores. In model 2 (Table 3, column 3), the 
adjusted association of individual-level demographic characteristics with a participants PTP score 
was explored. Similar to the univariate model, participants from the West [β=-0.38, SE (0.18), p-
value=0.04] and those who did not identify as gay [β=-0.57, SE(0.15), p-value<0.0001] had a 
significantly lower PTP score compared to those from the South and who identified as gay, 
respectively. 
In model 3 (Table 3, column 4), the association of social-factors with PTP scores was 
explored. Participants who were taking PrEP [β=0.81, SE(0.19), p-value<0.0001] had significantly 
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higher PTP scores compared to those who were not taking PrEP, and participants who reported 
taking drugs in the last three months [β=-0.40, SE(0.13), p-value=0.0028] had significantly lower 
PTP scores compared to those who did not take drugs during the same time period. The 
association with having a MP who was taking PrEP was no longer associated with the PTP score. 
(Table 3). Similar to the univariate analysis, there were no significant associations between state 
characteristics and PTP scores (Table 3, column 4).  
Model 5 (Table 3, column 6) shows the results from the full model with all individual-, 
social-, and state-level variables included.   All variables significant in the models 1-4 showed 
similar associations in the final adjusted model.  
Interaction Results 
All possible four-, three-, and two-way, interactions were tested among state-level LGBT 
equality, state-level racial equality, and both individual-level variables, sexual identity and 
race/ethnicity. The 2-way interaction, (race/ethnicity * state’s racial equality), had a p-value = 
0.057 which was <0.10 and deemed to be statistically significant. The significant interaction 
suggests an association of a participant’s racial/ethnic identity on PTP score varied on the level of 
the racial equality of the state. 
After  stratifying on the racial equality of the state, overall compared to whites, participants 
who identified as ‘other’ and who lived in a high racial equality state had the highest PTP score 
(β=0.73, p-value=0.05) and Asians who resided in states with low racial equality had the lowest 
PTP scores (β=-0.87, p-value=0.14) compared to all groups. (Figure 1) 
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When we stratified by race, with the exception of black participants, compared to white, 
all other races had higher PTP scores in high racial equality states (less racism) than in low racial 
equality states (more racism). Compared to white participants, black participants who lived in low 
racial equality states had higher PTP scores than they did in high racial equality states (β=0.29, p-
value=0.34 vs. β=-0.19, p-value=0.40). Compared to white participants, Hispanics (β=-0.34, p-
value=0.18 vs. β=-0.30, p-value=0.16) and ‘others’ (β=-0.42, p-value=0.33 vs. β=0.73, p-
value=0.06), both had negative PTP scores (less than whites) in low racial equality state (and 
positive PTP scores (higher than whites) in high racial equality states. Lastly, regardless of the 
equality of the states, compared to whites, Asians had negative PTP scores, albeit, the PTP scores 




Participants who were taking PrEP at the time of the study had significantly higher PTP 
scores, suggesting that PrEP use may be associated with an individual’s trust in their physician. 
Although anecdotally and not fully explored in the literature, PrEP use has been said to be 
accompanied with additional monitoring, both before initiating the drug as well as during use. This 
added interaction may result in increased communications within the healthcare system and 
healthcare workers overall. One study suggested that PrEP use may be a gateway to primary care 
for MSM, similar to how family planning clinics were and continue to be a gateway for women.41,42  
Marcus and colleagues, further extended this to hypothesize that PrEP users may be more 
motivated to care for their own health, and that this increasing engagement in healthcare either 
may have led to a person using PrEP or was a result from the experience of using PrEP itself.41 
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However, if there is a lack of communication and trust between a patient and a physician, the 
people who need PrEP the most may not be receiving the necessary information regarding PrEP. 
MSM who lack trust in their providers, may be less likely to disclose their behavior and therefore 
less likely to be prescribed the drug, and vice versa.43 Although increased contact within the 
healthcare system for someone taking PrEP, may have allowed patients to cultivate relationships 
and subsequently build trust with their physicians, further research should be conducted to better 
understand the association between PCP trust and the provision of PrEP. 
Another interesting finding of this study was the association or lack thereof between PTP 
scores and a few individual- and social-level factors including sexual identity, individual drug use, 
and race/ethnicity.  Sexual identity and drug use are often associated with various types of stigma 
and their significant association with PTP scores in this study, could suggest that individual-level 
stigma is a barrier to the relationship between a patient and a physician. While there has been 
improved measures regarding inclusive health care for sexual minorities, MSM, especially MSM of 
color, are less likely to have access to health care and to culturally competent clinicians who are 
knowledgeable in healthcare relevant to this population.44,45 The suboptimal access to healthcare 
and HIV prevention services among MSM has been linked to distrust of providers, difficulty 
disclosing MSM status, stigma/discrimination, poverty, and experienced and internalized 
homophobia.17,19,20 These types of barriers could prevent patients from disclosing sexual identity 
or discussing sexual behaviors with their PCPs or can potentially discourage and/or delay someone 
from seeking healthcare at all. As compared to the participants who identified as gay, participants 
who did not identify as gay had lower PTP scores. Our results are consistent with other studies 
which have highlighted that mistrust of medical institutions, health care providers, and the health 
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care system in general, is high among people of color and LGBTQ+ persons and could be a 
significant barrier to accessing HIV services and interventions, including PrEP.12,14  Even more so, 
MSM who do not identify as gay may be fearful of disclosing their same-sex behavior to a 
provider.43 This reluctance to disclose may further create additional barriers to PrEP uptake.43 The 
data presented here may suggest the need for specific targeted interventions for physicians on 
how to interact and better understand this form of stigma.  
Participants who reported drug use in the last three months had lower PTP scores than 
those who reported no drug use. A study documents that substance use is more highly stigmatized 
than many other health conditions and might explain this lower trust in providers among 
substance users.46 Further studies suggest that drug-using patients and their physicians possess a 
mutual uncertainty about how to interact with each other.47 While our study looked at any type 
of drug use, much of the literature has focused on opiate abuse that began as pain treatment and 
how that interaction spiraled into mistrust.48,49 One study noted that physicians often do not 
acknowledge addiction as a medical disorder and that they may interpret drug-using behaviors as 
dishonesty rather than as a side effect of a medical disorder.47 Furthermore, studies have reported 
that those participating in particular types of drug use, such as injecting drug use or opioid abuse, 
may frequent health care services intermittently and only after they become sick.47 Understanding 
the stigma associated with drug use requires physicians to address any personal biases they may 
have when working with this population.  
The results discussed above, highlight the potential role stigma may play in trust in one’s 
PCP. There has been much documented research regarding mistrust in racial and ethnic minority 
populations, specifically in the black and African American populations. Recognizing the historical 
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legacy of harm at the hands of the medical profession, including but not limited to the Tuskegee 
syphilis experiment, we were surprised that we did not find a significant association between PTP 
scores and race/ethnicity. However, the significance in our interaction analysis suggests that 
structural-level variables may modify individual-level race/ethnicity. The interaction analysis found 
that racial/ethnic identity was modified by the structural-level factor, racial equality of the state. 
We have not seen other studies that look at this relationship specifically, however, we hypothesize 
that state policies have the potential to influence social norms and may strengthen efforts to 
counter structural/institutional racism in the health care system. A state with more equality may 
have minority-friendly clinics, with a focus on vulnerable communities both for race/ethnicity and 
for sexual minorities. These types of interventions could lead to both sexual and racial/ethnic 
minorities to feel more comfortable discussing sexuality and behavior with a healthcare provider. 
In the interaction analysis, regardless of the state’s equality, Asians had the lowest PTP scores 
overall, although scores were slightly higher in the states with more equality. Our findings are 
consistent with other studies that have suggested that Asian-Americans have the lowest 
satisfaction with healthcare than of any ethnic or racial group.50,51 Lastly, we noted that in high 
equality states, blacks have less provider trust than whites while possessing more trust than whites 
in low equality states. Conversely, in low equality states Hispanics, Asians and those who identify 
as ‘other’ have lower trust than whites but higher (or less low in the case of Asians) trust than 
whites in high equality states. Further research is needed on race/ethnicity and its association with 
trust in providers.  
Lastly, our study showed very little variation in PTP scores between states; however, the 
geographic region where someone lives was associated with PTP scores. The Northeast, the 
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Midwest, and the West all had lower PTP scores as compared to the South, however, only the 
West was shown to be statistically significant. There has been limited research on the geographic 
variation of patient trust in healthcare or PCP. In one study, where the primary interest was 
geographic variation in racial/ethnic differences in PTP, they documented that distrust varied 
racially/ethnically across cities, but that, on average, minorities had a higher distrust of physicians 
than did Whites.  However, the study did show inconsistencies, where in some cities blacks 
reported higher mean levels of distrust than whites while in others the results were reversed. The 
study put forth that the variations  could be due to the composition or environmental differences 
of the region,12 highlighting the need to conduct further studies on the role that state 
characteristics may play on PTP. As suggested from our interaction analysis, the impact that state-
level factors like equality may have on their residents may differ depending on their race/ethnicity 
and sexual identity. It’s plausible that a state that has more LGBT protective laws may have more 
LGBT-friendly clinics allowing MSM to feel more comfortable discussing sexuality and behavior 
with a healthcare provider which, in turn, may lead to the provider prescribing PrEP. 
Understanding the potential impact state policies and environments have on patient-provider 
relationships may help us understand an individual’s decision to use PrEP.  
Limitations 
Study findings should be understood in light of their limitations. First, the data is from a 
cross-sectional study precluding inferences about temporality or causality. Another limitation is 
that we do not have data on why some participants had lower trust in physicians and the 
healthcare system than others, meaning that trust may be a confounder for unknown or 
unmeasured constructs. Furthermore, some state-level constructs do not have a generally 
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accepted and validated measure, thus the measures we used may have reliability and validity 
issues, including construct validity. While participants were recruited from all 50 states, 
recruitment methods may not have resulted in a representative sample of MSM in the US and 
therefore findings may lack eternal validity.  
CONCLUSION 
Trust is central to the patient-physician relationship. Understanding the potential impact 
state policies and environments have on a patients trust in their provider and how that trust may 
modify the association of individual-level factors with patient-provider relationships may help us 
better understand the lower than desired PrEP uptake among some of the highest risk groups.  
Further qualitative research could help us better understand how environment impacts trust in 
physicians and what interventions could help PCPs address theses biases institutionalized through 
unequal policies for sexual minorities and racism. In February 2019, the current administration 
announced, Ending the HIV Epidemic in America, a new initiative which seeks to reduce all new 
HIV infections by 90% in the next 10 years. Although there has been much improvement regarding 
LGBTQ+ and racial justice in the US, the equality landscape in the country varies greatly by state 
and recent rollbacks in federal laws of sexual and reproductive health rights, and rights for LGBTQ+ 
and their families are cause for alarm.52,53 Our findings suggest that the policies that increase 
inequality and growing racism decrease PTP among some groups and this may hinder the 
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TABLES AND FIGURES 
 
Table 4 - 1. Description of individual-, social-, and state-level characteristics and PTP mean scores 




Individual level characteristics 
    
Age 2750 
   










   
   18-29 
 
944 (34.3) 17.5 (3.1) 0.835 
   30-39 
 
597 (21.7) 17.5 (3.1) 
   40-49 
 
500 (18.2) 17.7 (2.8) 
   >50 
 
709 (25.8) 17.6 (3.6) 
Recruitment Website 2750 
   
   Adam4Adam 
 
599 (21.8) 17.5 (3.6) 0.001 
   Facebook 
 
319 (11.6) 17.8 (3.1) 
   Field 
 
239 (8.7) 18.0 (3.8) 
   Geospatial app (Grindr) 
 
1269 (46.2) 17.4 (3.0) 
   Porn sites 
 
324 (11.8) 17.9 (2.9) 
US Region of residence 2750 
   
   Northeast 
 
703 (25.6) 17.9 (3.3) <0.001 
   Midwest 
 
552 (20.1) 17.6 (2.9) 
   South 
 
863 (31.4) 17.6 (3.3) 
   West 
 
632 (23.0) 17.2 (3.3) 
Race/ethnicity 2750 
   
   Native American / Alaskan / 
Hawaiian / Pacific   Islander / Other 
 
138 (5.0) 17.8 (3.7) 0.177 
   Black 
 
213 (7.8) 17.7 (3.6) 
   Hispanic 
 
519 (18.9) 17.6 (3.3) 
   Asian 
 
108 (3.9) 17.2 (3.2) 
   White 
 
1772 (64.4) 17.6 (3.1) 
Education 2750 
   
   High School Diploma, GED,    or less 
 
384 (14.0) 17.5 (3.2) 0.387 
   Some College, Associates  Degree, or 
currently enrolled in college 
 
961 (35.0) 17.6 (3.2) 
   4-Year College Degree or more 
 
1405 (51.1) 17.6 (3.2) 
Sexual Identity 2750 
   
   Identify as gay 
 
2168 (78.8) 17.7 (3.2) <0.001* 
   Do not identify as gay 
 
582 (21.1) 17.1 (3.4) 
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Sexual Identity 2750 
   
   Gay 
 
2168 (78.8) 17.7 (3.2) <0.001 
   Bisexual 
 
518 (18.8) 17.1 (3.4) 
   Other 
 
64 (2.3) 17.2 (3.0) 
Interpersonal-level Characteristics 
    
PCP knowledgable about sex with 
men 
2750 
   
    No 
 
872 (31.7) 17.0 (3.2) <0.001* 
   Yes 
 
1878 (68.3) 17.9 (3.2) 
PrEP use 
    
   No 
 
2316 (84.2) 17.5 (3.3) <0.001* 
   Yes 
 
434 (15.8) 18.2 (2.9) 
 
Main Partner Status 2750 
   
   No Main Partner (MP) 
 
1677 (61.0) 17.6 (3.1) 0.054 
   MP is HIV-positive 
 
79 (2.9) 17.7 (3.6) 
   MP HIV status unknown or uncertain 
 
159 (5.8) 17.4 (3.7) 
   MP HIV negative and on PrEP 
 
67 (2.4) 18.6 (3.1) 
   MP HIV negative and not on PrEP 
 
768 (27.9) 17.5 (3.2) 
Number of partners in past 3 months 2750 
   
   '0 
 
341 (12.4) 17.5 (3.4) 0.406 
   '1 
 
556 (20.2) 17.7 (3.1) 
   2-5 
 
1017 (37.0) 17.7 (3.1) 
   >5 
 
836 (30.4) 17.4 (3.3) 
Drug use in the last 3 months 2750 
   
   No 
 
987 (35.9) 17.8 (3.3) <0.001 
   Yes 
 
1763 (64.1) 17.5 (3.2) 
STD in past 6 months 2750 
   
   No 
 
2436 (88.6) 17.6 (3.2) 0.334* 
   Yes 
 
314 (11.4) 17.5 (3.1) 
State-level Characteristics 
    
Equality  
    
HRC State Equality Index 2750 
   
   0 - Low equality 
 
1579 (57.4) 17.5 (3.3) 0.923* 
   1 - High equality 
 
1171 (42.6) 17.7 (3.1) 
Racial equality 2750 
   
   0 - Low equality 
 
1260 (45.8) 17.6 (3.3) 0.541* 
   1 - High equality 
 
1490 (54.2) 17.6 (3.2) 
Prevalence 2750 
   
   <10.0 
 
719 (26.2) 17.6 (3.0) 0.443 
   10.0-19.9 
 
1478 (53.8) 17.6 (3.3) 
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   20.0-29.9 
 
462 (16.8) 17.4 (3.5) 
   >/=30 
 
91 (3.3) 18.2 (2.4) 
Medicaid 2750 
   
   No 
 
920 (33.5) 17.6 (3.3) 0.586 
   Yes 
 
1830 (66.5) 17.6 (3.2) 
Prevalence 2750 
   









Poverty Rate 2750 
   









Percent Uninsured 2750 
   









* Wilcoxon Two-Sample Test, all others are Kruskall Willis 
1 Human Rights Campaign (HRC) state scorecard 
2 Variable created from The Geography of Racial Stereotyping: Evidence and Implications for VRA Preclearance After Shelby County 
3 2015 US Census Bureau's American Community Survey Briefs for poverty  





Table 4 - 2. Multilevel linear regression models with random intercept with variables entered in blocks by level 
Model Summary Model1 Model 2 Model 3 Model 4 Model 5 
Ʈ2 of random effects 0.1434 0 0.09158 0.03005 0 
VPC or ICC 4.2 0 2.7 0.91 0 

















Table 4 - 3. Five-level covariate-adjusted multilevel linear regressions (Estimate, Standard Errors, and P-value) between individual, 
social, and state level variables and PTP score 
 Variables 
Bivariate  
(Crude OR) Model1 Model 2 Model 3 Model 4 Model 5 
 Estimate (SE)                                                
P-value 
ICC 
Estimate (SE)                                                
P-value 
Estimate (SE)                                      
P-value 
Estimate (SE)                                                
P-value 
Estimate (SE)                                     
P-value 
Individual-level Characteristics 
Age       
   18-29 REF  REF   REF 
   30-39 
-0.02 (0.17)     
0.893  
-0.02 (0.17)  
0.913   
-0.06 (0.17)  
0.740 
   40-49 
0.22 (0.18)   
0.226  
0.27 (0.18)  
0.144   
0.21 (0.18)   
0.2507 
   >50 
0.10 (0.16)    
0.547  
0.16 (0.17)   
0.325   
0.10 (0.17)   
0.570 
US Region of 
residence       
   South REF  REF   REF 
   Northeast 
0.21 (0.17)   
0.241  
0.21 (0.18)  
0.245   
-0.15 (0.26)   
0.574 
   Midwest 
-0.04 (0.18)   
0.828  
-0.01 (0.18)  
0.969   
-0.24 (0.25)   
0.351 
   West 
-0.39 (0.18)   
0.035  
-0.38 (0.18)  
0.044   
-0.88 (0.27)  
 0.002 
Race/ethnicity       
   White REF  REF   REF 
   Black 
0.04 (0.23)   
 0.881 
 
0.10 (0.24)   
0.663 
  
0.01 (0.24)  
 0.968 
   Hispanic 
-0.001 (0.16)   
0.994 
 0.07 (0.17)  
0.980 




   Asian 
-0.35 (0.32)   
0.278 
 -0.32(0.32)  
0.320 
  -0.33 (0.33)  
 0.303 
   Other* 
0.21 (0.28)   
0.466 
 0.27 (0.29)  
0.344 
  0.22 (0.29)  
 0.439 
Education       
   High School 
Diploma, GED,    
or less REF  REF   REF 







0.15 (0.19)    
0.443 
 0.13 (0.18)  
0.511 
  0.14 (0.19)   
0.489 




0.10 (0.19)   
0.576 
 0.08 (0.19)  
0.693 
  0.01 (0.19)   
0.960 
Sexual 
Identity       
   Gay REF  REF   REF 
   Did not 
identify as gay 
-0.55 (0.15)  
<0.001 
 -0.57 (0.15)  
<0.001 
  -0.48 (0.15)   
0.003 
Social-level Characteristics 
PrEP User       
   No REF   REF  REF 
   Yes 
0.70 (0.17)  
<0.001 
  
0.81 (0.19)    
<0.001 
 





Status       
   No Main 
Partner (MP) REF   REF  REF 
   MP is HIV-
positive 
0.06 (0.37)   
0.869 
  -0.23 (0.37)  
0.984 
 -0.25 (0.38)   
0.513 




-0.23 (0.27)   
0.393 
  -0.10 (0.27)  
0.466 
 -0.16 (0.27)  
0.567 
   MP HIV 
negative and 
on PrEP 
1.02 (0.40)  
 0.012 
  0.62 (0.41)  
0.147 
 0.61 (0.41)   
0.145 
   MP HIV 
negative and 
not on PrEP 
-0.58 (0.14)   
0.679 
  -0.12 (0.15)  
0.443 




past 3 months       
   0 REF   REF  REF 
   1 
0.24 (0.22)  
0.272 
  0.35 (0.24)       
0.152 
 0.27 (0.24)   
0.260 
   2-5 
0.21 (0.20) 
0.293 
  0.23 (0.21)   
0.279 
 0.22 (0.21)   
0.292 
   >5 
-0.06 (0.21)   
0.791 
  -0.12 (0.22)  
0.585 
 -0.10 (0.22)   
0.636 
Drug use in 
the last 3 
months       
   No REF   REF  REF 
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   Yes 
-0.38 (0.13) 
0.005 
  -0.41 (0.13)   
0.003 
 -0.41 (0.13)   
0.004 
STD in past 6 
months       
   No REF   REF  REF 
   Yes 
-0.13 (0.19)  
0.510 
  -0.24 (0.20)   
0.239 
 -0.21 (0.20)   
0.308 
State-level Characteristics 
Equality        
HRC State 
Equality Index       
   Low equality REF    REF REF 
   High 
equality 
0.20 (0.16)  
0.231 
   0.16 (0.21)   
0.447 
0.33 (0.20)   
0.102 
State Racism     
 
 
   High racism  
REF    REF REF 
   Low racism 
0.04 (0.15)  
0.792 
   -0.12 (0.19)   
0.535 
0.17 (0.19)    
0.392 
Prevalence        
   < 10.0 REF    REF REF 
   10.0-19.9 
0.0003 (0.18)  
0.999 
   -0.20 (0.19)   
0.922 
-0.20 (0.19)   
0.302 
   20.0-29.9     
-0.17 (0.31)  
0.577 
-0.56 (0.31)   
0.080 
   ≥ 30     
0.70 (0.43)  
0.109 
0.16 (0.42)   
0.700 
Prevalence 
-0.26 (0.24)  
0.278 
   -0.05 (0.03)   
0.158 




P overty Rate 
0.58 (0.40)  
0.154 
   -0.001 (0.04)  
0.977 
0.04 (0.04)   
0.261 





0.04789 0.01004 0.04401 0.05676 0 
VPC or ICC  10.2766 10.2545 10.16 10.27 10.1438 
MOR  0.464 0.097812469 0.492829492 0.549639965 0.003000292 
   PCV       
Fit Statistic       
    AICC   14222 14199.3 14235.9 14200.9 
   BIC   14225.9 14203.1 14.239.8 14202.8 
 
* Native American / Alaskan / Hawaiian / Pacific   Islander / Other 
1Human Rights Campaign (HRC) state scorecard 
2 Variable created from The Geography of Racial Stereotyping: Evidence and Implications for VRA Preclearance After Shelby County 
3 2015 US Census Bureau's American Community Survey Briefs for poverty  
4 Kaiser Family Foundation - Health Insurance Coverage of the Total Population  
*Estimated variance of random effec
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Table 4 - 4. Two-way interaction exploring participant’s race/ethnicity stratified on state-level 
LGBTQ+ equality measures (p=0.057). 
 
 Low Racial Equality States High Racial Equality States 
Race Estimate SE P-value Estimate SE P-value 
White REF REF REF REF REF REF 
Black 0.2889 0.3405 0.3995 -0.1874 0.3221 0.5626 
Hispanic -0.3446 0.2513 0.1754 0.3017 0.2127 0.1606 
Asian -0.871 0.5853 0.1419 -0.04866 0.3809 0.8987 








































Change in PTP scores by Race/Ethnicity and 
States Racial Equality
Low Racial Equality States High Racial Equality States
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Men who have se with men (MSM) in the US are the most heavily affected by HIV. Although 
MSM make up approximately 2–3% of the US population, in 2017, this group accounted for 70% 
of the 38,739 new HIV diagnoses.1 MSM of color are further disproportionately represented and, 
if current rates persist, the CDC reports that in their lifetime, one-in-two black and one-in-four 
Latino MSM will be diagnosed with HIV, compared to one-in-eleven white MSM.2 At present, there 
are more tools in our HIV toolbox than ever before to prevent HIV acquisition, with pre-exposure 
prophylaxis (PrEP) being one of the newest.3 Despite its effectiveness, PrEP prescriptions are 
reaching only a small proportion of those who could benefit from the drug and prescription rates 
vary both by race and geographic region.4 The CDC reported that in 2016, among the estimated 
1.1 million people nationwide who are potential candidates for PrEP, only 8% were taking PrEP.5,6 
More specifically, black and Latinos, who make up about two-thirds of the potential candidates for 
PrEP, accounted for the smallest percentage of PrEP prescriptions to date and states in the South 
of the United States (US), which had 52% of new HIV diagnoses, made up only 27% of PrEP users.7   
In the last three decades, much of HIV research has focused on individual-level variables, 
with insufficient attention to structural-level factors and how they may influence both individual-
and social-level variables. Initial PrEP studies focused largely on the acceptability and willingness 
to use PrEP. Acceptability was generally high and, although demographic and behavioral factors, 
including age,8,9 race/ethnicity,10-13 sexual behavior,8,12,14 and education,9,14 were found to be 
associated with PrEP use, the associations were inconsistent across studies and no clear patterns 
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emerged. The contradictions between studies could be due to the impact of higher-level 
contextual factors working as confounders or modifiers of individual-level associations, factors 
including stigma and/or the policies of the state where one resides.15,16 There has been an 
increasing recognition of the multi-level nature of HIV and the need to study the impact of 
social/structural drivers of the epidemic in addition to individual-level factors.8,17  However, 
understanding the influence that structural-level factors have on the epidemic is more challenging 
than solely examining the influence of individual-level variables alone. One of the major challenges 
is the ‘complexity and “immensity” of structural factors,’ and exploring their definitions and how 
they affect the individual.18 For example, in this dissertation there is not an accepted nor validated 
measure for the racism of a state, we used a measure that we considered most closely represented 
the construct of racism of a state, but, in fact, could instead be a causal marker for an unknown 
factor and this may be a limitation to our study.  Nonetheless, understanding the synergy of both 
the individual- and the structural- level factors is critical to understanding why the epidemic is 
more manageable in some populations than in others, and this dissertation is a start along that 
path.  
The social ecological model (SEM) contextualizes individuals’ behaviors using dimensions 
made up of intrapersonal, interpersonal, community, and public policy to provide a framework for 
describing the impact of factors at different levels and their interactions between each level.19 The 
SEM recognizes that, although individuals are responsible for their own health, an individual’s 
ability to assume this responsibility may be influenced by factors within and across each level.20 
Using the SEM as a backdrop, this dissertation attempted to examine how factors working at and 
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interacting across multiple levels of organization may explain why some groups are more likely to 
use PrEP than other groups. 
RESEARCH QUESTIONS 
Data from a cross-sectional survey of MSM residing in all 50 US states was used to test a 
series of hypotheses regarding PrEP use.  Specifically, we explored if (a) variables at the individual- 
(i.e. demographics, racial/ethnic and sexual identity), social- (main partner [MP] factors and social 
behaviors), and state-levels (state LBGTQ+ equality, racism, HIV prevalence, socio-economic 
factors) influenced the outcome (PrEP use and patient trust in provider [PTP] scores) among MSM 
with a focus on state equality (LBGTQ+ and racism). We further extended this hypothesis to 
examine if our state equality measures modified the association between individual racial/ethnic 
and sexual identity and our outcomes (PrEP use or PTP scores), and (b) if the association of state-
level (LGBTQ+ and racism) and individual-level sexual and race/ethnic identity variables with PrEP 
use was mediated through PTP.  We examined these hypotheses among all participants, and 
conducted a sub-analysis looking at the first hypothesis among only MSM of color, as this group 
currently has the highest HIV incidence in the US and we felt warranted a closer look in an attempt 
to tease out reasons for this high risk.21   
The outcome for aims 1 and 2 was PrEP use. In aim 1, we looked at all participants, 
irrespective of race/ethnicity, then, in aim 2, we focused on MSM of color only, excluding 
participants who reported their race/ethnicity as non-Hispanic white.  The outcome for aim 3 was 
patient trust in physician (PTP) and all participants who reported they had a primary care physician 
(PCP) were included in the analysis.  
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SUMMARY OF FINDINGS 
Aim 1 and Aim 2 
Aim 1 included 4,165 HIV-negative MSM of whom 13.4% (N = 560) were taking PrEP at the 
time of the survey. In Aim 2, there were 1,465 HIV-negative MSM of color, of whom 13.6% (N = 
199) were taking PrEP.  In both aims 1 and 2, our results suggested that both individual and 
structural-level factors are important as main effects, as seen with the LGBTQ+ and the sexual 
identity variables remaining significant even after controlling for all other variables. LGBTQ+ 
equality of a state may be a marker for multiple causal factors or even play a direct role in 
influencing PrEP use among MSM. This is consistent with findings in other studies examining 
equality and health outcomes, and suggests that LBGTQ+ inequality may impact the risk and 
health-seeking behaviors of MSM and/or hinder access to appropriate healthcare.22-25 LGBTQ+ 
friendly states may also have a stronger LGBTQ+ community which can provide social support, 
more awareness of HIV and prevention interventions, and more access to healthcare that focuses 
on MSM-specific health needs.26  Similarly, in both aims, sexual identity was also shown to be 
associated with PrEP use. Participants who did not identify as gay had significantly lower odds of 
taking PrEP than those who identified as gay. Participants who did not identify as gay may be less 
comfortable discussing their sexual behavior with a healthcare provider and/or may be less 
integrated into the LGBTQ+ community, which may impact knowledge/access to PrEP.  
Unlike the LGBTQ+ equality variable, in aims 1 and 2 our measure of state-level racism was 
not associated with PrEP use. However, in aim 2 among MSM of color, race/ethnicity was 
significantly associated with PrEP use.  There has been a considerable amount of research showing 
that MSM of color feel isolated from the broader LGBTQ+ community or have experienced 
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racism/discrimination within that community,27 and therefore we had hypothesized that those 
with dual minority identities, sexual and racial, might be more impacted by the co-occurrence of 
LBGTQ+ and racial inequality. However, in both aims, exploration of interaction did not support 
this hypothesis, and the racism and LBGTQ+ equality of the state were not found to be modifiers 
of the association of individual-level identity in predicting PrEP use. Although in both aims, our 
measure of state racism was not predictive, in Aim 2, there was evidence that PrEP use varied by 
a participant’s race/ethnic identity. Participants who identified as either Latino or Asian had lower 
odds of taking PrEP compared to black participants, suggesting that PrEP use is not only suboptimal 
among MSM of color, but that it is differential by race/ethnicity among racial/ethnic minorities, 
even after controlling for individual level factors. These results suggest that MSM of color are not 
one panethnicity and that even within MSM communities of color, there is ethnic and racial 
diversity which should be considered and addressed with specific culturally appropriate HIV 
prevention strategies. 
In both Aims 1 and 2, several social and behavioral variables were strongly associated with 
PrEP use, specifically the MP variable. Participants with MP’s who were HIV-positive or were 
currently taking PrEP had much higher odds of taking PrEP themselves, while, in both aims, 
participants who had a negative MP who was not on PrEP had lower odds of taking PrEP. Only in 
Aim 1, participants whose MP HIV status was unknown had lower odds of taking PrEP compared 
to participants with no MP. In Aim 2, this category was not significant. The MP findings may be 
related to HIV-specific social support and communication within couples and requires further 
research. Similarly, participants with more sexual partners or a recent STI diagnosis also had higher 
odds of taking PrEP. However, due to the nature of this study, we were unable to deduce whether 
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the higher number of sexual partners or an STI diagnosis was a cue to initiate PrEP or whether 
those on PrEP were more likely to have increased number of partners or a higher likelihood of 
STIs. Age was also associated with higher odds of using PrEP, in both aims, participants between 
30-39 years had higher odds of taking PrEP compared to the youngest group, while only in Aim 1, 
participants between 40-49 were also shown to have higher odds of taking PrEP compared to the 
youngest group. 
Interestingly, in both aims, in model 2 of the logistic regression, the individual-level model, 
both the Northeast and the West were associated with higher PrEP use, however in the final 
adjusted model both variables lost significance. In addition, in aim 1, in model 2, we saw a reversal 
in the significance of association of age. In the individual-level model, >50 years of age was 
significantly associated with lower PrEP use, however, in the final adjusted model this 
characteristic lost significance, but those who were younger, between 30-39 and 40-49 years, 
became significantly associated with higher odds of using PrEP. Similarly, in aim 2, education lost 
significance from model 2 to model 5. These changes suggest that the social- and/or structural -
level factors may have been confounding the associations in models looking only at the individual-
level and therefore the inconsistency we saw in previous research could have been due to not 
adjusting for these larger multi-level variables.  
Aim 3 
In aim 3, we included 2,750 HIV-negative participants who reported having a primary care 
provider (PCP). The average PTP score for all participants was 17.6 (Range = 5 - 25). Aim 3 showed 
very little variation in PTP scores between states, however, after controlling for individual-, social-
, and structural-level factors, geographic region was associated with PTP. Overall, taking PrEP was 
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associated with significantly higher PTP scores, while participants from states in the West (versus 
the South), those who did not identify as gay (versus gay), and those who reported taking drugs in 
the last three months had significantly lower PTP scores.   
Although we did not see the individual racial/ethnic identity or the state LBGTQ+ equality 
or racism variables to be associated with PTP scores, our interaction analysis did suggest that 
racial/ethnic identity influenced PTP differently depending on the racism at the state-level. After  
stratifying on the racial equality of the state, the results suggest  that, with the exception of black 
participants, all other races had higher PTP scores compared to whites in high racial equality states 
(less racism) than in low racial equality states (more racism). In addition, compared to whites, 
participants in the ‘other race’ category who lived in a high racial equality state had the highest 
PTP score, while Asians who resided in states with low racial equality had the lowest PTP scores 
compared to all groups. Lastly, in our final analysis in aim 3 we found that PTP was not a mediator 
between individual identity, state level equality variables and PrEP use (see appendix A). 
Overall, the findings from the analysis from Aim 1, 2, and 3 suggest that there is a 
complicated relationship among and between the individual-, social-, and the structural-level 
factors and how they impact for whom and where in the US PrEP is being used. In aims 1 and 2, 
LGBTQ+ equality was significantly associated with PrEP use, while in aim 3, PTP scores are also 
associated with PrEP. Although we concluded that PTP was not a mediator between individual 
identities and the equality of the state and PrEP use, further exploration may be needed using 




This is one of the first studies that explored several multi-level predictors of PrEP use and, 
given our large sample, it also offered a unique opportunity to examine the influence of state-level 
factors on PrEP use as  main effects, effect modifiers, and factors farther back on the causal 
pathway working via mediators. The results of our work suggest that individual-, social-, and state-
level variables, specifically the LGBTQ+ equality of the state of residence, are associated with PrEP 
use. In the last decade, there has been much improvement regarding LGBTQ+ and racial justice in 
many states in the US; however, the equality landscape in the country varies greatly by state. In 
February 2019, the current administration announced, Ending the HIV Epidemic in America, a new 
initiative which seeks to reduce all new HIV infections by 90% in the next 10 years.28 Unfortunately, 
there has been concerns over the approach of the current administration to HIV, both globally and 
domestically, and specifically in their work towards undoing much of the equality progress that 
has been made here in the US.29 In the last three years, there has been rollbacks in federal laws of 
sexual and reproductive health rights, as well as the rights for LGBTQ+ and their families,30,31 a 
move away from harm reduction to a more punitive approach to drug use,32 and lastly, the many 
steps this administration has taken to weaken the Affordable Care Act.33  The findings of this study 
suggest that policies that increase inequality may have a detrimental impact on HIV prevention 
interventions and may hinder the administration’s new initiation. 
FUTURE RESEARCH 
Our research identified a number of individual-, social-, and structural-level factors that 
may be associated with PrEP use and can inform future studies as well strengthen the existing 
literature. Below we lay out potential future research at the state and at the individual/social 
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levels to better understand potential predictors of PrEP use and subsequently improved effective 
PrEP interventions.  
State-Level Characteristics 
An important finding of this dissertation at the state level suggested that participants who 
resided in states with more LGBTQ+ equality had a higher odds of using PrEP even after controlling 
for individual-, social-, and structural-level factors. This could mean that states with more equality 
may have the ability or the resources to reach this population and to provide more access to 
culturally relevant healthcare, specifically healthcare that focuses on minority health. Other 
studies suggest that state policies are a factor when assessing health in gender minority 
populations.23,34 Hatzenbuehler and colleagues found in a number of studies that structural 
discrimination led to increased risk of psychiatric disorders among LGBT populations.23,34 In a 
quasi-natural experiment conducted by Hatzenbuehler and colleagues, after gay marriage was 
legalized in Massachusetts, hospital utilization, psychiatric visits, and overall healthcare 
expenditures was significantly reduced among gay men.35  Future research is needed to fully 
disentangle the role state LGBTQ+ equality has on LGBTQ+ people and what the driving factors are 
when it comes to the health of this population. In aim 3, we did not see an association with the 
LGBTQ+ equality of the state and PTP, nor did we see that PTP mediates the relationship between 
LGBTQ+ equality and PrEP use, however, we did see that PTP scores were associated with PrEP 
use. Therefore it would be important to see what at the state level impacts PrEP use, including but 
not limited to the policies and resources that are provided to providers. The policies and resources 
provided by the state may encourage more providers to prescribe PrEP or not. In addition, more 
research should look at the role of the provider in states with both high and low LGBTQ+ equality. 
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Moreover, future research should explore other forms of stigma at higher levels, including 
stigma specifically associated with PrEP, state racism, and PCP stigma/discrimination. First, it 
would be important to see how PrEP-stigma manifests in all populations in need of HIV prevention. 
In both aims 1 and 2, we explored the association between state racism and PrEP use, and we 
extended this analysis in aim 2, where we attempted to explore the intersectionality of multiple 
minority identities interacting with multiple forms of inequality and subsequently its impact on 
PrEP use. The findings in this dissertation did not find a significant association between PrEP use 
and the state racism score, nor did we find any evidence of interaction among minority identities 
and state-level equality measures.  In future research, it would be important to further explore 
the effects of racism on PrEP use, specifically racism experienced by MSM of color. The current 
stigma research often focuses on the consequences of only one form of stigma. MSM of color 
likely experience the stress of multiple minority stigmas which are often correlated and 
interrelated and their combined effects may not just be additive.36 The statistics have shown that 
MSM of color are not only disproportionately affected by HIV but also that this group at times feels 
isolated from the broader LGBTQ+ communities and/or have experienced racism and 
discrimination from within the gay community.27,37 We did not explore racism within the gay 
community as the data we had did not include this information. Moving forward, exploring racism 
experienced within the gay community and its association with PrEP would be important as it could 
suggest that the racism experienced at the community-level is more important in the health-
seeking behaviors of MSM of color than racism at the state-level as a whole.   
Furthermore, state-level racism is difficult to measure and our variable may not have 
captured this construct adequately. Although our measure of state racism was not predictive, we 
131 
 
did find variation in the odds of PrEP use by individual race/ethnic identity.  Among participants or 
color in our study, those who identified as either Latino or Asian had lower odds of taking PrEP 
compared to black participants, suggesting that PrEP use is both suboptimal among MSM of color 
overall and differential by race/ethnicity, even after controlling for multi-level factors. MSM of 
color should not be treated as a panethnicity, and each group, as well as other factors including 
sexual identity and nativity, need to be considered and addressed with specific culturally 
appropriate HIV prevention strategies.  
Individual- and Social-Level Characteristics 
With the understanding that the effectiveness of PrEP is associated with adherence, a 
better understanding of the dynamics of non-adherence is crucial. In both aims 1 and 2, MP HIV 
and PrEP use were strongly associated with participant PrEP use. Compared to those with no MP, 
participants with a MP who was HIV-positive or who was taking PrEP at time of study were more 
likely to be taking PrEP themselves while those who had a negative MP who was not on PrEP or 
whose MP HIV status was unknown, had lower odds of taking PrEP. There have been many studies 
using the theory of interdependency to better understand the health-enhancing behaviors 
undertaken by those within a couple. One study looked at the motivations of HIV-negative couples 
to use PrEP and suggested the importance of incorporating relationship dynamics into biomedical 
strategies.38 Importantly, this should also be explored among MSM of color, as studies have cited 
that most intervention research on black MSM have focused on individual-level barriers and 
facilitators, rather than those at the couple-level.39 Therefore, research to understand how best 
to provide appropriate and effective PrEP roll out to MSM in relationships could be a facilitator in 
PrEP uptake.  
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Lastly, both aim 1 and 2 showed that participants who did not identify as gay were less 
likely to use PrEP. Those who do not identify as gay may not feel comfortable discussing their 
sexual behavior with a healthcare provider and/or may be less integrated into the LGBTQ+ 
community, which may impact knowledge and access to PrEP. Therefore, understanding the 
dynamics that sexual identity has on health-seeking behavior is important and could be beneficial 
for the healthcare community. 
Study design 
Multilevel modeling (MLM) is a statistical approach that can be used in analyzing clustered 
data or data collected at more than one level in order to demonstrate a relationship.40,41  Similar 
to the data source used in this dissertation, of the studies that have conducted MLM and HIV 
prevention, have been mostly of a cross-sectional design.42,43  Therefore a longitudinal MLM study 
exploring both individual and structural level factors and its association with PrEP acceptability in 
an MSM population would be very relevant to the literature. 
LIMITATIONS  
Overall  
There are a number of potential limitations that should be mentioned. First, the data used 
for each aim was from a cross-sectional survey not originally designed to answer the questions 
posed in this dissertation. Analyses from cross-sectional studies, where the exposures and 
outcome are simultaneously assessed, would preclude inferences about temporality or causality 
for our variables of interest. For example, for aims 1 and 2, a participant could have lived in a state 
with high equality and initiated PrEP and then moved to a state with low equality and continued 
taking PrEP. Although we do not believe that this would have occurred often enough to get a 
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reverse association, it is worth noting that not controlling for this type of migration could make a 
causal relationship impossible to be determined or at least in this case it could have 
underestimated the true association.  Similarly, in aim 3, we did not have data on whether 
participants had ever had a PCP or about their experiences with the healthcare system (i.e. 
frequency, if they had a nurse practitioner vs a pcp). This could have led to misclassification of the 
outcome as they would have been excluded from the analysis for not having a PCP.  
Another limitation is that the study relied on self-reported data. Taking PrEP has been 
associated with several types of stigma, including the stigma of being related to HIV, HIV risk, and 
also the negative reputation of enabling promiscuity, inconsistent condom use, and unsafe sex.44 
Therefore, the sensitive nature of some of the social behavioral questions (i.e. drug use, partner 
number, history of STI, or even the outcome, PrEP use) may have led to social desirability bias or 
to some respondents to answer falsely. Although these questions were conducted either privately 
online or on an ACASI, due to the nature of online surveys there is the potential for sampling bias, 
potential false reporting due to social desirability bias, recall error, misunderstanding of the 
questions, or error in entering the response may also have resulted in non-differential 
misclassification. Another limitation is that some of the state-level constructs we used did not have 
a generally accepted and validated measure, thus the measures used may have reliability and 
validity issues, including construct validity. Generalizability should also be mentioned as a 
limitation, although participants included residents from all 50 US states, recruitment, for the most 
part was conducted online and may not have resulted in a representative sample of MSM in the 
US, and therefore our findings may lack external validity. Lastly, the data we used for this 
secondary analysis was collected in 2015-2016. As we’ve seen over the past five years, the 
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landscape for PrEP is rapidly evolving and therefore, some of the information we present in this 
dissertation may be outdated. 
Finally, a limitation specific to aims 1 and 2 was our use of multilevel modeling (MLM) for 
a dichotomous outcome, PrEP use. The statistics used to quantify fitness (i.e. pseudo-R2) of a MLM 
with a dichotomous outcome are often difficult to interpret.45 Although there are other statistical 
models which will account for clustering of data, our interest in this study was to identify how 
much variation in PrEP use was due to state-level versus individual-level factors and not just 
estimate population average effects for variables at these different levels. For this reason, we used 
MLM as we considered this the best statistical method that could accomplish our aim, despite the 
difficulty in interpreting some of the measures when the outcome is dichotomous.  
FINAL CONCLUSION 
Biomedical individualism is the view that the causes of disease can always be tracked to an 
individual biological factor.46 Focusing only on individual-level factors of HIV conveys a myopic 
focus of a virus that is so enwrapped in social determinants. This view excludes structural 
conditions as factors that exert influence on the individual including the equality, discrimination, 
and access/affordability that might be associated with where a person resides.  The HIV epidemic 
is complex, and understanding the environment certain groups at higher risk must be explored. To 
do this, we need to conduct studies at multiple levels if we want a clear picture of facilitators and 
barriers to PrEP. PrEP is one of the newest biomedical tools in our toolkit and a successful scale-
up plan will require a biomedical, behavioral and social intervention to maximize its preventative 
impact. In final, PrEP will not be the last preventative tool and establishing effective policies and 
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APPENDIX A: SENSITIVITY ANALYSIS FOR EQUALITY AND RACISM 
VARIABLES 
 
DESCRIPTION OF ANALYSIS 
 
Sensitivity analysis to determine variables to be include in model as well as to determine 
categorizations for main predictor variables. Variables to consider:  
a. Main predictors:  LGBT stigma variable (HRC) and Racism variable 
b. Additional state characteristics: 
i. HIV prevalence 
ii. Income and income inequality 
1. GINI 
2. State median 
3. Poverty level 
iii. Healthcare Access 
1. Medicaid 
2. Percent uninsured 
METHODS 
 
1. Run Correlations between all continuous state variables (GINI, state median, poverty level, 
percent uninsured) 
2. Plot continuous variables that appear to correlate (See below) 
3. Plot continuous variables with the LGBT categorical variable (See below) 
4. Bivariate analysis of state variables 




Pearson Correlation Coefficients, N = 4165  
Prob > |r| under H0: Rho=0 


















































































































Using information from the correlations, plots, bivariate, and multivariate analysis we conducted 
a sensitivity analysis for state-level variables to be included in our analysis with a focus on the 
LGBTQ+ and Racism variable.In addition, we explored the categorizations for our state-level 
predictors. When we had four categories, for the LGBTQ+ equality variable, we saw no difference 
in the results. For the racism variable, there was evidence of a dose response, however, none of 
the four categories were significant. Our decision to collapse was based on parsimony and our 
final adjusted model. In our final model, we did not have enough power to include multiple 
categories, therefore we decided to collapse the variables. In final, the variables to be included in 




Final Variable Analysis: 
 
1. Removed GINI due to lack of variation. GINI a good measure of inequality between 
countries not US states 
2. Collapsed HRC and racism variable to a binary variable for parsimony 
3. Additional state characteristics: Removed state median due to multicollinearity with many 
of the variables as well as with the main HRC predictor 
FINAL VARIABLES: MAIN PREDICTORS - Collapsed HRC, Racism OTHER-HIV Prevalence 









Gini vs poverty rate 
Pearson’s Correlation = 0.4286
 
Gini vs Prevalence 




Poverty rate versus Prevalence 









Poverty Rate vs Racial stigma 




Poverty rate versus % uninsured 
Pearson’s Correlation = 0.4353 
 
 
Prevalence versus %uninsured 
Pearson’s Correlation = 0.4353 
 
 
Racial Stigma versus %uninsured 
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Pearson’s Correlation = -0.613 
 
Poverty rate versus State median 
Pearson’s Correlation = -0.644 
 
 
Racial stigma versus State median 





Percent uninsured versus State median 
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Racial Stigma vs. LGBT stigma 




Medicaid vs. LGBT stigma 
Pearson’s Correlation = -0.618 
 
 
Poverty Rate  vs. LGBT stigma 
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Pearson’s Correlation = 0.2402 
 
 
Prevalence vs. LGBT stigma 
Pearson’s Correlation = -0.01 
 
 
State Median vs. LGBT stigma 





Table A - 1. Bivariate Analysis of State-Level Characteristics 
State-level Characteristics Odds Ratio 95% CI 
Main predictors - Equality      
HRC state Equality Index     
   Lowest equality REF REF 
   Low equality 1.00 0.684, 1.460  
   High equality 1.77 1.255, 2.493 
   1 - Highest equality 1.68 1.282, 2.205 
HRC (collapsed)     
   Lowest equal REF REF 
   Highest equal 1.71 1.372,2.139 
Structural Racism (continuous) 1.014 1.004, 1.0024 
Structural Racism (Collapsed)   
   High racism REF REF 
   Low racism 1.441 1.117, 1.860 
Structural Racism (Collapsed)     
   1-12 (High Racism) REF REF 
   13-21 1.12 0.757, 1.649 
   22-29 1.13 0.734, 1.742 
   30-50 (Low Racism) 1.41 0.969, 2.055 
Income and Income inequality      
GINI (continuous)  >999.999 30.787, >999.999 
US Census Gini coefficient by state     
   Less than 0.470 REF REF 
   0.470-0.485 0.932 0.685, 1.268 
   <0.485 1.419 1.032, 1.951 
State median (continuous)  1.00 . 
US Median Household Income     
   Less than $50,000 REF REF 
   $50,000 to $59,999 1.333 0.958, 1.854 
   $60,000 or more 1.89 1.354, 2.638 
Poverty Rate 0.991 0.938, 1.047 
Healthcare Access     
Participated in Medicaid Expansion     
   No REF REF 
   Yes 1.294 0.977, 1.714 
Percent Uninsured (continuous) 0.91137 0.93, 1.01 
Other     
HIV Prevalence (continuous)  1.014 1.001, 1.028 
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Prevalence     
   <10.0 REF REF 
   10.0-19.9 1.054 0.777, 1.43 
   20.0-29.9 0.821 0.54, 1.249 




Table A - 2. LGBTQ+ In 4 Categories for Bivariate, State, and Multivariate Model 
 Variables Model 1 Model 2 Model 3 Model 4 
 
OR (CI)                                                
P-value 
OR (CI)                                          
P-value 
OR (CI)                                                
P-value 




    
Age 
    
   18-29 REF 
  
REF 
   30-39 1.18 (0.93, 1.50)   
0.1779 
  
1.34 (1.02, 1.76) 
   40-49 1.09 (0.84, 1.43)  
0.5079 
  
1.36 (1.01, 1.84) 
   >50 0.77 (0.59, 1.00)  
0.0499 
  
0.94 (0.69, 1.28) 
US Region of 
residence 
    
   South REF 
  
REF 
   Northeast 1.41 (1.03, 1.94)  
0.035 
  
1.52 (0.84, 2.77) 
   Midwest 0.99 (0.72, 1.36)  
0.940 
  
1.04 (0.65, 1.69) 
   West 1.38 (1.01, 1.86)  
0.041 
  
0.97 (0.56, 1.67) 
Race/ethnicity 
    
   White REF 
  
REF 
   Black 1.41 (1.02, 1.94)  
0.035 
  
1.42 (0.99, 2.05) 
   Hispanic 0.92 (0.71, 1.20)  
0.537 
  
0.97 (0.72, 1.30) 
   Asian 0.69 (0.42, 1.12)  
0.127 
  
0.74 (0.44, 1.27) 
   Other 1.01 (0.66, 1.54)  
0.971 
  
1.08 (0.68, 1.73) 
Education 
    
   High School 





   Some College 1.23 (0.85, 1.77)  
0.273 
  
1.02 (0.69 ,1.52) 
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   4-Year College 
Degree or more 
2.29 (1.62, 3.24)  
<0.01 
  
1.76 (1.21, 2.56) 
Sexual Identity 
    
   Gay REF 
  
REF 
   Other  0.55 (0.41, 0.74)  
<0.001 
  




    
Main Partner 
Status 
    






   MP is HIV-
positive 
 
4.63 (3.03, 7.09)  
<0.001 
 
4.46 (0.36, 0.67)  




0.34 (0.19, 0.61)   
<0.001 
 
0.34 (0.19, 0.62)  
   MP HIV 
negative and on 
PrEP 
 





   MP HIV 
negative and not 
on PrEP 
 
0.46 (0.35, 0.61)  
<0.001 
 
0.47 (0.35, 0.62)  
Number of 
partners in past 
3 months 
    





   '1 
 
1.301 (0.756, 2.240)  
0.340 
 
1.16 (0.67, 2.01)  
   2-5 
 
3.276 (2.083, 5.153)  
<0.001 
 
3.16 (2.00, 4.99)  
   >5 
 





Drug use in the 
last 3 months 
    





   Yes 
 
1.33 (1.04, 1.69)  
0.022 
 
1.28 (0.99, 1.64)  
STD in past 6 
months 
    







   Yes 
 
3.25 (2.55, 4.14)  
<0.001 
 
3.16 (2.46, 4.05)  
State-level 
Characteristics 
    
Equality  
    
HRC state 
Equality Index 
    




   3- Low equality 
  
0.88 (0.55 1.41) 
0.573 
1.02 (0.59, 1.79) 
   2- high equality 
  
1.76 (1.22, 2.54) 
0.004 
1.34 (0.75, 2.39) 
   1 - Highest 
equality 
  
1.45 (1.05, 2.00) 
0.024 




1.32 (0.99, 1.76) 
0.060 
1.10 (0.72, 1.67) 
Prevalence 






0.95 (0.724, 1.234 ) 
0.6736 
0.71 (0.51, 0.99) 
2=20.0-29.9 
  
0.99 (0.65, 1.51) 
0.958 
0.73 (0.41, 1.30) 
3=>/=30 
  
1.80 (1.12, 2.91)  
0.017 
1.33 (0.69, 2.57) 
Poverty Rate 
  
1.02 (0.96, 1.07) 
0.582 




1.01 (0.96, 1.06) 
0.793 
1.03 (0.97, 1.10) 




0.01602 0.05931 0.004963 0 
VPC or ICC 0.485 1.77 0.15 0 
MOR 1.128 1.262 1.070 1 
PCV 80.1 26.1 93.8 0 
Fit Statistic 
    
    AICC 3192.54 2658.99 3255.27 2595.47 
152 
 





Table A - 3. LGBTQ+ and Racism in 4 Categories for Bivariate, State, and Multivariate Model 
 Variables Model 2 Model 3 Model 4 Model 5 
 
OR (CI)                                                
P-value 
OR (CI)                                      
P-value 
OR (CI)                                        
P-value 





    
Age 
    
   18-29 REF 
  
REF 
   30-39 1.18 (0.93, 1.50)   
0.1779 
  
1.34 (1.03, 1.76)  
0.003 
   40-49 1.09 (0.84, 1.43)  
0.5079 
  
1.36 (1.01, 1.84 )  
0.047 
   >50 0.77 (0.59, 1.00) 
0.050 
  
0.94 (0.69, 1.28)  
0.705 
US Region of 
residence 
    
   South REF 
  
REF 
   Northeast 1.41 (1.03, 1.94)  
0.035 
  
1.48 (0.77, 2.84)  
0.240 
   Midwest 0.99 (0.72, 1.36)  
0.940 
  
1.03 (0.60, 1.75)  
0.917 
   West 1.38 (1.01, 1.86)  
0.041 
  
1.08 ( 0.59, 1.96)  
0.829 
Race/ethnicity 
    
   White REF 
  
REF 
   Black 1.41 (1.02, 1.94)  
0.035 
  
1.42 (0.99, 2.05)  
0.554 
   Hispanic 0.92 (0.71, 1.20)  
0.537 
  
0.97 (0.73, 1.31)  
0.859 
   Asian 0.69 (0.42, 1.12)  
0.127 
  
0.74 (0.43, 1.27) 
0.269 




Pacific   
Islander / 
Other 
1.01 (0.66, 1.54)  
0.971 
  
1.08 (0.67, 1.72)  
0.740 
Education 
    
154 
 
   High School 





   Some 
College 
1.23 (0.85, 1.77)  
0.2728 
  
1.02 (0.69, 1.52)  
0.920 




2.29 (1.62, 3.24)  
<0.001 
  
1.76 (1.21, 2.56)  
0.004 
Sexual Identity 
    
   Gay REF 
  
REF 
   Other  0.55 (0.41, 0.74)  
0.001 
  




    
Main Partner 
Status 
    






   MP is HIV-
positive 
 
4.63 (3.03, 7.09)  
<0.001 
 
4.46 (2.89, 6.90)  
<0.001 





0.34 (0.19, 0.61)   
<0.001 
 
0.34 (0.19, 0.62)  
<0.001 




16.30 (9.65, 27.53) 
<0.001 
 
16.80 (9.82, 28.73)    
<0.001 
   MP HIV 
negative and 
not on PrEP 
 
0.46 (0.35, 0.61)  
<0.001 
 




past 3 months 
    





   1 
 
1.30 (0.76, 2.24)  
0.340 
 
1.16 (0.67, 2.02)  
0.597 
   2-5 
 
3.28 (2.08, 5.15)  
<0.001 
 
3.16 (2.00, 4.99)  
<0.001 
   >5 
 
6.65 (4.26, 10.39)  
<0.001 
 




Drug use in 
the last 3 
months 
    





   Yes 
 
1.33 (1.04, 1.69)  
0.022 
 
1.27 (0.99, 1.64)  
0.058 
STD in past 6 
months 
    





   Yes 
 
3.25 (2.55, 4.14)  
<0.001 
 




    
Equality  
    
HRC state 
Equality Index 
    
   Lowest  
  
REF REF 
   Low  
  
1.05 (0.66, 1.67) 1.10 ( 0.65, 1.89) 
   High  
  
2.07 (1.49, 2.87) 1.42 (0.86, 2.36) 
   Highest  
  
1.68 (1.22, 2.31) 1.76 (1.10, 2.81) 
Structural 
Racism 
    
   ≤13 
  
REF REF 
   13 - 22 
  
1.10 (0.71, 1.71) 0.92 (0.55, 1.53) 
   23-30 
  
1.09 (0.66, 1.80) 0.83 (0.44, 1.58) 
   >30 
  
1.15 (0.71, 1.87) 0.88 (0.44, 1.78) 
Prevalence 






0.92 (0.69, 1.21) 0.72 (0.50, 1.03) 
20.0-29.9 
  
0.96 (0.62, 1.49) 0.73 (0.41,1.30) 
≥30 
  
1.71 (1.04, 2.82) 1.32 (0.67, 2.56) 
Poverty Rate 
  




1.01 (0.96, 1.06) 1.02 (0.94, 1.10) 
Model 
Summary 





0.01602 0.05931 0 0 
156 
 
VPC or ICC 0.485 1.77 0 0 
MOR 1.13 1.26 1 1 
PCV 80.1 26.1 0 0 
Fit Statistic 
    
    AICC 3192.54 2658.99 3255.27 2602.83 





APPENDIX B: CHAPTER 3 MEDIATION ANALYSIS 
 
Aim 3d: Explore Patient trust in physician (PTP) as a mediator of the association between 
individual- and state-level factors and PrEP use. 
METHODS 
 
 In Aim 3 we examined the relationship among individual-, social- and state-level factors 
and patient trust in their physician (PTP). The fourth sub-aim of aim 3, (3d), was to explore PTP 
as a mediator between individual-level sexual and race/ethnic identity and state-level LBGTQ+ 
equality and racism and PrEP use. However, in our analyses for aim 1, we found that individual-
level race/ethnicity was not associated with PrEP use and in the analyses for aim 3 our results 
suggested that state-level LBGTQ+ equality and racism were not associated with PTP.  These null 
findings suggest that our mediation hypothesis is unlikely to be supported with our data.  
However, in the interest of completing the analyses proposed for this dissertation, we conducted 
a formal assessment of PTP as a mediator in the relationship between individual (sexual and racial 




Mediation analysis investigates the mechanisms that underlie an observed relationship 
between an exposure variable and an outcome variable.  It examines whether a third 
intermediate variable, the mediator,  explains the relationship between the exposure and the 
outcome variable.1 The traditional approach, the Barron / Kenny method, is based on using 




the total and direct effects.2 However, recent methodological papers have shown that there are 
potential issues to this approach.1,3 One issue is that this approach doesn’t test the significance 
of the indirect pathway, where the independent variable (IV) affects the dependent variable (DV) 
through the pathway via the mediator which can fail to measure some or partial mediation 
effects.1,4 However, the traditional approach is still considered useful, as it can be used as a 
preliminary step to assess the potential for the proposed mediation process. 
New advances in mediation analysis have been made by using the counterfactual 
framework which has allowed for definitions of direct and indirect effects and for decomposition 
of a total effect.5 The causal inference method extends past the traditional approach and can 
address some of the issues of the Baron / Kenny approach. Furthermore, this approach provides 
a better understanding of the causal structure of the variables involved in a model, where the 
direct and indirect effects in a counterfactual framework are defined and alternative analytical 
methods have been introduced to improve the validity and interpretation of mediation analysis.3 
One methodological approach, one that can explain unseen or partial mediation, are the methods 
described by Valeri and Vanderweele, where they aim to calculate the indirect effect.   
In this mediation analysis we used both the Baron / Kenny and the causal inference 
approach using the Valeri and Vanderweele SAS mediation macros to explore if PTP was a 
mediator between state- and individual-level exposures and PrEP use. Due to the nature of the 
data, we will conduct additional bootstrapping analysis in conjunction with the causal inference 
approach. Bootstrapping is a non-parametric method based on resampling with replacement 
which we will do 1000 times, however can be run up to 5000 times.6 Bootstrapping is a popular 
method of testing the indirect effect and is an alternative to the Delta method which calculates 




which will not hold with our analysis as we are using logistic regression and could lead to overly 






• Outcome: PrEP use:  Dichotomous indicator for yes the participant is taking PrEP vs. No 
• State-level exposures:  
o State racial equality (racialstigma_binary): Dichotomous indicator for low racial 
equality vs. high racial equality. This variable was a measure by Elmendorf and 
Spencer et al., the variable ranks states by the proportion of its non-black residents 
who regard blacks more negatively than the national median.7 Using  their results, 
each state was ranked from 1-50, with 1 representing the state with the highest 
proportion of nonblack residents who are ‘prejudiced overall’.7 This measure was 
then dichotomized at the median. 
o State LGBTQ+ equality (hrc_lgbt_1): Dichotomous indicator for Low LGBTQ+ vs. 
High LGBTQ+ equality. The LGBTQ+ equality measure came from the Human 
Rights Campaign (HRC) state scorecard which assigns a score based on statewide 
laws and policies that affect LGBTQ people and their families.8 The HRC categorizes 
these scores into four groups: 1) High Priority to Achieve Basic Equality, 2) Building 
Equality, 3) Solidifying Equality, and 4) Working Toward Innovative Equality. We 
Patient Trust in 
Provider (PTP) 
PrEP use 
1. State equality (LGBTQ+ 
equality, racial equality) 







dichotomized the variable into low (categories 1 and 2) and high (categories 3 and 
4) LGBTQ equality states. 
• Individual identity exposures:  
o Individual race/ethnicity (race_reg): Dichotomous indicator for identifying as 
other vs. white (Note: The original race/ethnicity variable used in other models in 
this dissertation were polytomous (white, black, Hispanic, Asian, and other). This 
variable was dichotomized due to lack of mediation analysis methodology for 
polytomous exposure variables.) 
o Sexual identity (sexident_reg): Dichotomous indicator for identifying as other vs. 
identifying as gay.  
o Mediator: Patient trust: pcp_score_binary  Dichotomous indicator for ≤ 18 vs. > 
18. Using responses from a 5-question validated survey where the response 
options were in 5-point Likert scale from strongly agree to strongly disagree. 
Responses were summed (range 5–25), with higher scores indicating more trust.9 
The variable was dichotomized at the median. 
Steps 
Each exposure variable was examined separately. 
1. Baron and Kenny approach to mediation analysis (using SAS proc freq): 
1. Assessed the relationship between each exposure variable and PrEP use.  
2. Conducted an analysis to determine whether PTP may be a potential mediator of 
the relationship between exposure variables and PrEP use.  
i. Assessed whether adjusting for the mediator (PTP score) reduces the 




3. Using the Causal Inference approach to mediation analysis (using the Valeri  and 
Vanderweele SAS mediation macros):  
i. Assess the direct and indirect effects 
ii. Assess using bootstrapping method to confirm results. 
RESULTS 
The step-by-step results for both the state and the individual-level exposures are reported 
at the end of each section for each methodology, the Baron/Kenny approach and the Valeri and 
Vanderweele methods. Overall the results using both methods yielded consistent results.  
State-level variables 
There was a strong association between state racial equality variable and PrEP use. The 
analysis suggested that participants who lived in states with high racial equality had higher odds 
(OR=1.5, 95% CI: 1.254, 1.914) of taking PrEP than those who lived in a low racial equality state. 
PTP was associated with taking PrEP with those who had high PTP scores having an odds of taking 
PrEP that is 1.3 times greater than those with low PTP scores (95%CI 1.051, 1.593). However, PTP 
scores were not significantly associated with racism of the state (OR=1.4, 95% CI:0.997, 1.903), 
suggesting that PTP is not a mediator between state racism and PrEP use according to the 
Baron/Kenny approach. 
The Causal Inference methodology showed a significant direct effect of a state’s racial 
equality on odds of taking PrEP (OR=1.6, 95% CI: 1.26 – 1.91), however, there was not a significant 
indirect effect of racial equality on the odds of PrEP use through the PTP score (OR=1.0, 95% CI: 
0.99-1.01). The bootstrapping based method yielded the same results. 
The LGBTQ+ equality variable showed similar results to the racial equality as an exposure 




who lived in states with high LGBTQ+ equality had higher odds (OR=1.8, 95% CI: 1.448, 2.188) of 
taking PrEP than those who lived in a low LGBTQ+ equality states. LBGTQ+ equality was associated 
with PrEP use (OR=1.3, 95%CI 1.050, 1.593), but, similar to the racial equality variable, LGBTQ+ 
equality was not significantly associated with PTP scores (OR=1.0, 95%CI 0.844, 1.153) and thus 
our mediation hypothesis was not supported by the data.  
Using the Causal Inference methodology, we found a significant direct effect of the state’s 
LGBT+ equality on odds of taking PrEP (OR=1.8, 95% CI: 1.45, 2.19). However, there was not a 
significant indirect effect on PrEP use through the PTP score (OR=1.00, 95% CI: 0.99, 1.01). 
Bootstrapping provided similar results.  
Overall, for both state equality variables, the controlled direct effects were equivalent to 
the natural direct effects, indicating lack of mediation. In each case, there were significant direct 
effects of the state-level equality variables (i.e. racial and LGBTQ+) on the odds of taking PrEP, 
however, there was not a significant indirect effect through PTP score. 
Individual-level variables 
The association between individual race/ethnic identity and PrEP use was not significant 
(OR=1.1, 95% CI: 0.875, 1.338). The association between race/ethnicity and PTP scores was also 
not significant (OR=1.0, 95% CI: 0.860, 1.187), but PTP was significantly associated with PrEP use 
(OR=1.3, 95%CI 1.050, 1.593). Thus the mediation hypothesis was not supported by the data 
using the Baron/Kenny approach. 
Similarly, using the Causal Inference methodology, showed there was no  significant direct 
effect of individual race/ethnic identity on the odds of taking PrEP (OR=1.1, 95% CI: 0.874, 1.34), 
nor was there a significant indirect effect of race/ethnicity on the odds of using PrEP through PTP 




Using the Baron/Kenny approach, sexual identity  was strongly associated with PrEP use 
such that those who did not identify as gay had significantly lower odds of taking PrEP than those 
who identify as gay (OR=0.4, 95% CI: 0.329, 0.609). Participants who did not identity as gay also 
had significantly lower odds (OR=0.7, 95% CI: 0.593, 0.876) of having high PTP compared to 
participants who identify as gay. And, as shown in all the analyses above, PrEP use was 
significantly associated with PTP scores (OR=1.3, 95%CI 1.050, 1.593). Thus the criteria for 
mediation are met, but when using the Valeri and Vanderwheele Causal Inference methodology 
we found a significant direct effect of identity on odds of taking PrEP (OR=0.45, 95% CI: 0.334, 
0.629), but there was not a significant indirect effect through PTP (OR=0.98, 95% CI: 0.962, 1.00). 
The bootstrapping method gave similar conclusions that no meditation was occurring.  
Thus we conclude that the impact of state level LBGT+ equality and racism and individual 
sexual and racial/ethnic identity on PrEP use is not mediated through PTP.  In all analyses, the 
controlled direct effects were equivalent to the natural direct effects, signifying lack of mediation. 
Limitations 
 
These methods have a number of limitations that should be considered and are listed here. 
1. Although there is clustering within states, we analyzed the data as if there were no 
clustering.  However, our findings regarding the associations from the main analyses in 
aims 1 and 3 that did account for cluster suggest that mediation is unlikely.   
2. According to the literature, in a multi-level modeling mediator analysis, it is recommended 
that the dependent variable (DV) and the mediator variable (MV) be continuous variables, 
while the independent variable (IV) can be either.10 The literature cites that the odds ratio 
of a binary outcome that is common in nature may be a problem when conducting logistic 




ratios are not directly comparable. Therefore, the traditional approach to mediation even 
if there is no X-M association will result in a non-interpretable estimate.10 In our case, our 
data did not allow for the DV (PrEP use) to be a continuous variable. Therefore, we 
conducted this analysis violating this rule. Currently there is no methodology that we 




1. ICC of the mediator and the outcome 
 
ICC of the mediator: PTP score 
 
proc mixed data=aim3_data cl covtest noclprint; 
class zip_state; 




Covariance Parameter Estimates 
Cov Parm Subject Estimate Standard 
Error 
Z Value Pr > Z Alpha Lower Upper 
Intercept ZIP_STATE 0.04789 0.03397 1.41 0.0793 0.05 0.01715 0.3995 
Residual   10.2766 0.2780 36.97 <.0001 0.05 9.7528 10.8440 
 
ICC of the outcome: PrEP use 
 
*ICC of the outcome; 
proc mixed data=aim3_data cl covtest noclprint; 
class zip_state; 




Covariance Parameter Estimates 
Cov Parm Subject Estimate Standard 
Error 
Z Value Pr > Z Alpha Lower Upper 
Intercept ZIP_STATE 0.001668 0.000854 1.95 0.0253 0.05 0.000750 0.006375 













1. Relationship of state racial equality variable and PrEP use: 
 
proc sort data=aim3_data; 
by descending racialstigma_binary descending prep_user; 
run; 
 
proc freq data=aim3_data order=data; 
table racialstigma_binary*prep_user / relrisk chisq; 
run; 
 
Table of racialstigma_binary by prep_user 
racialstigma_binary prep_user(dichotmous variable for PrEP use) 
Yes No Total 









































Odds Ratio and Relative Risks 
Statistic Value 95% Confidence Limits 
Odds Ratio 1.5491 1.2540 1.9138 




Odds Ratio and Relative Risks 
Statistic Value 95% Confidence Limits 
Relative Risk (Column 2) 0.9348 0.9054 0.9652 
 
Those who live in states with high racial equality have odds of not taking PrEP that are 1.5 
greater than that of those who live in a low racial equality state. The 95% confidence interval 
is (1.254, 1.914), which does not include the null value one, and, therefore this increased odds 
is statistically significant at the 0.05 level. 
 
2. Determine whether PTP score may be a potential mediator of the relationship between the 
state’s racial equality variable and PrEP use.  
 
a. Are PTP scores associated with living in more racially equal states (mediator to 
exposure)? 
proc sort data=aim3_data; 
by descending racialstigma_binary descending pcp_score_binary; 
run; 
 
proc freq data=aim3_data order=data; 
table racialstigma_binary*pcp_score_binary/relrisk chisq nopercent norow nocol; 
run; 
 
Table of racialstigma_binary by pcp_score_binary 
racialstigma_binary pcp_score_binary 
High PTP score  Low PTP score Total 






















Odds Ratio and Relative Risks 
Statistic Value 95% Confidence Limits 
Odds Ratio 0.9734 0.8338 1.1363 
Relative Risk (Column 1) 0.9833 0.8930 1.0828 
Relative Risk (Column 2) 1.0102 0.9529 1.0710 
 
Those who live in states with high racially equality, have odds of having high PTP scores that is 1.0 
times greater than that of those who live in low equality states.  The 95% confidence interval is 
(0.834, 1.114), which includes the null value one, and, therefore this increased odds is not 
statistically significant at the 0.05 level. 
b. Are PTP scores associated with taking PrEP (mediator to outcome)? 
proc sort data=aim3_data; 
by descending pcp_score_binary descending prep_user; 
run; 
 
proc freq data=aim3_data order=data; 
table pcp_score_binary*prep_user/relrisk chisq nopercent norow nocol; 
run; 
 
Table of pcp_score_binary by prep_user 
pcp_score_binary prep_user(dichotmous variable for PrEP use) 
Yes No Total 



















Odds Ratio and Relative Risks 
Statistic Value 95% Confidence Limits 
Odds Ratio 1.2935 1.0506 1.5927 




Odds Ratio and Relative Risks 
Statistic Value 95% Confidence Limits 
Relative Risk (Column 2) 0.9593 0.9267 0.9929 
 
Those who have higher PTP scores, have a higher odds of taking PrEP that is 1.3 greater times 
than that of those with low PTP scores.  The 95% confidence interval is (1.051, 1.593), which 







3. Valeri’s mediation macro 
 
Macro Inputs: 
 data: name of your dataset 
 yvar: name of your outcome variable 
 avar: name of your exposure variable 
 mvar: name of your mediator variable 
 cvar: name of your other covariates (must be dummy variables, leave blank if none) 
 a0: baseline level of exposure 
 a1: new exposure level 
 m: level of the mediator at which the controlled direct effect is to be estimated 
 nc: number of covariates used (leave blank if none) 
 yreg: type of regression to be used to model outcome variable (linear, logistic) 
 mreg: type of regression to be used to model mediator variable (linear, logistic) 
 interaction: specify if exposure-mediator interaction is present (true, false) 
 output: reduced (leave blank) or full output (=full)* 
 c: level of covariates to calculate conditional effects (default is mean level if left blank) 
 casecontrol: use if using case-control data (leave blank, true) 
boot: bootstrapping option (true [runs 1,000 samples] or number of samples,) or delta 
method (leave blank) 
 
*Reduced output=controlled direct effect, natural direct effect, natural indirect effect, total effect 
Full output = also displays “pure” effects, effects conditional on covariates and the effects 
evaluated at the mean level of covariates 
 
Did not add confounders/covariates as it was not in proposal. 
 
Racial equality mediation macros 
 
**Question 6a for racial equality**; 






Obs Effect Estimate p_value _95__CI_lower _95__CI_upper 
1 cde 1.55324 0.00005 1.25699 1.91932 
2 nde 1.55324 0.00005 1.25699 1.91932 
3 nie 0.99830 0.73526 0.98848 1.00821 





There is a significant direct effect of a state’s racial equality on odds of taking PrEP (OR=1.6, 95% 
CI: 1.26 – 1.91), however, there is not a significant indirect effect of a state’s equality on odds of 
PrEP use through the PTP score (OR=1.00, 95% CI: 0.99-1.01). Lastly, the controlled direct effects 
were equivalent to the natural direct effects, signifying lack of mediation. 
 
 
Now running with bootstrapping using 100 samples. 
 






m=logistic y=logistic bootstrap=100 
 
Obs Effect Estimate s_e_ _95__CI_lower _95__CI_upper 
1 cde 1.55518 0.15874 1.27704 1.85276 
2 nde 1.55518 0.15874 1.27704 1.85276 
3 nie 0.99892 0.00567 0.98802 1.01019 
4 marginal total effect 1.55349 0.15868 1.27489 1.85642 
 



























1.  Relationship of state LGBTQ+ equality and PrEP use: 
 
proc sort data=aim3_data; 
by descending hrc_lgbt_1 descending prep_user; 
run; 
 
proc freq data=aim3_data order=data; 
table hrc_lgbt_1*prep_user / relrisk chisq; 
run; 
 
Table of hrc_lgbt_1 by prep_user 
hrc_lgbt_1 prep_user(dichotmous variable for PrEP use) 
Yes No Total 









































Odds Ratio and Relative Risks 
Statistic Value 95% Confidence Limits 




Odds Ratio and Relative Risks 
Statistic Value 95% Confidence Limits 
Relative Risk (Column 1) 1.6222 1.3642 1.9290 
Relative Risk (Column 2) 0.9113 0.8805 0.9431 
 
Those who live in states with high LGBTQ+ equality have odds of taking PrEP that are 1.8 
greater than that of those who live in a low LGBTQ+ equality state. The 95% confidence interval 
is (1.4481, 2.1882), does not include the null value, and, therefore this increased odds is 
statistically significant at the 0.05 level. 
2. Determine whether PTP score may be a potential mediator of the relationship between state 
equality variables and PrEP use.  
a. Are PTP scores associated with living in more LGBTQ+ equal states (mediator to exposure)? 
 
proc sort data=aim3_data; 
by descending hrc_lgbt_1 descending pcp_score_binary; 
run; 
 
proc freq data=aim3_data order=data; 
table hrc_lgbt_1*pcp_score_binary/relrisk chisq nopercent norow nocol; 
run; 
Table of hrc_lgbt_1 by pcp_score_binary 
hrc_lgbt_1 pcp_score_binary 
High PTP score Low PTP score Total 



















Odds Ratio and Relative Risks 
Statistic Value 95% Confidence Limits 




Odds Ratio and Relative Risks 
Statistic Value 95% Confidence Limits 
Relative Risk (Column 1) 0.9916 0.8996 1.0929 
Relative Risk (Column 2) 1.0051 0.9478 1.0659 
 
Those who live in high LGBTQ+ equality states have odds of having high PTP scores that is 1.0 
times greater than that of those who live in low LGBTQ+ equality states.  The 95% confidence 
interval is (0.440, 1.153), which includes the null value one. Therefore this increased odds is not 
statistically significant at the 0.05 level. 
b. Are PTP scores associated with taking PrEP (mediator to outcome)? 
 
proc sort data=aim3_data; 
by descending pcp_score_binary descending prep_user; 
run; 
 
proc freq data=aim3_data order=data; 
table pcp_score_binary*prep_user/relrisk chisq nopercent norow nocol; 
run; 
 
Table of pcp_score_binary by prep_user 
pcp_score_binary prep_user (dichotmous variable for PrEP use) 
Yes No Total 



















Odds Ratio and Relative Risks 
Statistic Value 95% Confidence Limits 
Odds Ratio 1.2935 1.0506 1.5927 
Relative Risk (Column 1) 1.2408 1.0429 1.4763 





Those who have higher PTP scores have an odds of taking PrEP that is 1.3 greater times than 
that of those with low PTP scores.  The 95% confidence interval is (1.050, 1.593), which does 







2. Valeri’s mediation macro 
 
Macro Inputs: 
 data: name of your dataset 
 yvar: name of your outcome variable 
 avar: name of your exposure variable 
 mvar: name of your mediator variable 
 cvar: name of your other covariates (must be dummy variables, leave blank if none) 
 a0: baseline level of exposure 
 a1: new exposure level 
 m: level of the mediator at which the controlled direct effect is to be estimated 
 nc: number of covariates used (leave blank if none) 
 yreg: type of regression to be used to model outcome variable (linear, logistic) 
 mreg: type of regression to be used to model mediator variable (linear, logistic) 
 interaction: specify if exposure-mediator interaction is present (true, false) 
 output: reduced (leave blank) or full output (=full)* 
 c: level of covariates to calculate conditional effects (default is mean level if left blank) 
 casecontrol: use if using case-control data (leave blank, true) 
boot: bootstrapping option (true [runs 1,000 samples] or number of samples,) or delta 
method (leave blank) 
 
*Reduced output=controlled direct effect, natural direct effect, natural indirect effect, total effect 
Full output = also displays “pure” effects, effects conditional on covariates and the effects 
evaluated at the mean level of covariates 
 
Did not add confounders/covariates as it was not in proposal. 
 
LGBTQ+ equality  
 
**For LGBTQ equality**; 






Obs Effect Estimate p_value _95__CI_lower _95__CI_upper 
1 cde 1.78394 0.00000 1.45088 2.19346 
2 nde 1.78394 0.00000 1.45088 2.19346 
3 nie 0.99914 0.86463 0.98930 1.00907 





There is a significant direct effect of a state’s LGBT equality on odds of taking PrEP (OR=1.8, 95% 
CI: 1.45 - 2.19). However, there is not a significant indirect effect of a state’s equality on odds of 
PrEP use through the PTP score (OR=1.00, 95% CI: 0.99-1.01). Lastly, the controlled direct effects 
were equivalent to the natural direct effects, signifying lack of mediation. 
 
Now running with bootstrapping using 100 samples. 
 







m=logistic y=logistic bootstrap=100 
 
Obs Effect Estimate s_e_ _95__CI_lower _95__CI_upper 
1 cde 1.79489 0.20255 1.46425 2.20128 
2 nde 1.79489 0.20255 1.46425 2.20128 
3 nie 1.00066 0.00514 0.99053 1.01166 
4 marginal total effect 1.79621 0.20415 1.46863 2.22000 
 





3. ICC of the mediator and the outcome 
 
ICC of the mediator 
 
proc mixed data=aim3_data cl covtest noclprint; 
class zip_state; 




Covariance Parameter Estimates 
Cov Parm Subject Estimate Standard 
Error 
Z Value Pr > Z Alpha Lower Upper 
Intercept ZIP_STATE 0.04789 0.03397 1.41 0.0793 0.05 0.01715 0.3995 
Residual   10.2766 0.2780 36.97 <.0001 0.05 9.7528 10.8440 
 
ICC of the outcome 
 
*ICC of the outcome; 
proc mixed data=aim3_data cl covtest noclprint; 
class zip_state; 




Covariance Parameter Estimates 
Cov Parm Subject Estimate Standard 
Error 
Z Value Pr > Z Alpha Lower Upper 
Intercept ZIP_STATE 0.001668 0.000854 1.95 0.0253 0.05 0.000750 0.006375 














1. Baron and Kenny methodology 
 
 
Race / Ethnicity 
 
1. Relationship of identity variables and PrEP use: 
 
*RACIAL/ETHNICTY IDENTITY; 
proc sort data=aim3_data; 
by descending race_reg descending prep_user; 
run; 
proc freq data=aim3_data order=data; 
 table race_reg*prep_user / relrisk chisq; 
run; 
The FREQ Procedure  
Table of race_reg by prep_user 
race_reg prep_user(dichotmous variable for PrEP use) 
Yes No Total 









































Odds Ratio and Relative Risks 
Statistic Value 95% Confidence Limits 




Odds Ratio and Relative Risks 
Statistic Value 95% Confidence Limits 
Relative Risk (Column 1) 1.0685 0.8939 1.2773 
Relative Risk (Column 2) 0.9875 0.9543 1.0219 
 
Those who identify as non-white, have odds of taking PrEP that are 1.08 times greater than those 
who identify as white. The 95% CI is (0.8748, 1.3384) which includes the null value and therefore 
is not statistically signicant at the 0.5 level.  
2. Use stratified analysis methods to determine whether having a high PTP score may be a potential 
mediator of the relationship between state equality variables and PrEP use.  
a. Are PTP scores associated with race (mediator to exposure)? 
 
*RACE IDENTITY; 
proc sort data=aim3_data; 
by descending race_reg descending pcp_score_binary; 
run; 
proc freq data=aim3_data order=data; 




Table of race_reg by pcp_score_binary 
race_reg pcp_score_binary 
High PTP Score Low PTP score Total 



















Odds Ratio and Relative Risks 
Statistic Value 95% Confidence Limits 




Odds Ratio and Relative Risks 
Statistic Value 95% Confidence Limits 
Relative Risk (Column 1) 1.0066 0.9106 1.1128 
Relative Risk (Column 2) 0.9960 0.9373 1.0585 
 
 
Participants who identity as non-white have odds of having high PTP scores that is 1.01 times 
greater than that of white participants. The 95% Confidence Interval (0.860, 1.187) includes the 
null value of one, therefore this increased odds is not statistically significant.  
 
b. Are PTP scores associated with taking PrEP (mediator to outcome)? 
 
proc sort data=aim3_data; 
by descending pcp_score_binary descending prep_user; 
run; 
 
proc freq data=aim3_data order=data; 
table pcp_score_binary*prep_user/relrisk chisq nopercent norow nocol; 
run; 
 
Table of pcp_score_binary by prep_user 
pcp_score_binary prep_user(dichotmous variable for PrEP use) 
Yes No Total 



















Odds Ratio and Relative Risks 
Statistic Value 95% Confidence Limits 
Odds Ratio 1.2935 1.0506 1.5927 
Relative Risk (Column 1) 1.2408 1.0429 1.4763 
Relative Risk (Column 2) 0.9593 0.9267 0.9929 
 




Those who have higher PTP scores have odds of taking PrEP that is 1.3 greater times than that of 
those with low PTP scores.  The 95% confidence interval is (1.051, 1.593), which does not include 






2. Valeri Macro’s 
 
Macro Inputs: 
 data: name of your dataset 
 yvar: name of your outcome variable 
 avar: name of your exposure variable 
 mvar: name of your mediator variable 
 cvar: name of your other covariates (must be dummy variables, leave blank if none) 
 a0: baseline level of exposure 
 a1: new exposure level 
 m: level of the mediator at which the controlled direct effect is to be estimated 
 nc: number of covariates used (leave blank if none) 
 yreg: type of regression to be used to model outcome variable (linear, logistic) 
 mreg: type of regression to be used to model mediator variable (linear, logistic) 
 interaction: specify if exposure-mediator interaction is present (true, false) 
 output: reduced (leave blank) or full output (=full)* 
 c: level of covariates to calculate conditional effects (default is mean level if left blank) 
 casecontrol: use if using case-control data (leave blank, true) 
boot: bootstrapping option (true [runs 1,000 samples] or number of samples,) or delta 
method (leave blank) 
 
*Reduced output=controlled direct effect, natural direct effect, natural indirect effect, total effect 
Full output = also displays “pure” effects, effects conditional on covariates and the effects 
evaluated at the mean level of covariates 
  
Did not add confounders/covariates as it was not in proposal 
 
Obs Effect Estimate p_value _95__CI_lower _95__CI_upper 
1 cde 1.08152 0.47047 0.87419 1.33803 
2 nde 1.08152 0.47047 0.87419 1.33803 
3 nie 1.00065 0.89785 0.99072 1.01068 
4 marginal total effect 1.08223 0.46726 0.87456 1.33921 
 
There is a not a significant effect of a person’s race on odds of taking PrEP (OR=1.1, 95% CI: 
0.874, 1.34), nor is there a significant indirect effect of a person’s race on the odds of using PrEP 
through PTP score PrEP (OR=1.0, 95% CI: 0.991, 1.01). Lastly, the controlled direct effects were 





m=logistic y=logistic bootstrap=100 
 
Obs Effect Estimate s_e_ _95__CI_lower _95__CI_upper 
1 cde 1.08381 0.10816 0.87598 1.30464 
2 nde 1.08381 0.10816 0.87598 1.30464 
3 nie 1.00140 0.00581 0.98937 1.01511 
4 marginal total effect 1.08527 0.10789 0.87486 1.31205 
 










proc sort data=aim3_data; 
by descending sexident_reg1 descending prep_user; 
run; 
proc freq data=aim3_data order=data; 
 table sexident_reg1*prep_user / relrisk chisq; 
run; 
 
Table of sexident_reg1 by prep_user 
sexident_reg1(identity collapsed 
into dichotomous variable) 
prep_user(dichotmous variable for PrEP use) 
Yes No Total 








































Odds Ratio and Relative Risks 
Statistic Value 95% Confidence Limits 
Odds Ratio 0.4476 0.3290 0.6090 
Relative Risk (Column 1) 0.4960 0.3758 0.6546 





Those who do not identify as gay have odds of taking PrEP that are 0.45 times lower than those 
who identify as gay. The 95% CI is (0.3290, 0.6090) does not include the null value, and therefore 
is statistically significant at the 0.5 level.  
2. Use stratified analysis methods to determine whether having a high PTP score may be a potential 
mediator of the relationship between state equality variables and PrEP use.  
a. Are PTP scores associated with sexual identity (mediator to exposure)? 
 
*SEXUAL IDENTITY; 
proc sort data=aim3_data; 
by descending sexident_reg1 descending pcp_score_binary; 
run; 
proc freq data=aim3_data order=data; 
 table sexident_reg1*pcp_score_binary/relrisk chisq nopercent norow nocol; 
run; 
 
Table of sexident_reg1 by pcp_score_binary 
sexident_reg1(identity 
collapsed into dichotomous 
variable) 
pcp_score_binary 
High PTP Score  Low PTP Score Total 



















Odds Ratio and Relative Risks 
Statistic Value 95% Confidence Limits 
Odds Ratio 0.7212 0.5936 0.8761 
Relative Risk (Column 1) 0.8098 0.7111 0.9222 
Relative Risk (Column 2) 1.1229 1.0523 1.1983 
 
 




Participants who do not identity as gay have odds of having high PTP scores that are 0.72 times 
lower than that of participants who identify as gay. The 95% Confidence Interval (0.711, 0.922) 
does not include the null value, therefore this increased odds is statistically significant.  
 
b. Are PTP scores associated with taking PrEP (mediator to outcome)? 
 
proc sort data=aim3_data; 
by descending pcp_score_binary descending prep_user; 
run; 
 
proc freq data=aim3_data order=data; 
table pcp_score_binary*prep_user/relrisk chisq nopercent norow nocol; 
run; 
 
Table of pcp_score_binary by prep_user 
pcp_score_binary prep_user(dichotmous variable for PrEP use) 
Yes No Total 



















Odds Ratio and Relative Risks 
Statistic Value 95% Confidence Limits 
Odds Ratio 1.2935 1.0506 1.5927 
Relative Risk (Column 1) 1.2408 1.0429 1.4763 
Relative Risk (Column 2) 0.9593 0.9267 0.9929 
 
Those who have higher PTP scores have an odds of taking PrEP that is 1.3 greater times than that 
of those with low PTP scores.  The 95% confidence interval is (1.051, 1.593), which does not 








 data: name of your dataset 
 yvar: name of your outcome variable 
 avar: name of your exposure variable 
 mvar: name of your mediator variable 
 cvar: name of your other covariates (must be dummy variables, leave blank if none) 
 a0: baseline level of exposure 
 a1: new exposure level 
 m: level of the mediator at which the controlled direct effect is to be estimated 
 nc: number of covariates used (leave blank if none) 
 yreg: type of regression to be used to model outcome variable (linear, logistic) 
 mreg: type of regression to be used to model mediator variable (linear, logistic) 
 interaction: specify if exposure-mediator interaction is present (true, false) 
 output: reduced (leave blank) or full output (=full)* 
 c: level of covariates to calculate conditional effects (default is mean level if left blank) 
 casecontrol: use if using case-control data (leave blank, true) 
boot: bootstrapping option (true [runs 1,000 samples] or number of samples,) or delta 
method (leave blank) 
 
*Reduced output=controlled direct effect, natural direct effect, natural indirect effect, total effect 
Full output = also displays “pure” effects, effects conditional on covariates and the effects 
evaluated at the mean level of covariates 
  
Did not add confounders/covariates as it was not in proposal 
 
 
m=logistic y=logistic delta 
 
Obs Effect Estimate p_value _95__CI_lower _95__CI_upper 
1 cde 0.45490 0.000001 0.33421 0.61916 
2 nde 0.45490 0.000001 0.33421 0.61916 
3 nie 0.98199 0.078922 0.96228 1.00210 
4 marginal total effect 0.44670 0.000000 0.32823 0.60793 
 
There is a significant direct effect of a person’s sexual identity on odds of taking PrEP (OR=0.45, 
95% CI: 0.334, 0.629), however, there is not a significant indirect effect of a person’s sexual 




the controlled direct effects were equivalent to the natural direct effects, signifying lack of 
mediation. 
 
m=logistic y=logistic bootstrap=100 
 
Obs Effect Estimate s_e_ _95__CI_lower _95__CI_upper 
1 cde 0.45512 0.075597 0.33334 0.61876 
2 nde 0.45512 0.075597 0.33334 0.61876 
3 nie 0.98063 0.011964 0.95226 0.99765 
4 marginal total effect 0.44629 0.074244 0.32578 0.60999 
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